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Abstract 
Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic 
septicemic disease. V. anguillarum infects more than 50 fresh and salt-water fish 
species including various species of economic importance to the larviculture and 
aquaculture industry. In vibriosis, V. anguillarum invades its host fish through the 
intestine and skin. Infected fish usually die with systemic infection of V. anguillarum. 
Bacterial hemolysins are exotoxins that cause lysis of erythrocytes in the host and thus 
the release of the intracellular heme, and are therefore identified as important 
virulence factors. Moreover, hemolysins are known to also cause lysis in other cell 
types, including mast cells, neutrophils and polymorphonuclear cells. Two hemolysin 
gene clusters, vah1-plp and rtxACHBDE, have been previously identified and described. 
The activities of the protein encoded by the plp gene were not known.  
In the first manuscript, we describe the biochemical activities of the 
plp-encoded protein and its role in pathogenesis. The plp gene, one of the components 
in vah1 cluster, encodes a 416-amino-acid protein (Plp), which has homology to 
lipolytic enzymes containing the catalytic site amino acid signature SGNH. Hemolytic 
activity of the plp mutant increased 2-3-fold on sheep blood agar indicating that plp 
represses vah1; however, hemolytic activity of the plp mutant decreased by 2-3-fold on 
fish blood agar suggesting that Plp has different effects against erythrocytes from 
different species. His6-tagged recombinant Plp protein (rPlp) was over-expressed in E. 
coli. Purified and re-folded active rPlp exhibited phospholipase A2 activity against 
phosphatidylcholine and no activity against phosphatidylserine, 
phosphatidylethanolamine, or sphingomyelin. Characterization of rPlp revealed broad 
optimal activities at pH 5–9 and at temperatures of 30-64°C. Divalent cations and metal 
chelators did not affect activity of rPlp. We also demonstrated that Plp was secreted 
using thin layer chromatography and immunoblot analysis. Additionally, rPlp had 
strong hemolytic activity towards rainbow trout erythrocytes, but not to sheep 
erythrocytes suggesting that rPlp is optimized for lysis of phosphatidylcholine-rich fish 
erythrocytes. Further, only the loss of the plp gene had a significant effect on hemolytic 
activity of culture supernatant on fish erythrocytes, while the loss of rtxA and/or vah1 
had little effect. However, V. anguillarum strains with mutations in plp or in plp and 
vah1 exhibited no significant reduction in virulence compared to the wild type strain 
when used to infect rainbow trout. 
In the next manuscript, we used degenerate PCR to identify a positive 
hemolysin regulatory gene, hlyU, from the unsequenced V. anguillarum genome.  
The hlyU gene of V. anguillarum encodes a 92-amino acid protein and is highly 
homologous to other bacterial HlyU proteins.  An hlyU mutant was constructed, 
which exhibited ~5-fold decrease in hemolytic activity on sheep blood agar with no 
statistically significant decrease in cytotoxicity of the wild type strain. 
Complementation of the hlyU mutation restored both hemolytic and cytotoxic activity.  
Both semi-quantitative RT-PCR and real time RT-qPCR were used to examine 
expression of the hemolysin genes under exponential and stationary phase conditions 
in wild type, hlyU mutant, and hlyU complemented strains.  Compared to the wild 
type strain, expression of rtx genes deceased in the hlyU mutant while expression of 
vah1 and plp was not affected in the hlyU mutant.  Complementation of the hlyU 
mutation restored expression of the rtx genes and increased vah1 and plp expression to 
levels higher than in the wild type. The transcriptional start sites in the intergenic 
regions of both vah1/plp and rtxH/rtxB genes were determined using 5’-RACE and the 
binding sites for purified HlyU was discovered using DNA gel mobility shift 
experiments and DNase protection assays.  
In the third manuscript, we identified the hns gene, which encodes the H-NS 
protein, and acts as a negative regulator of both gene clusters.  The V. anguillarum 
H-NS protein shares strong homology with other bacterial H-NS proteins.  An hns 
mutant exhibited increased hemolytic activity and cytotoxicity compared to the wild 
type strain.  Complementation of the hns mutation restored hemolytic activity and 
cytotoxicity levels to near wild type levels.  Further, expression of rtxA, rtxH, rtxB, 
vah1 and plp increased in the hns mutant, and decreased in the complemented hns 
mutant strain when compared to the wild type strain.  Additionally, experiments 
using DNase I, showed that purified recombinant H-NS protected multiple sites in the 
promoter region of both gene clusters.  The hns mutant also exhibited significantly 
attenuated virulence against rainbow trout.  Complementation of the hns mutation 
restored virulence to wild type levels, suggesting that H-NS regulates many genes that 
affect fitness and virulence.  Previously, we showed that HlyU is a positive regulator 
of expression for both gene clusters. In this study, we demonstrate that up-regulation 
by hlyU is hns-dependent, suggesting that H-NS acts to repress or silence both gene 
clusters, and HlyU acts to relieve that repression or silencing.  
In the last manuscript, we aimed to create avirulent and immunogenic V. 
anguillarum strains that can be used as a live vaccine for fish, without knocking out 
any of the hemolysin genes. For this purpose, six genes (mdh, icd, sucA, sucC, sdhC, 
and fumA) encoding enzymes in tricarboxylic acid (TCA) cycle and one gene (cra) 
encoding a fructose metabolism repressor were identified and mutated in wild type V. 
anguillarum M93Sm (serotype O2a). Among all mutants, icd mutant showed high 
attenuation of virulence and lowest cell density limit in two forms of rich media. All 
mutants exhibited the same or higher levels of hemolysin gene expression compared to 
wild type during log phase. Further, fish that were pre-treated by immersion with icd 
mutant protected rainbow trout from the subsequent challenge of V. anguillarum 
M93Sm; and fish that were pre-treated with injection of the icd mutant elicited 
cross-serotype immunity against the subsequent challenge of V. anguillarum NB10 
(serotype O1). The results suggest the TCA cycle mutation approach is likely to be an 
easy method to construct modified live vaccine for a wide variety of pathogenic 
bacteria.
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PREFACE 
This dissertation has been prepared in the Manuscript Format according to 
the guidelines of the Graduate School of the University of Rhode Island. The first 
manuscript: “Characterization of Plp, a phosphatidylcholine-specific phospholipase 
and hemolysin of Vibrio anguillarum” was submitted to BMC Microbiology on 
August, 12th, 2013 and is in review. The second manuscript: “HlyU is a positive 
regulator of hemolysin expression in Vibrio anguillarum” was published in Journal of 
Bacteriology in 2011. The third manuscript: “H-NS is a Negative Regulator of the 
Two Hemolysin/Cytotoxin Gene Clusters in Vibrio anguillarum” was published in 
Infection and Immunity in 2013, and the fourth manuscript: “A Vibrio anguillarum 
isocitrate dehydrogenase mutant is highly attenuated and immunogenic in rainbow 
trout (Oncorhynchus mykiss).” has been written in the same form as the third 
manuscript and will be submitted for publication. 
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Abstract 
Background 
Vibrio anguillarum is the causative agent of vibriosis in fish. Several extracellular 
proteins secreted by V. anguillarum have been shown to contribute to virulence. While 
two hemolysin gene clusters, vah1-plp and rtxACHBDE, have been previously 
identified and described, the activities of the protein encoded by the plp gene were not 
known.  Here we describe the biochemical activities of the plp-encoded protein and its 
role in pathogenesis. 
Results 
The plp gene, one of the components in vah1 cluster, encodes a 416-amino-acid protein 
(Plp), which has homology to lipolytic enzymes containing the catalytic site amino acid 
signature SGNH. Hemolytic activity of the plp mutant increased 2-3-fold on sheep 
blood agar indicating that plp represses vah1; however, hemolytic activity of the plp 
mutant decreased by 2-3-fold on fish blood agar suggesting that Plp has different effects 
against erythrocytes from different species. His6-tagged recombinant Plp protein (rPlp) 
was over-expressed in E. coli. Purified and re-folded active rPlp exhibited 
phospholipase A2 activity against phosphatidylcholine and no activity against 
phosphatidylserine, phosphatidylethanolamine, or sphingomyelin. Characterization of 
rPlp revealed broad optimal activities at pH 5–9 and at temperatures of 30-64°C. 
Divalent cations and metal chelators did not affect activity of rPlp. We also 
demonstrated that Plp was secreted using thin layer chromatography and immunoblot 
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analysis. Additionally, rPlp had strong hemolytic activity towards rainbow trout 
erythrocytes, but not to sheep erythrocytes suggesting that rPlp is optimized for lysis of 
phosphatidylcholine-rich fish erythrocytes. Further, only the loss of the plp gene had a 
significant effect on hemolytic activity of culture supernatant on fish erythrocytes, 
while the loss of rtxA and/or vah1 had little effect. However, V. anguillarum strains with 
mutations in plp or in plp and vah1 exhibited no significant reduction in virulence 
compared to the wild type strain when used to infect rainbow trout. 
Conclusion 
The plp gene of V. anguillarum encoding a phospholipase with A2 activity is specific 
for phosphatidylcholine and, therefore, able to lyse fish erythrocytes, but not sheep 
erythrocytes.  Mutation of plp does not affect the virulence of V. anguillarum in 
rainbow trout. 
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Background 
Vibrio anguillarum, a highly motile marine member of the γ-Proteobacteria , is one of 
the causative agents of vibriosis, a fatal hemorrhagic septicemic disease of both wild 
and cultured fish, crustaceans, and bivalves [1].  Fish infected with V. anguillarum 
display skin discoloration and erythema around the mouth, fins, and vent.  Necrotic 
lesions are also observed in the abdominal muscle [2].  Mortality rates in infected fish 
populations range as high as 30-100% [1, 3].  Vibriosis has caused severe economic 
losses to aquaculture worldwide [1, 3] and affects many farm-raised fish including 
Pacific salmon, Atlantic salmon, sea bass, cod, and eel [3, 4].  V. anguillarum enters its 
fish host through the gastrointestinal tract (GI) and quickly colonizes this nutrient rich 
environment [2, 5].  Garcia et al. [6] have shown that V. anguillarum grows extremely 
well in salmon intestinal mucus and that mucus-grown cells specifically express a 
number of different proteins, including several outer membrane proteins [6] and the 
extracellular metalloprotease EmpA [2, 5]. 
 
Several genes have been reported to be correlated with virulence by V. anguillarum, 
including the vah1 hemolysin cluster [7, 8], the rtx hemolysin cluster [9], the 
siderophore mediated iron transport system [10], the empA metalloprotease [2, 5], and 
the flaA gene [11].  Hemolytic activity of V. anguillarum has been considered to be the 
virulence factor responsible for hemorrhagic septicemia during infection [10].  We 
have identified two hemolysin gene clusters in V. anguillarum that contribute to the 
virulence of this pathogen [8, 9].  One gene cluster, rtxACHBDE, encodes a MARTX 
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toxin and its type I secretion system [9].  The second hemolysin gene cluster in V. 
anguillarum strain M93Sm contains the hemolysin gene vah1 linked to two putative 
lipase-related genes (llpA and llpB) and a divergently transcribed hemolysin-like gene 
(plp) that appears to function as a repressor of hemolytic activity [8].  The plp-encoded 
protein has very high sequence similarity to phospholipases found in other pathogenic 
Vibrio species [8].  However, the enzymatic characteristics of Plp in V. anguillarum 
were not described. 
 
Generally, phospholipases are divided into several subgroups depending on their 
specificity for hydrolysis of ester bonds at different locations in the phospholipid 
molecule.  Phospholipases A (PLAs) cleave long chain fatty acids at sn-1 (PLA1) or 
sn-2 (PLA2) position from phospholipid to yield lysophospholipid and free fatty acid; 
phospholipases C (PLCs) cleave phospholipid into diacylglycerol and a 
phosphate-containing head group; and phospholipases D (PLDs) cleave phospholipid 
into phosphatidic acid and an alcohol.  It is known that some phospholipid products 
are used as secondary messages, which play a central role in signal transduction [12]. 
 
In this study, we determined that plp encodes a phospholipase A2 in V. anguillarum, 
and then purified recombinant Plp protein (rPlp) from E. coli to investigate 
biochemical characteristics. We also described the contribution and specificity of rPlp 
for hydrolysis of phospholipids, and its ability to lyse fish erythrocytes. 
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Results 
Identification of a putative phospholipase gene plp. Previously, a putative 
phospholipase gene, plp, was identified in the vah1 hemolysin cluster of V. 
anguillarum strain M93Sm [8]. The 1251-bp plp gene (Genbank accession EU650390) 
was predicted to encode a protein of 416 amino acids. A BLASTx [13] search revealed 
that the deduced Plp amino acid sequence exhibited homology with many lipolytic 
enzymes including the phospholipase/lecithinase/hemolysin of Vibrio vulnificus 
(identity, 69%; similarity, 82%); the lecithin-dependent hemolysin (LDH)/ 
thermolabile hemolysin (TLH) of Vibrio parahaemolyticus (identity, 64%; similarity, 
80%); the lipolytic enzyme/hemolysin VHH of Vibrio harveyi (identity, 63%; 
similarity, 78%); and the thermolabile hemolysin of Vibrio cholerae (identity, 62%; 
similarity, 78%);  The phylogenetic tree created by the Clustal-W program from 17 
Plp homologous proteins revealed that while the most closely related Plp proteins 
were all from pathogenic members of the genus Vibrio, the Plp of V. anguillarum was 
an outlier among the Vibrio species (Fig. 1).   According to Flieger’s classification 
[14, 15], the alignment of Plp with other homologous proteins indicated that Plp could 
be classified into subgroup B of this lipolytic family with its long N-terminal tail prior 
to the block I [14].  Additionally, close examination of the amino acid sequences of 
these enzymes revealed that the typical GDSL motif for lypolytic enzymes is not 
totally conserved in all of these 17 proteins, in which leucines (L) are replaced with 
isoleucines (I) in Photobacterium, Marinomonas, and Shewanella (Fig. 1).  In this 
case, V. anguillarum Plp should be considered as a member of the SGNH hydrolase 
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family, based on the Molgaard's suggestion that only four amino acids (S, G, N, and 
H) are completely conserved among the GDSL proteins [16].  
 
Plp affects hemolysis of fish erythrocytes. The hemolysin gene vah1 is divergently 
transcribed from plp [17]. Mutation of plp increased hemolytic activity by 2-3-fold on 
Trypticase soy agar plus 5% sheep blood (TSA-sheep blood) plate compared with wild 
type strain (M93Sm) (Fig. 2A) [8].  Rock and Nelson [8] also demonstrated that the 
plp mutant had increased vah1 transcription (by 2-4-fold), indicating that Plp is a 
putative repressor of vah1. Previously, we demonstrated that a double mutant in vah1 
and rtxA resulted in a hemolysis negative mutant when plated on TSA-sheep blood 
agar [9]. Similar results were observed when using Luria-Bertani broth plus 2% NaCl 
plus 5% sheep blood (LB20-sheep blood) agar (data not shown). However, on LB20 
plus 5% rainbow trout blood (LB20-rainbow trout blood) agar, the plp mutant 
exhibited a smaller zone of hemolysis compared to wild type strain M93Sm (Fig. 2B); 
complementation of plp restored the hemolytic activity of the mutant strain (Fig. 2B). 
Similar results were observed when using LB20 plus 5% Atlantic salmon blood agar 
(data not shown), suggesting that the ability of Plp to lyse erythrocytes is dependent 
upon the source of erythrocytes and, therefore, their lipid composition. 
 
Plp has phospholipase A2 activity. Thin layer chromatography (TLC) was used to 
examine the pattern of phospholipid cleavage by Plp.  BODIPY-labeled 
phosphatidylcholine (BPC) was incubated with various enzyme standards, including 
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phospholipase A2 (PLA2), phospholipase C (PLC), or phospholipase D (PLD).  TLC 
analysis revealed distinct cleavage patterns (Fig. 3A) by these standard enzymes 
indicating that BPC was an appropriate substrate to examine Plp activity.  Cell lysate 
prepared from E. coli strain S299, which contains the shuttle plasmid pSUP202-plp 
that was able to complement the plp mutation in V. anguillarum [8], cleaved BPC to 
yield BODIPY-lysophosphatidylcholine (BLPC) (Fig. 3B Lane 5) plus unlabeled free 
fatty acid (FFA) that is not detected. The cleavage products were identical to those 
generated by PLA2 (Fig. 3A) and demonstrate that Plp has phospholipase A2 activity.  
Additionally, the culture supernatant from S299 had only ~5% of the activity of that in 
cell lysate, indicating that Plp accumulated in the cell lysate instead of being secreted 
by the E. coli strain.  No phospholipase activity was detected in PBS buffer or in E. 
coli DH5α containing only the pSUP202 vector (Fig. 3B).  Further, phospholipase 
A2 activity was examined in various subcellular fractions prepared from E. coli strain 
S299, including cytoplasmic, cytoplasmic membrane, and outer membrane fractions.  
Most Plp activity was detected in Tween-20 soluble membrane fraction, indicating 
that Plp was mainly localized in the cytoplasmic membrane of E. coli S299 (data not 
shown).   No BODIPY-labeled free fatty acid (FFA) (at sn-1 position) was detected 
in the TLC analysis when an apolar solvent was used (data not shown), and 
BODIPY-labeled LPC was not further degraded by Plp in the reaction, indicating that 
Plp had no lysophospholipase or phospholipase B activity. 
 
Enzymatic characteristics of rPlp protein. To examine the enzymatic characteristics 
of Plp, the entire coding sequence of plp was cloned and inserted into the expression 
9 
vector pQE60, which adds a His6 (His-6×) tag to the carboxyl end of Plp.  The 
over-expressed recombinant Plp (rPlp) formed inclusion bodies in E. coli. To recover 
active rPlp, purification of the inclusion bodies followed by solubilization under mild 
conditions and re-folding was performed (16) as described in the Materials and 
Methods. Purity of refolded rPlp protein was confirmed by SDS-PAGE and silver 
staining (data not shown).  The final concentration of purified rPlp protein was 8 
µg/ml with a recovery of <10%. 
 
Subsequently, the enzymatic characteristics of refolded rPlp were examined under 
various chemical and physical conditions.  The enzymatic activity of rPlp was 
positively correlated to its concentration from 1 µg/ml to 8 µg/ml (Fig. 4A); therefore, 
4 µg/ml rPlp protein was routinely used in other activity assays. The enzymatic 
activity unit of refolded rPlp (1 unit = amount of protein that cleaves 1 µmole of 
BODIPY-PC per minute) was about 2,500-fold higher than standard PLA2 enzyme 
extracted from porcine pancreas (Sigma# P8910), which indicated that Plp had a high 
activity against the BPC phospholipid substrate.  Plp enzyme activity exhibited a 
broad temperature optimum from 37ºC to 64ºC (Fig. 4B) with 75% activity retained at 
27ºC and 50% activity at 20ºC.  While rPlp activity rapidly decreased at temperatures 
above 70ºC, the enzyme retained full activity at 64°C for at least 1 h. The data 
demonstrate that rPlp is a relatively themostable phospholipase. 
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The effect of pH on enzyme activity was determined for pH values ranging from 2 to 
12.  The data showed that rPlp had a broad pH optimum from pH 5.3 to pH 8.7 with 
activity dropping off rapidly at pH values above and below the optimum (Fig. 4C).  
rPlp activity was not affected by treatment with the chelating reagents EGTA (Fig. 
4D) or EDTA (data not shown) at concentrations up to 100 mM. Additionally, 
treatment with divalent metal ions, such as calcium or magnesium had no effect on 
activity (data not shown). 
 
Plp is a secreted protein in V. anguillarum.  Subcellular fractions from V. 
anguillarum strains M93Sm and S262 (plp) were prepared and phospholipase A2 
activity examined using BPC and TLC.  Initial studies revealed that at 37ºC 
phospholipase A2 activity was detected in all cell fractions, including the culture 
supernatant, periplasm, cytoplasm, cytoplasmic membrane, and outer membrane, from 
both M93Sm and S262 (Fig. 5A).  However, when the assay was performed at 64ºC 
(to inactivate heat labile phospholipases), phospholipase A2 activity in S262 was 
significantly decreased in all fractions including the supernatant (Fig. 5B). 
Additionally, when the assay was performed at 64°C for M93Sm subcellular fractions, 
only the culture supernatant exhibited phospholipase activity against BPC (about 
100-fold higher activity compared to the phospholipase activity of the S262 
supernatant).  The data demonstrated that Plp was secreted into the culture 
supernatant of V. anguillarum.  TLC results also revealed that there was at least one 
other protein in V. anguillarum M93Sm exhibiting phospholipase A2 activity besides 
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the secreted, heat stable Plp protein.  This was a themolabile PLA2 activity 
inactivated at 64ºC. 
 
In order to confirm that Plp was localized in the supernatant of V. anguillarum, protein 
samples prepared from various subcellular fractions were separated by SDS-PAGE 
and analyzed by western blot analysis using polyclonal rabbit anti-Plp antiserum.  An 
immuno-reactive band of ~45 kDa was detected only in the supernatant of M93Sm, 
but was absent in the supernatant of plp mutant (Fig. 5C).  Taken together with the 
phospholipase A2 activity data, these data indicate that Plp is a secreted protein in V. 
anguillarum.  
 
rPlp has a specific activity against phosphatidylcholine.  Various 
fluorescently-labeled phospholipid substrates (described in Materials and Methods) 
were used to determine the specificity of the rPlp protein.  rPlp exhibited high 
activity against phosphatidylcholine, cleaving BPC to yield BLPC and free fatty acid 
(Fig. 3 and 6A).  However, rPlp had almost no activity against both 
NBD-phosphatidylethanolamine (NBD-PE) (Fig. 6B) and NBD-phosphatidylserine 
(NBD-PS) (Fig. 6C), showing only 2% and 5%, respectively, of the activity of the 
standard PLA2 protein against each of the substrates.  The data indicated that the rPlp 
protein does not efficiently cleave either phosphatidylethanolamine or 
phosphatidylserine.  Additionally, unlike the standard sphingomyelinase (Sigma), 
rPlp was not able to cleave the NBD-sphingomyelin into the NBD-ceramide and 
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phosphocholine (Fig. 6D), indicating that rPlp had no sphingomyelinase activity.  
Taken together, the data demonstrated that Plp is a phosphatidylcholine-specific PLA2 
enzyme. 
 
rPlp is able to lyse the fish erythrocytes directly. Membrane phospholipid 
compositions are quite varied among the animal species, especially for 
phosphatidylcholine.  It is known that phosphatidylcholine makes up 58% of the total 
phospholipid in fish erythrocytes [18]; however, no phosphatidylcholine is found in 
sheep erythrocytes [19].  In order to determine whether the differential hemolysis 
observed for plp mutants of V. anguillarum (Fig. 2) is due to the activity of Plp against 
PC, we tested the ability of purified rPlp to lyse Atlantic salmon erythrocytes.  
Addition of recombinant Plp resulted in the lysis of Atlantic salmon erythrocytes, with 
the amount of lysis directly related to the amount of rPlp added to the blood 
suspension (Fig. 7).  In contrast, addition of rPlp to a suspension of sheep 
erythrocytes resulted in no lysis of those cells (Fig. 7).  These data show that Plp has 
phosphatidylcholine-specific phospholipase A2 activity and can directly lyse fish 
erythrocytes. 
 
Plp is one of the hemolysins of V. anguillarum.    Previously, we demonstrated 
that there are two major hemolysin gene clusters in the M93Sm, the vah1 cluster [8] 
and the rtxA cluster [9]. Mutation of both vah1 and rtxA completely eliminated the 
hemolytic activity of M93Sm on TSA-sheep blood agar [9].  While, mutation of the 
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plp gene resulted in 2-3-fold increased hemolytic activity on TSA-sheep blood agar, 
with vah1 expression increased both transcriptionally and translationally in the plp 
mutant, indicating that Plp is a putative repressor of vah1 [9], Plp also has hemolytic 
activity against fish erythrocytes due to its phosphatidylcholine-specific activity (Figs. 
6 and 7).  To investigate the relationship of the three hemolysins, culture supernatants 
obtained from various V. anguillarum strains (Table 1) were used to examine the 
hemolytic activity against the fish blood (Table 2). 
 
In contrast to the strong hemolytic activity against 5% rainbow trout blood mixed with 
culture supernatant from the wild type strain M93Sm, hemolytic activity of culture 
supernatant from strain S262 (plp) declined by >70% (Table 2).  Additionally, all 
mutants containing a knockout of plp exhibited significant declines (P< 0.05) in 
hemolytic activity.  The triple hemolysin mutant, XM90 (plp vah1 rtxA) had no 
ability to lyse fish erythrocytes (Table 2). However, mutations in either vah1 or rtxA, 
but not plp, resulted in little or no decline in hemolytic activity against fish 
erythrocytes compared to supernatants from wild type cells (Table 2).  Further, 
complementation of plp restored the hemolytic activity of supernatants from both the 
plp-complemented strains (XM31, plp+ and XM93, vah1 rtxA plp+) (Table 2).Taken 
together, these data clearly demonstrate that Plp is the major hemolytic enzyme 
responsible for the lysis of fish erythrocytes by culture supernatants of V. anguillarum. 
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Plp is not a major virulence factor for V. anguillarum during fish infection. In 
order to determine whether the plp gene affects virulence in fish, an infection study 
was performed by inoculating rainbow trout by IP injection with either the wild type 
strain M93Sm or mutant strains S262 (plp) or JR03 (vah1plp). The results of this 
experiment (Fig. 8) indicated that there were no statistical differences in mortality 
between the three strains.  This suggested that mutation of either or both plp or vah1 
did not decrease the virulence of M93Sm. These results are consistent with our 
previous observations that rtxA is a major virulence factor of M93sm and that 
mutation of vah1 does not affect virulence [8], and demonstrate that Plp is not a major 
virulence factor in the V. anguillarum M93Sm. 
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Discussion 
In this report, we describe the characteristics of the V. anguillarum phospholipase 
protein (Plp) encoded by plp, and its contribution to the hemolytic activity of V. 
anguillarum.  Specifically, we show that Plp is a secreted phospholipase with A2 
activity with specificity for phosphatidylcholine.  The enzyme has a broad 
temperature optimum (37 – 64°C) and a broad pH optimum (pH5.5 – 8.7).  
Phospholipases are broadly distributed among the Vibrionaceae and often contribute 
to the virulence of the pathogenic members of this family.  For example, the TLH 
(synonym: lecithin-dependent hemolysin, LDH) of V. parahaemolyticus [20-22] was 
the first well-studied lecithin-dependent PLA / lysophospholipase [23].  A lecithinase 
(encoded by lec) was also identified in V. cholerae [24].  Fiore et al[24] found that a 
lec mutant strain was unable to degrade lecithin and the culture supernatant exhibited 
decreased cytotoxicity.  However, the mutant did not exhibit decreased fluid 
accumulation in a rabbit ileal loop assay, suggesting that fluid accumulation in animals 
is not affected by lecithinase activity.  Additionally, the phospholipase A (PhlA) in V. 
mimicus was found to exhibit hemolytic activity against trout and tilapia erythrocytes 
and was cytotoxic to the fish cell line CHSE-214 [25].  Recently, the V. harveyi 
hemolysin (VHH) was shown to be a virulence factor during flounder infection and 
also had phospholipase activity on egg yolk agar [26].  Rock and Nelson [8] reported 
that the putative phospholipase gene (plp) from V. anguillarum exhibits 69% amino 
acid identity with the V. cholerae lec gene. Both plp and lec are located divergently 
adjacent to a hemolysin gene (vah1 and hlyA, respectively) [8, 24].  Additionally, 
data strongly suggested that functional plp repressed transcription of its adjacent 
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hemolysin gene, vah1, in V. anguillarum[8].  However, the enzymatic characteristics 
of Plp in V. anguillarum were not described.  
 
Usually, phospholipases are divided into phospholipases A (A1 and A2), C, and D 
according to the cleavage position on target phospholipids.  Most of lipolytic 
enzymes contain a putative lipid catalytic motif (GDSL) that was previously 
demonstrated in other bacterial and eukaryotic phospholipases [27]. However, 
Molgaard [16] proposed that four amino acid residues (SGNH) form a catalytic site, 
and are conserved in all members of the phospholipase family; therefore, 
phospholipases were re-named as a SGNH family.  Multiple alignment analysis of 17 
phospholipase homologues (Fig. 1) demonstrates that V. anguillarum Plp belongs to 
SGNH hydrolase family, instead of GDSL family, since the GSDL motif was not fully 
conserved in these proteins (Fig. 1).   Recently, it was reported that mutation of the 
serine residue in the SGNH motif resulted in the complete loss of the phospholipase 
and hemolytic activities of VHH in V. harveyi [28] demonstrating the importance of 
this motif on the activity of phospholipase.  
 
In contrast to the similarities of their catalytic motifs, the biochemical characteristics 
of bacterial phospholipases appear to be variable. For example, V. mimicus PhlA has a 
phospholipase A activity, which cleaves the fatty acid at either sn-1or sn-2 position, 
but no lysophospholipase activity [25].  Two phospholipases identified from 
mesophilic Aeromonas sp.serogroup O:34 show phospholipase A1 and C activity [29].  
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In addition, TLH of V. parahaemolyticus has PLA2 and lysophospholipase activity, 
and demonstrates a loss of activity at 55ºC for 10 min [20].  In this report, we show 
that V. anguillarum Plp has PLA2 activity, and is able to maintain activity at 64ºC for 
1 h (Figs. 6 and 7). Therefore, the enzymatic characteristics of specific phospholipases 
are distinct even when they all belong to the SGNH hydrolase family (Fig. 1). 
 
Phospholipases have been implicated in the pathogenic activities of a number of 
bacteria [30, 31]. It is known that phospholipase activities often lead to cell destruction 
by degrading the phospholipids of cell membranes [30, 32]. However, the 
relationships between phospholipases and virulence are not always clear. While the 
purified rPlp exhibits strong hemolytic activity against Atlantic salmon erythrocytes 
(Fig. 7), Rock and Nelson [8] showed that a knock-out mutation of either the plp gene 
or the vah1 gene in V. anguillarum did not affect virulence of V. anguillarum during 
an infection study on juvenile Atlantic salmon. In this report, we show that when 
groups of rainbow trout are infected with either a plp mutant or a plp vah1 double 
mutant there is no significant difference in mortalities compared to fish infected with 
the wild type strain.  Our data suggest that neither plp nor vah1 are major virulence 
factors during pathogenesis of salmonids. It was also reported that the deletion of 
lecithinase (Lec) activity in V. cholerae did not significantly diminish fluid 
accumulation in the rabbit ileal loop assay, indicating the lecithinase activity does not 
contribute significantly to enterotoxin activity [24].  In contrast, the direct IP 
injection of purified V. harveyi VHH protein caused the death of flounder with an 
LD50 of about 18.4 µg protein/fish [26].  The rPhlA of V. mimicus also has a direct 
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cytotoxic effect on the fish cell line CHSE-214 [25] suggesting that this phospholipase 
is a virulence factor during fish infection.  In addition, the lecithinase purified from 
A. hydrophila (serogroup O:34) has been shown to be an important virulence factor to 
rainbow trout and mouse [29].   
 
Generally, the hemolytic activity of phospholipases is dependent upon the hydrolysis 
of the phospholipids that reside in the erythrocyte membrane.  Erythrocytes contain 
various phospholipids including phosphatidylcholine (PC), phosphatidylethanolamine 
(PE), phosphatidylserine (PS), phosphatidylinositol (PI), and sphingomyelin (SM).  
PC makes up 58% of the total erythrocyte phospholipids in the Atlantic salmon [33], 
but only 34% and 1% in rabbit and sheep erythrocytes, respectively [19].  Taken 
together with the high specificity of rPlp for PC (Fig. 6), it was not surprising that rPlp 
was able to lyse the fish erythrocytes, but not sheep erythrocytes (Fig. 7), and that the 
plp mutant had decreased hemolytic activity on LB20-fish blood agar (Fig. 2).  Our 
results are consistent were those reported for V. mimicus PhlA[25] and V. harveyi 
VHH [26], in which PhlA and VVH specifically lyse the fish erythrocytes.  
 
We have previously reported that there are two hemolysin gene clusters in V. 
anguillarum M93Sm, the vah1-plp cluster and rtxACHBDE cluster [9] and have 
described their regulation by H-NS and HlyU [17, 34].  Mutation of both vah1 and 
rtxA results in the loss of all hemolytic activity on TSA-sheep blood agar [9], which is 
consistent with the data reported here that Plp has no activity on sheep erythrocytes.  
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We have also previously demonstrated that Plp is a putative repressor of Vah1, since 
mutation of plp increases vah1 expression by 2-3 fold [8].  In this report, we 
examined the hemolytic activity of various hemolysin mutants using freshly collected 
Rainbow trout blood (Table 2) to investigate the relationships among three hemolysins 
of V. anguillarum.  While culture supernatants from two of the three single mutants 
(JR1 and S123) and one of three double mutants (S183) exhibited ≥94%of the 
hemolytic activity as supernatants from the wild type strain M93Sm (Table 2), the 
hemolytic activity of one single mutant (S262, plp) and two double mutants (JR03, plp 
vah1 and S187, plp rtxA) were reduced to 28%, 14%, and 12% of that in M93Sm, 
respectively.  Our data indicate that only the loss of the plp gene has a significant 
effect on hemolysis of fish erythrocytes by V. anguillarum culture supernatant, while 
the loss of rtxA and/or vah1 has little effect. Further, supernatant from the hemolysin 
triple mutant XM90 (vah1 rtxA plp) exhibits no hemolytic activity on fish blood 
compared to M93Sm (Table 2), indicating that Vah1, RtxA, and Plp are responsible 
for all secreted hemolytic activity by V. anguillarum.  Finally, complementation of 
any plp mutant with plp (in trans) restores hemolytic activity to V. anguillarum culture 
supernatant (Table 2). 
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Conclusion 
V. anguillarum Plp is a secreted hemolysin with phosphatidylcholine-specific 
phospholipase A2 activity. The ability of Plp to digest the abundant 
phosphatidylcholine found in the membrane of fish erythrocytes causes their lysis. The 
three hemolysins, Plp, Vah1 and RtxA, account for all hemolytic activity in V. 
anguillarum culture supernatant under the experiment conditions described in this 
study.  Finally, infection studies in rainbow trout demonstrate that the plp and vah1 
genes are not required for virulence. 
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Methods 
Bacterial strains, plasmids, and growth conditions. All bacterial strains and 
plasmids used in this report are listed in Table 1.  V. anguillarum strains were 
routinely grown in Luria-Bertani broth plus 2% NaCl (LB20) [35], supplemented with 
the appropriate antibiotic, in a shaking water bath at 27°C.  E. coli strains were 
routinely grown in Luria-Bertani broth plus 1% NaCl (LB10).  Antibiotics were used 
at the following concentrations: streptomycin, 200 µg/ml; ampicillin, 100 µg/ml 
(Ap100); chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V. 
anguillarum; kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V. 
anguillarum; tetracycline, 15 µg/ml (Tc15) for E. coli, 1 µg/ml (Tc1) for V. 
anguillarum grown in liquid medium, and 2 µg/ml (Tc2) for V. anguillarum grown on 
agar plates. 
 
Insertional mutagenesis. Insertional mutations were made by using a modification of 
the procedure described by Milton et al.[25]. Briefly, primers (Table3) were designed 
based on the target gene sequence of M93Sm. Then a 200-300 bp DNA fragment of 
the target gene was PCR amplified and ligated into the suicide vector pNQ705-1 
(GenBank accession no. KC795685)after digestion with SacI and XbaI.The ligation 
mixture was introduced into E. coli Sm10 by electroporation using BioRad Gene 
Pulser II (BioRad, Hercules, CA).Transformants were selected on LB10 Cm20 agar 
plates. The construction of the recombinant pNQ705 was confirmed by both PCR 
amplification and restriction analysis. The mobilizable suicide vector was transferred 
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from E. coli Sm10 into V. anguillarum by conjugation. Transconjugants were selected 
by utilizing the chloramphenicol resistance gene located on the suicide plasmid. The 
incorporation of the recombinant pNQ705was confirmed by PCR amplification. 
 
Allelic exchange mutagenesis. The allelic exchange rtxA mutation in V. 
anguillarum S264 was made by using a modification of the procedure described by 
Milton et al.[25].The 5′region of rtxA was amplified using the primer pair pm256 and 
pm257 (Table3), digested with XhoI and XbaI, and then cloned into the region 
between the XhoI and XbaI sites on pDM4 (GenBank accession no. KC795686), 
deriving pDM4-rtxA5’. The 3′ region of rtxA was amplified using the primer pair 
pm258 and pm259 (Table3), digested with XbaI and SacI, and then cloned into the 
region between the XbaI and SacI sites on the pDM4-rtxA5’. The resulting 
pDM4-rtxA5’-rtxA3’ was transformed into E. coli Sm10 to produce the transformant 
strain S252, which was mated with V. anguillarum S171 (vah1). Single-crossover 
transconjugants were selected with LB20 Kan80 Sm200 Cm5 plates and, subsequently, 
double-crossover transconjugants were selected with LB20 Kan80 Sm200 5% sucrose 
plates. The resulting V. anguillarum colonies were transferred to TSA-sheep blood 
agar (Northeast Laboratories Service, Waterville, ME) and screened for non-hemolytic 
colonies (vah1 rtxA). The resulting colonies were checked for the desired allelic 
exchange using PCR amplification. 
 
Complementation of mutants. The various mutants were complemented by cloning 
the appropriate target gene fragment into the shuttle vector pSUP202 (GenBank 
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accession no. AY428809) as described previously by [8]. Briefly, primers (Table 3) 
were designed with EcoRI and AgeI sites and then used to amplify the entire target 
gene plus ~500 bp of the 5’ and ~200 bp 3’flanking regions from genomic DNA of V. 
anguillarum M93Sm. The DNA fragment was then ligated into pSUP202 after 
digestion with EcoRI and AgeI, and the ligation mixture was introduced into E. coli 
Sm10 by electroporation using a BioRad Gene Pulser II. Transformants were selected 
on LB10 Tc15 Ap100 agar plates. The complementing plasmid was transferred from E. 
coli Sm10 into the V. anguillarum mutant by conjugation. Transconjugants were 
selected by tetracycline resistance (Tc2). The transconjugants were then confirmed by 
PCR amplification and restriction digestion. 
 
Bacterial conjugation. Bacterial conjugations were carried out using the procedure 
modified from by Varina et al [36]. Briefly, 100 µl V. anguillarum grown overnight 
was added into 2.5 ml nine salts solution (NSS) [37]; 100 µl E. coli culture overnight 
was added into 2.5 ml 10 mM MgSO4. The resulting V. anguillarum and E. coli 
suspension was mixed, vacuum filtered onto an autoclaved 0.22-µm-pore-diameter 
nylon membrane (Millipore, USA.), placed on an LB15 agar plate (LB-plus-1.5% 
NaCl), and allowed to incubate overnight at 27°C. Following incubation, the cells 
were removed from the filter by vigorous vortex mixing in 1 ml NSS. Cell suspensions 
(70 µl) were spread on LB20 plated with appropriate antibiotics and the plates were 
incubated at 27°C until V. anguillarum colonies were observed (usually 24 to 48 h). 
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Cloning, over-expression, purification, and refolding of the Plp protein. The 
whole length of the plp gene (stop codon not included) was amplified by PCR with a 
sense primer introducing a BamHI site and an antisense primer introducing BglII site, 
respectively. Genomic DNA extracted from V. anguillarum M93Sm was used as 
template. The amplified PCR product was digested with BamHI and BglII, and ligated 
into a pQE60 (QIAGEN, USA) vector, which was also cut with BamHI and BglII.  
The ligation mix was transformed into E. coli M15 (pREP4) and clones with 
pQE60-plp were selected on LB10 agar containing kanamycin and ampicillin. A clone 
harboring plasmid pQE60-plp was selected and the plasmid DNA sequence isolated 
from the clone confirmed by sequencing. The clone was designated as S269.  
Subsequently, E. coli strain S269 was grown at 37°C in 500 ml LB10 broth to OD600 = 
0.5, and isopropyl-β-D-thiogalactopyranoside (IPTG) was added to the culture (final 
concentration, 1 mM) to induce the expression of Plp. Then, the induced E. coli cells 
grown for 4 h at 37 °C were harvested at 8000 × g for 10 min.  The cell pellet was 
stored at -20°C overnight to improve lysis.  Inclusion bodies of Plp were crudely 
purified using Cellytic B reagent (Sigma, USA).  Refolding of Plp protein from the 
inclusion body preparation was carried out using a modification of the method 
described by Santa et al [38].  Briefly, 500 µl of purified inclusion body (2 mg 
protein/ml) was completely solubilized in 1ml of 50 mM Tris buffer (pH 12) 
containing 2 M urea. The solubilized Plp was diluted into 20 ml dilution buffer (50 
mM Tris–HCl, pH8.0; 0.2 M glycine; 10% glycerol; 2 M urea; 0.5 mM EDTA, and 
0.2 mM DTT) at 4 °C.  No aggregation was observed during the dilution.  The 
diluted Plp protein was dialyzed with the addition of 500 ml 50 mM Tris–HCl (pH8.0) 
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until the total dialysis volume up to 3 L.  The dialyzed Plp protein was concentrated 
with QIAGEN Ni-NTA Protein Purification Kit (QIAGEN) under native purification 
condition according to the instructions of the manufacturer.  
 
Hemolytic assays.  The hemolytic activity of V. anguillarum strains was measured 
by two methods.  First, single V. anguillarum colonies were transferred onto 
TSA-sheep blood agar, LB20-sheep blood agar (LB20 agar plus 5% sheep blood with 
heparin, obtained from Hemostat Laboratories) or LB20-fish blood agar (LB20 agar 
plus 5% rainbow trout or Atlantic salmon blood with heparin). Hemolytic activity of 
each colony was determined by measuring hemolytic zone surrounding the colonies 
after 24 h at 27°C.  Additionally, the level of hemolytic activity was also quantitated 
using a microcentrifuge tube assay.  The tubes contained 500 µl 5% erythrocytes 
(fish or sheep, suspended in 10 mM Tris-Cl, pH 7.5 – 0.9% NaCl buffer) were mixed 
with 500 µl of bacterial supernatant or rPlp and incubated for 20 h at 27ºC.  The 
samples were centrifuged at 1500 × g for 2 min at 4Cº, and the optical density of the 
resulting supernatant was read at 428 nm. 
 
Phospholipase assay and thin-layer chromatography (TLC) analysis.  
Phospholipase assays were performed in vitro with a BODIPY-phosphatidylcholine 
(BPC or 
2-decanoyl-1-(O-(11-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-prop
ionyl)amino)undecyl)-sn-glycero-3-phosphocholine; Invitrogen), 
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NBD-phosphatidylethanolamine (NBD-PE, 
N-(NBD-Aminododecanoyl)L-1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine; 
Sigma), NBD-phosphatidylserine (NBD-PS or 
1-Palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-
3-Phospho-L-Serine; Avanti Polar Lipid), NBD-sphingomyelin (NBD-SM, 
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-Sphingosine-1-Phospho
choline; Avanti Polar Lipid).  20 µM phospholipid substrates (10 µl) were reacted 
with an equal volume (10µl) of various samples, and incubated at different conditions, 
as described for each experiment.  For some experiments, purified standard 
phospholipases were used: PLA2 (Sigma) from porcine pancreas, PLC (Sigma) from 
Clostridium perfringens, and PLD (Sigma) from cabbage.  The reaction products 
were analyzed by thin-layer chromatography (TLC).  Briefly, 20µl of 1-butanol was 
added to the above reaction mixes (20 µl), followed by vigorous vortex mixing for 30 
s and centrifugation (10,000 × g, 1 min). The upper lipid extract layer (5 µl) was 
loaded onto a plastic-backed silica gel G60 plate without fluorescent indicator (Sigma) 
and air-dried for 20 min.  TLC was performed either with 
chloroform-methanol-water-acetic acid (45/45/10/1 by vol.) when BODIPY-PC was 
used as the substrate, or with chloroform-methanol-acetic acid (60/20/1 by vol.) when 
NBD-PE, NBD-PS, or NBD-SM used as the substrates.  For some experiments, an 
apolar solvent (n-hexane (70): diethyl ether (30): acetic aid (4)) was used.   
Fluorescence was detected and quantified using a Typhoon 9410 laser scanner.  
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Subcellular fractionation. V. anguillarum cells were fractionated as described 
previously [6] and the subcellular location of Plp determined.  Briefly, 100 ml 
NSS-washed overnight grown bacteria cells were resuspended in 10 ml of ultrapure 
water for 20 min to cause osmotic shock and centrifuged (10,000 × g, 5ºC, 10 min) to 
collect the periplasmic fraction (the supernatant). The remaining pellets were washed 
twice with ultrapure water and lysed by sonication. The sonicated cells were 
centrifuged (10,000 × g, 5ºC, 20 min) to remove cell debris and any unlysed cells, and 
the supernatant cell lysate was separated by ultracentrifugation (200,000 × g, 1 h, 4ºC) 
to yield the cytosolic (supernatant) and membrane (pellet) fractions. The membrane 
fraction was treated with 1% Sarkosyl to obtain Sarkosyl-soluble (inner membrane) 
and -insoluble (outer membrane) fractions. Protein concentration in various fractions 
was measured using BCA protein determination kit (Pierce).    
 
Preparation of polyclonal antibody. Truncated Plp protein was over-expressed and 
purified to serve as the antigen to create polyclonal antibody against Plp.  Briefly, 
primer Pm212 and Pm213 (listed in Table 3) were used to amplify central portion of 
the plp gene, which encodes the truncated Plp protein (amino acid 93 to 293).  PCR 
product was ligated into pQE30UA vector (QIAGEN), and transformed into E. coli 
M15 and transformants were selected on LB10 agar containing kanamycin and 
ampicillin. Plasmid DNA was purified and the sequence confirmed by DNA 
sequencing.  Protein purification was performed under denaturing conditions 
according to the instructions of the manufacturer (QIAGEN, USA) and protein purity 
was determined by SDS-PAGE and Coomassie blue staining.  Subsequently, the 
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purified truncated Plp was used as antigen to prepare polyclonal antibody in two New 
Zealand White rabbits (Charles River Lab, MA).  Briefly, 1 ml purified antigen 
(concentration = 100 µg/ml) was vigorously mixed with 1 ml TiterMax Gold adjuvant 
(Sigma) into a homogeneous suspension.  About 10 ml of blood was withdrawn from 
the rabbits before immunization as a control.  For the first injection, antigen-adjuvant 
mix was subcutaneously injected at 4 sites (over each shoulder and thigh; 100 µl/site). 
The rabbits were boosted with single injections of antigen-adjuvant (100 µl) at day 28, 
42, and 56.  Blood was withdrawn 7-10 days after the 2nd and 3rd boosts to test the 
titer of antiserum using the western blot analysis. Antiserum with a high titer (> 1: 
10,000) was aliquoted and stored at -70ºC.  
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blot analysis.  Purified proteins or other protein samples were separated in 
10% SDS-polyacrylamide gels.  Prestained protein standards (Bio-Rad) and Laemmli 
sample buffer (Sigma) were used in all gels.  Electrophoresis was performed at 100 V 
for 60-90 min. Gels were stained with either Coomassie blue G-250 or silver stain 
(Pierce, USA) to visualize the protein bands. Alternatively, proteins were transferred 
to nitrocellulose membranes for western blot analysis using the mini-Protean II system 
(Bio-Rad).  Protein transfers were performed as described by Towbin et al [39] at 
100 V for 1 h.  Nitrocellulose membranes were blocked with the addition of 5% skim 
milk.  Detection of specific protein bands was accomplished by reacting the blot with 
the 1:5000 diluted anti-Plp antibody, followed by the addition of the secondary 
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antibody goat anti-rabbit IgG conjugated with peroxidase, and then developed by 
TMB Development Liquid (Sigma, USA).   
 
DNA sequence and analysis.  All DNA sequencing was done at the URI Genomics 
and Sequencing Center (University of Rhode Island, Kingston, RI), using an ABI 
3170xl Genetic Analyzer unit (Applied Biosystems).  Multiple alignment and 
phylogenic tree were analyzed using the Clustal-W method in DNA-STAR 
Lasergene7 program.   
 
Fish infection studies.  Various V. anguillarum strains were tested for virulence with 
rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection as described by 
Mou et al [29].  Briefly, V. anguillarum cells grown in LB20 supplemented with 
appropriate antibiotics for 22 h at 27°C were harvested by centrifugation (9,000 × g, 5 
min, 4°C), washed twice in NSS, and resuspended in NSS (~2 × 109 cells ml-1).  
Initial cell density was estimated by measurement of optical density at 600 nm.  The 
actual cell density of NSS suspensions was determined by serial dilution and spot 
plating.  All fish were examined prior to the start of each experiment to determine 
that they were free of disease or injury.  Fish were anesthetized with tricaine 
methanesulfonate (Western Chemical, Ferndale, WA), with 100 mg/L for induction 
and 52.5 mg/L for maintenance.  V. anguillarum strains were IP-injected into fish in 
100 µl NSS vehicle.  Fish that were between 15 and 25 cm long were injected with 
bacteria diluted with NSS at various doses or NSS only as negative control.  Five fish 
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were used for each experimental group.  Fish inoculated with different bacterial 
strains were maintained in separate 10-gallon tanks with constant water flow (200 
ml/min) at 19 ± 1 ºC.  The tanks were separated to prevent possible 
cross-contamination.  Death due to vibriosis was determined by the observation of 
gross clinical signs and confirmed by the recovery and isolation of V. 
anguillarum cells resistant to the appropriate antibiotics from the head kidney of dead 
fish.  Observations were made for 14 days.  All fish used in this research project 
were obtained from the URI East Farm Aquaculture Center.  All fish infection 
protocols were reviewed and approved by the University of Rhode Island Institutional 
Animal Care and Use Committee (URI IACUC reference number AN06-008-002; 
protocols renewed 14 January 2013). 
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Figure 1. The phylogenetic tree (A) and amino acid sequence alignment (B) of V. 
anguillarum Plp with members of the SGNH family.  Sequences of the 16 closest 
matches to Plp are aligned along the five conserved blocks of the SGNH family 
(Block IV not shown).  The rectangle bars above the alignment indicate the amount 
of conservation of amino acid residues. The four residues conserved in all SGNH 
family members are boxed. 
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Figure 2.  Hemolytic activity of M93Sm and S262 (plp) on TSA-sheep blood agar 
(A) and LB20 + 5% rainbow trout blood agar (B).  A single colony of M93Sm and 
S262  was transferred onto each of the blood agars and incubated at 27ºC for 24 h.  
The zones of hemolysis were measured and the diameters were given in the figure.  
This is a representative experiment from 3 replicate trials. 
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Figure 3.  Thin-layer chromatography (TLC) demonstrates phospholipase A2 
activity of Plp.  BODIPY-labeled phosphatidylcholine (BPC) was incubated with 
various standard enzymes or sample preparations for 1 h at 37ºC.  Subsequently, the 
lipids were extracted and separated by TLC.  (A) The cleavage patterns of BPC by 
standard proteins PLA2, PLC, and PLD were able to distinguish the different 
phospholipase activities.  (B) Cleavage patterns of BPC by supernatants (lanes 2 and 
3) and cell lysates (lanes 4 and 5) from E. coli DH5α containing cloned plp (lanes 3 
and 5) or just the cloning vector pSUP202 (lanes 2 and 4).  Lane 1 contains only BPC 
incubated in the presence of PBS buffer.  BLPC, BODIPY-labeled 
lysophosphatidylcholine; PA, phosphatic alcohol; PBt, phosphaticbutanol; DAG, 
di-acylglycerol. 
40 
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Figure 4. Effects of chemical and physical conditions on rPlp activity.  (A) The 
enzymatic activity was proportional to rPlp concentration between 1 µg/ml to 8 µg/ml.  
(B) The effect of temperature on rPlp activity indicated that rPlp activity was optimal 
at 37ºC and stable up to 64ºC.  (C) The pH effect on rPlp protein indicated that the 
optimal pH for rPlp activity ranged from 5 to 9.  (D) EGTA did not have any effect 
on rPlp activity.      
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Figure 5.  Plp is a secreted protein.  The phospholipase activity assays of various 
cell fractions prepared from wild type (wt) strain M93sm and plp mutant strain S262 
(plp-) were performed at 37ºC (A) and 64ºC (B).  PBS buffer, LB20, and PBS buffer 
+ 1% sarcosylate were served as negative controls. The refolded rPlp protein (PLP +) 
served as positive control.  The top spots on each chromatogram are the BPC 
substrate and the bottom spots are the BLPC reaction product.  The proteins from the 
same cell fractionation preparations were analyzed by SDS-PAGE and Western blot 
analysis (C) as described in the Materials and Methods. The refolded rPlp protein was 
served as positive control.  
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Figure 6.  rPlp has specific activity against phosphatidylcholine.  BPC, NBD-PE, 
NBD-PS, and NBD-Sm were used as phospholipid substrates to examine the 
specificity of rPlp. Phosphate-buffered saline (PBS) was used as a negative control, 
and PLA2 enzyme from porcine pancreas as a positive control.   TLC analysis 
showed that rPlp only cleaved BPC into BLPC and FFA (A), but could not cleave 
other phospholipids (B, C, and D).  BPC: BODIPY-labeled phosphatidylcholine; 
BLPC: BODIPY-labeled lysophosphatidylcholine; NBD-PE: NBD-labeled 
phosphatidylethanolamine; NBD-LPE: NBD-labeled lysophosphatidylethanolamine; 
NBD-PS: NBD-labeled phosphatidylserine; NBD-FFA: NBD-labeled free fatty acid; 
NBD-SM: NBD-labeled sphingomyelin; NBD-CE: NBD-labeled ceramide.  
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Figure 7.  Lysis of Atlantic salmon erythrocytes by recombinant Plp protein (rPlp).  
500 µl 5% fish (triangle) and sheep (square) erythrocytes were incubated with various 
concentration rPlp at 27°C for 20 h.  The lysis of erythrocytes was measured at 428 
nm.  Erythrocyte resuspension buffer (10mM Tris-HCl, 0.9% NaCl, pH7.2) was used 
as negative control.  All values were calculated from three independent experiments. 
Error bars show one standard deviation.  
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Figure 8. Fish infection experiment. Survival rate of rainbow trout injected IP with 
wild type and mutant  strains of V. anguillarum strains at doses of A) 3 x 106, B) 3 x 
105 or C) 3 x 104 CFU/fish. No statistically significant difference was observed 
between the strains. 
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TABLE 1. Bacterial strains and plasmids used in this study. 
Strain or 
plasmid Description Reference 
V. anguillarum 
strains    
M93sm Spontaneous Smr mutant of M93 (serotype O2a) [2] 
JR1 Smr Cmr vah1; insertional vah1 mutant of M93Sm [8] 
XM21 Smr Cmr Tcr vah1+; vah1 complement strain of JR1 This study 
S262 Smr Cmr plp; insertional plp mutant of M93Sm This study 
XM31 Smr Cmr Tcr plp+; plp complement strain of S262 This study 
S123 Smr Cmr rtxA; insertional rtxA mutant of M93Sm [9] 
JR3 Sm
r
 Cmr Kmr vah1 plp; insertional vah1mutant of 
JL01 [8] 
S183 Sm
r
 Cmr Kmr vah1 rtxA; insertional rtxA mutant of 
S171 [9] 
XM62 Sm
r
 Cmr Kmr Tcr vah1+ rtxA; vah1 complement 
strain of S183 This study 
S187 Sm
r
 Cmr Kmr plp rtxA; insertional rtxA mutant of 
JL01 This study 
XM90 Sm
r
 Cmr Kmr vah1 plp rtxA; insertional plp mutant of 
S264 This study 
XM93 Sm
r
 Cmr Kmr Tcr vah1 plp+ rtxA; plp complement 
strain of XM90 This study 
JL01 Smr Kmr plp; mini-Tn10Km insertion into plp [8] 
S171 Smr Kmr vah1; allelic exchange vah1 mutant [9] 
S264 Sm
r
 Kmr vah1 rtxA; allelic exchange vah1 and rtxA 
mutant This study 
E. coli strains   
Sm10 thi thr leu tonA lacY supE recA RP4-2-Tc::Mu::Km (λ pir) [40] 
52 
S253 Kmr Cmr; Sm10 containing plasmid pNQ705-plp This study 
S118 Kmr Cmr; Sm10 containing plasmid pNQ705-rtxA [9] 
S250 Kmr Cmr; Sm10 containing plasmid pDM4-rtxA5' This study 
S252 Km
r
 Cmr; Sm10 containing plasmid 
pDM4-rtxA5'-rtxA3' This study 
U21 Km
r
 Apr Tcr; Sm10 containing plasmid 
pSUP202-vah1 This study 
U31 Kmr Apr Tcr; Sm10 containing plasmid pSUP202-plp This study 
M15 Nal
S StrS RifS thi– lac– ara+ gal+ mtl– F– recA+ uvr+ lon+ 
(pREP4) 
QIAGEN, 
USA 
S238 Kmr Apr; M15 containing plasmid pQE30UA-plp  This study 
S269 Kmr Apr; M15 containing plasmid pQE60-plp This study 
Plasmid   
PCR2.1 Kmr Apr; Cloning vector Invitrogen, USA 
pNQ705-1 Cmr; suicide vector with R6K origin [41] 
pNQ705-vah1 Cmr; for insertional vah1mutation [8] 
pNQ705-plp Cmr; for insertional plp mutation This study 
pNQ705-rtxA Cmr; for insertional rtxA mutation [9] 
pDM4 Cmr SacBCr; suicide vector with R6K origin [11] 
pDM4-rtxA5'-r
txA3' Cm
r
 SacBCr; for allelic exchange rtxA mutation This study 
pSUP202 Cmr Apr Tcr; E. coli – V. anguillarum shuttle vector  [40] 
pSUP202-vah1 Apr Tcr; for complementation of vah1 This study 
pSUP202-plp Apr Tcr; for complementation of plp This study 
pQE-30 UA Apr; expression vector with N-terminal His6-tag QIAGEN, USA 
53 
pQE30UA-plp  Ap
r; for expression of rPlp that is used to make 
anti-Plp This study 
pQE60 Apr; expression vector with C-terminal His6-tag QIAGEN, USA 
pQE-60-plp Ap
r; for expression of rPlp for enzymatic activity 
analysis This study 
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Table 2.  Hemolytic activity of culture supernatant from V. anguillarum wild-type 
and various V. anguillarum mutant strains against rainbow trout blood cells 
V. anguillarum strain or treatment 
Hemolytic Activity (% of Wild-Type control 
± SD) a 
M93Sm 1.00 (±0.12) 
JR1 (vah1) 0.98 (±0.16) 
XM21 (vah1+) 1.20 (±0.28) 
S262 (plp) 0.28 (±0.09)b 
XM31 (plp+) 0.99 (±0.04) 
S123 (rtxA) 0.94 (±0.22) 
JR03 (plp vah1) 0.14 (±0.09)b 
S183 (vah1 rtxA) 1.51 (±0.29) 
XM62 (vah1+ rtxA) 0.73 (±0.03) 
S187 (plp rtxA) 0.12 (±0.09)b 
XM90 (vah1 rtxA plp) -0.04 (±0.09)b 
XM93 (vah1 rtxA plp+) 1.33 (±0.01) 
Water (positive control) 1.15 (±0.16) 
 
aHemolytic activity assays carried out using the tube assay method as described in the 
Materials and Methods.  Hemolysis by M93Sm was given the value of 1.00.  The 
data are representative of two independent experiments, each with three replicates, ± 
one standard deviation (SD). 
bStatistically different from hemolytic activity for M93Sm (P< 0.05). 
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TABLE 3. Primers used in this study 
Primers 
Sequence (5' to 3', 
underlined sequences are 
designed restriction sites) 
Purpose and description Reference 
Pm262 ATCGAGGATCCATGAA
ACTAATGACGTTATTG 
For whole Plp protein, 
forward 
This study 
Pm263 ATCGAAGATCTTTGAA
ATTGAAATGACGCGAG 
For whole Plp protein, 
reverse 
This study 
Pm212 GACACCTCACAATATG
AAATAAAA 
For truncated Plp protein, 
forward 
This study 
Pm213 TTTGAGCTGCGGGGCTT
TGGTTGC 
For truncated Plp protein, 
reverse 
This study 
Pm261 ATCGAGAGCTCGCAGA
ATCGTGACTGACGCCG 
For insertional plp 
mutation, forward, with 
SacI site 
This study 
SD 
Lip/Heme 
R1 
GCTAGTCTAGAACGGA
TACCACCTCAGA 
For insertional plp 
mutation, reverse, with 
XbaI site 
[8] 
pr1 GGGGAATTCTTATTCAA
ATTGAAATGACGCGAG 
For plp complement, 
forward, with EcoRI site 
This study 
pr2 GGGACCGGTGAATACC
CATTTTTTATTTTTTC 
For plp complement, 
reverse, with AgeI site 
This study 
pr3 GTTGAATTCGTATTTTC
TGCAATCGCCATG 
For vah1 complement, 
forward, with EcoRI site 
This study 
pr4 GGGACCGGTCTATTTTA
TAATAAATTGAATACC
AT 
For vah1 complement, 
reverse, with AgeI site 
This study 
Pm256 ATCGACTCGAGCTGGA
GAAGATGTACTCTGCG 
For allelic exchange rtxA 
mutation, flanking the 5' 
region, forward, with 
XhoI site 
This study 
Pm257 ATCGATCTAGACGTATC
ATCTACAGCTTTTGC 
For allelic exchange rtxA 
mutation, flanking the 5' 
region, reverse, with XbaI 
site 
This study 
56 
Pm258 ATCGATCTAGATTATAT
TAATCATGTCTTTTATG
GG 
For allelic exchange rtxA 
mutation, flanking the 3' 
region, forward, with 
XbaI site 
This study 
Pm259 ATCGAGAGCTCCTGATT
GCCTAGCAGTAGCCC 
For allelic exchange rtxA 
mutation, flanking the 3' 
region, reverse, with SacI 
site 
This study 
pr7 CAGGAAACAGCTATGA
CCATGATTACG 
For sequencing of the 
DNA fragment inserted in 
pCR2.1 TA-ligation site 
This study 
pr8 CTACGGGCTTGAGCGT
GACAATC 
For sequencing of the 
DNA fragment inserted in 
pSUP202 AgeI site 
This study 
pr25ex GCTGTCCCTCCTGTTCA
GCTACTGACGGGGTGG
TGCG 
For sequencing of the 
DNA fragment inserted in 
pNQ705-1 Multi-cloning 
site 
This study 
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Abstract 
The two hemolysin gene clusters previously identified in V. anguillarum, the 
vah1 cluster and the rtxACHBDE cluster, are responsible for the hemolytic and 
cytotoxic activities of V. anguillarum in fish.  In this study, we used degenerate PCR 
to identify a positive hemolysin regulatory gene, hlyU, from the unsequenced V. 
anguillarum genome.  The hlyU gene of V. anguillarum encodes a 92-amino acid 
protein and is highly homologous to other bacterial HlyU proteins.  An hlyU mutant 
was constructed, which exhibited ~5-fold decrease in hemolytic activity on sheep 
blood agar with no statistically significant decrease in cytotoxicity of the wild type 
strain. Complementation of the hlyU mutation restored both hemolytic and cytotoxic 
activity.  Both semi-quantitative RT-PCR and real time RT-qPCR were used to 
examine expression of the hemolysin genes under exponential and stationary phase 
conditions in wild type, hlyU mutant, and hlyU complemented strains.  Compared to 
the wild type strain, expression of rtx genes deceased in the hlyU mutant while 
expression of vah1 and plp was not affected in the hlyU mutant.  Complementation of 
the hlyU mutation restored expression of the rtx genes and increased vah1 and plp 
expression to levels higher than in the wild type. The transcriptional start sites in the 
intergenic regions of both vah1/plp and rtxH/rtxB genes were determined using 
5’-RACE and the binding sites for purified HlyU was discovered using DNA gel 
mobility shift experiments and DNase protection assays.   
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Introduction 
 Vibrio anguillarum is a marine member of the class Gammaproteobacteria.  This 
highly motile gram-negative bacterium is the causative agent of warm-water vibriosis, 
a fatal hemorrhagic septicemic disease in fish, crustaceans, and bivalves (1).  The 
mortality rate from V. anguillarum infections ranges from 30% to 100% (1).  
Infections by these bacteria have resulted in severe economic losses to aquaculture 
worldwide (1, 21) and affect many farm-raised fish including Pacific salmon, Atlantic 
salmon, sea bass, cod, and eel (1, 4, 5, 21).  
Hemolytic activity has been considered to be a virulence factor for V. 
anguillarum and is thought to contribute to the hemorrhagic septicemia characteristic 
of vibriosis (7, 16).  Rock and Nelson (16) reported that the vah1 hemolysin gene 
cluster contains at least two genes, vah1 and plp, that affect hemolytic activity.  Vah1 
is a putative pore-forming hemolysin, which causes vacuolization of target cells (10).  
It was suggested that pore-forming hemolysins, like HlyA in E. coli, cause direct lysis 
of blood cells by disrupting the membrane integrity (13).  Mutations in the 
divergently transcribed plp result in both increased expression of vah1 and increased 
hemolysis, suggesting that Plp is a putative repressor of vah1 transcription (16).  
Additionally, restoration of plp by complementation restores the wild-type level of 
vah1 transcription and hemolysis (16). Plp is a phosphatidylcholine (PC)-specific 
PLA2, which causes lysis of PC–rich fish erythrocytes (9). 
Besides the vah1 cluster, a second hemolysin gene cluster, rtxACHBDE, was 
identified in the V. anguillarum (10).  This gene cluster contains rtxA, which encodes 
a potent MARTX toxin and the specialized Type I Secretion System (T1SS) genes 
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(rtxDBE) responsible for the secretion of the RtxA hemolysin/cytotoxin.  A mutant 
containing mutations in both vah1 and rtxA completely lost hemolytic activity on 
sheep blood agar (10).  Additionally, RtxA also exhibits cytotoxic activity and causes 
Atlantic salmon kidney (ASK) cells to round and die (10). 
 HlyU, a member of SmtB/ArsR family, is a metal-regulated transcriptional 
regulatory protein (17).  It has been reported that HlyU is a positive regulator of 
hemolysin and toxin genes in Vibrio species.  In V. cholerae, the HlyU protein 
positively regulates expression of hemolysin gene hlyA, as well as the 
HlyA-co-regulated gene, hcp (22, 23). Williams et al (22) reported that a mutation in 
hlyU attenuates V. cholerae O17 in the infant mouse cholera infection model.  
Recently, HlyU was also identified in V. vulnificus, and appears to be a positive 
regulator of virulence genes (8, 11).  Kim et al (8) reported that HlyU of V. vulnificus 
may be one of the master regulators of in vivo virulence gene expression.  
Specifically, in a V. vulnificus hlyU mutant cytotoxic activity against HeLa cells was 
nearly abolished and the LD50 dose of V. vulnificus in mice by intraperitoneal infection 
was increased by 10- to 50-fold (8).  Liu et al (11) also demonstrated that HlyU was 
required for virulence of RtxA1, a homologue of RtxA of V. anguillarum in V. 
vulnificus CMCP6.  In V. vulnificus, HlyU acted as a competitor that antagonized the 
binding of H-NS, a repressor of rtxA1, in the upstream region of the rtxA1 operon so 
that the presence of HlyU resulted in derepression of rtxA1 (12).   
 In this report, we identified the hlyU homologue in V. anguillarum by degenerate 
PCR and constructed an hlyU mutant strain and its complement.  The hemolytic 
activity and cytotoxicity of the mutant were determined and compared to the wild type 
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and complemented strains.  We also identified the transcriptional start site of genes in 
both the vah1 cluster and rtxA operon and localized the HlyU binding sites to the 
upstream region of the two hemolysins by gel mobility shift and DNase protection 
assays.  Additionally, the amounts of transcription from various hemolysin genes, 
including vah1, plp, rtxA, rtxH and rtxB were determined in the hlyU mutant and its 
isogenic wild-type parent and complement by real-time RT-PCR. 
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Materials and Methods 
Fish cell line, bacterial strains, plasmids and growth conditions. Atlantic salmon 
kidney (ASK) cells (ATCC CRL-2747) were cultured at 20ºC in Leibovitz-15 medium 
containing 100 µg/ml ampicillin, 100 µg/ml streptomycin, and 20% Fetal bovine 
serum (FBS, Invitrogen, USA).  All bacterial strains and plasmids used in this report 
are listed in Table 1.  V. anguillarum strains were routinely grown in Luria-Bertani 
broth plus 2% NaCl (LB20) (6), supplemented with the appropriate antibiotic, in a 
shaking water bath at 27°C.  Overnight cultures of V. anguillarum, grown in LB20, 
were harvested by centrifugation (8,000 × g, 10 min), and the pelleted cells washed 
twice with Nine Salt Solution (NSS) (6).  Washed cells were resuspended to 
appropriate cell densities in experimental media.  Specific conditions are described in 
the text for each experiment.  E. coli strains were routinely grown in Luria-Bertani 
broth plus 1% NaCl (LB10) (18).  Antibiotics were used at the following 
concentrations: streptomycin, 200 µg/ml (Sm200); ampicillin, 100 µg/ml (Ap100); 
chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V. anguillarum; 
kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V. anguillarum; 
tetracycline, 15 µg/ml (Tc15) for E. coli and 2 µg/ml (Tc2) for V. anguillarum. 
 
Degenerate PCR. Degenerate PCR was used to identify the hlyU gene in V. 
anguillarum.  Previously sequenced hlyU genes including their flanking genes from 
various Vibrio species were obtained from the NCBI website 
(http://www.ncbi.nlm.nih.gov), and aligned using CLUSTW program (20).  
Degenerate primers (Table II) were designed from the conserved regions (Fig. 1), and 
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used to amplify the possible hlyU gene from V. anguillarum M93Sm genomic DNA. 
The PCR products were separated and purified from a 1% agarose gel and then 
subcloned into PCR2.1 vector (Invitrogen, USA).  Colonies containing the cloned 
hlyU in PCR2.1 were selected on LB10 plates plus Ap100 and Km50 and the presence 
of hlyU confirmed by plasmid purification and DNA sequencing.  
 
Insertional mutagenesis of hlyU.  Insertional mutagenesis by homologous 
recombination was used to create a gene interruption within the hlyU gene by using a 
modification of the procedure described by Milton and Wolf-Watz (14).  Briefly, 
primers (Table 2) were designed based on the hlyU gene sequence of M93Sm 
(GenBank accession no. HQ149334). Then a 161-bp hlyU DNA fragment was PCR 
amplified by using primer pair Pm297 and Pm298 (Table 2) and cloned into the 
suicide vector pNQ705 by using SacI and XbaI restriction sites to yield the pNQ705 
derivative plasmid, which was confirmed by both PCR amplification and restriction 
analysis.  The mobilizable suicide vector was transferred from E. coli Sm10 (λpir) 
into V. anguillarum M93Sm by conjugation (14).  Transconjugants were selected by 
utilizing the chloramphenicol resistance gene located on the suicide plasmid.  The 
incorporation of the suicide vector into the hlyU gene was confirmed by PCR analysis, 
as described previously (14).  The resulting V. anguillarum hlyU mutant was 
designated S305 (Table 1) for future use.  
 
Complementation of the hlyU mutant.  The mutant was complemented by cloning 
the appropriate hlyU gene fragment into the shuttle vector pSUP202 (GenBank 
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accession no. AY428809) as described previously by Rock and Nelson (16).  Briefly, 
primers (Table 2) were designed and EcoRI sites were introduced at the 5’ end of 
primers. The primer pair was then used to amplify the entire hlyU gene plus ~500 bp 
of the 5’ and 3’flanking regions from genomic DNA of V. anguillarum M93Sm.  The 
PCR product was cloned into the PCR2.1 vector (Invitrogen, USA) and digested with 
EcoRI restriction enzyme and the DNA fragments separated on a 1% agarose gel. 
Subsequently, the gel-purified PCR fragment was ligated into pSUP202 after digestion 
with EcoRI and the ligation mixture introduced into E. coli Sm10(λpir) by 
electroporation with BioRad Gene Pulser II.  Transformants were selected on 
LB10-Ap100 agar plates.  The complementing plasmid,  pSUP202-hlyU plasmid, 
was transferred from E. coli Sm10 into the V. anguillarum hlyU mutant (S305) by 
conjugation using the procedures described previously (16).  The transconjugants 
were confirmed by PCR amplification and restriction digestion. 
 
Hemolytic activity assay. Hemolytic activities of various V. anguillarum strains were 
determined by measuring the diameter of β-hemolysis on TSA plus sheep blood agar 
plates after 24 h at 27°C as previously described (16).  
 
Cytotoxicity assay.  Cytotoxic activity of V. anguillarum strains was determined by 
changes to cell morphology or by measurement of released lactate dehydrogenase 
(LDH).  ASK cells were seeded into a six-well microtiter plate (Costar) in 
Leibovitz’s L-15 medium supplemented with 20% fetal bovine serum and grown at 
20°C to a cell density of ~2 ×105 cells ml-1. V. anguillarum cultures grown overnight 
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were harvested, washed twice in NSS, and resuspended in NSS (at a cell density of ~2 
× 109 cells ml-1). Washed bacterial cells were added to ASK cells at multiplicities of 
infection (moi) = 100, and incubated at 20°C for 4 h.  Changes in cell morphology 
were assessed and photographed by viewing live cells with an inverted microscope 
(Nikon TE2000 model).  To determine the released LDH, a CytoTox-ONE™ 
Homogeneous Membrane Integrity Assay Kit (Promega, USA) was used.  Briefly, 
ASK cells were seeded into a 96-well white wall microtiter plate (Costar) as described 
above at a cell number of 20,000 cells /well.  NSS-washed bacterial cells were added 
to each well at moi=10, 20, 50, and 100, and then incubated at 20°C for 4 h. The assay 
measures the generation of the fluorescent resorufin product, which is proportional to 
the amount of LDH at 560 nmExcitation/590 nmEmission.  
 
RNA isolation.  Exponential-phase cells (~0.5 × 108 CFU ml-1) and stationary-phase 
cells (2 × 109 CFU ml-1) of various V. anguillarum strains were harvested by 
centrifugation.  Total RNA was isolated using the RNeasy kit (QIAGEN, USA) 
according to the manufacturer’s instructions. All purified RNA samples were 
quantified spectrophotometrically by measuring absorption at 260 nm and 280 nm 
using a NanoDrop® spectrophotometer and stored at -75ºC for future use.  
 
Semi-quantitative RT-PCR and Real-time RT-qPCR.  Total RNA was isolated 
from exponential and stationary growth phase V. anguillarum cells as described above.  
All RNA samples were treated with DNase and 100 µg RNA used as the template for 
reverse transcription (RT)-PCR.  RT-PCR was performed using Brilliant SYBR 
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Green single-step quantitative RT-PCR (qRT-PCR) Master Mix (Stratagene).  
Briefly, gene-specific primers (Table 2) were used to reverse transcribe the specific 
cDNA from RNA templates, and the resulting cDNA was used as the template with 
which to amplify the specific DNA product, using 25-cycle regular PCR to give a 
semi-quantitative determination of the original RNA amount.  Genomic DNA (100 
µg) extracted from wild-type strain M93Sm was used as the positive control. The 
thermal profile was 50°C for 30 min and 95°C for 15 min and then 25 cycles of 95°C 
for 30 s, 55°C for 30 s, and 72°C for 30 s. PCR product was visualized in a 1% 
agarose gel use a 100-bp DNA molecular weight ladder (Promega) as a standard.  All 
Real-time quantitative RT-PCR (RT-qPCR) were performed using an Mx3005 or 
Mx4000 Multiplex Quantitative PCR System (Stratagene, USA).  Primers used were 
the same as the semi-quantitative RT-PCR (Table 2).  Quantitation of various 
mRNAs was performed using Brilliant SYBR Green Single-Step QRT-PCR Master 
Mix (Stratagene) with 10 ng of total RNA in 25 µl reaction mixtures.  The thermal 
profile was 50°C for 30 min, 95°C for 15min, and then 40 cycles of 95°C for 30 s and 
55°C for 30 s. Fluorescence was measured at the end of the 55°C-step during every 
cycle.  Samples were run in triplicate plus no-RT control and no-template control. 
 
5’RACE assay.  Total RNA was isolated from exponential phase V. anguillarum 
cells grown in LB20 using the RNeasy Kit (QIAGEN).  To identify the 
transcriptional start site, RNA was subjected to 5’-rapid amplification of cDNA ends 
(5’-RACE) using the 2nd generation 5’-RACE kit (2).  Primers used in RT-PCR are 
listed in Table 2.  Briefly, 5 µg of RNA was used to generate specific first-strand 
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cDNA from target mRNA (vah1, plp, rtxH, or rtxB) in a reverse transcriptase reaction 
with a gene specific primer.  Poly(A) tails were added to the 3’- cDNA end using 
dATP and terminal deoxynucleotidyl transferase (or in some cases, poly(G) tails were 
added with dGTP and terminal deoxynucleotidyl transferase).  A PCR product was 
amplified from the tailed cDNA by using a 5’ RACE anchor primer (AP) (Table 2) 
and the primer specific for that sequence.  The PCR product was cloned into PCR2.1 
cloning vector (Invitrogen, USA), and plasmids from appropriate transformants were 
purified and sequenced. 
 
DNA sequence and analysis.  All DNA sequencing was done at the RI Genomics 
and Sequencing Center (University of Rhode Island, Kingston, RI), using an ABI 
3170xl Genetic Analyzer unit (Applied Biosystems).  Multiple alignment and 
phylogenic tree were analyzed using the Clustal-W method in DNA-STAR 
Lasergene7 program. 
Overexpression and purification of the V. anguillarum HlyU protein.  The DNA 
fragment encoding HlyU was PCR amplified using primers Pm303 And Pm304 (Table 
2), and cloned into the 6×His tag expression plasmid, pQE30-UA (QIAGEN, Inc), 
generating the plasmid pQE30-UA/HlyU which encodes HlyU with an N-terminal 
fusion tag. The correct recombinant clone confirmed by sequencing was used for 
expression of His-tagged HlyU protein in E. coli M15 (S301). Ten milliliters of 
overnight bacteria culture growing at 37°C in Luria broth supplemented with 50 µg/ml 
kanamycin and 100 µg/ml ampicillin was inoculated in 250 ml of the same fresh 
medium. When the OD600 reached 0.6, 1 mM IPTG was added to induce the 
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expression of HlyU protein. After bacteria were grown for an additional 5 h at 37°C, 
the cells were collected by centrifugation (8000 ×g, 10 min) and the cell pellets 
resuspended in 5 ml lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 
pH8.0).  The cell suspension was incubated with lysozyme (0.5 mg/ml) on ice for 30 
min, and then sonicated (six bursts, 20 s per burst with 30 s intervals on ice).  The 
resulting cell lysate was centrifuged (10,000 ×g, 20 min) and the soluble supernatant 
containing HlyU-His6 was collected. The recombinant protein was then purified from 
this fraction by affinity chromatography using Ni-nitrilotriacetic acid resin (QIAGEN, 
Inc) according to the manufacturer's instructions. The concentration of the purified 
HlyU protein was determined by measuring the absorbance at 280 nm using a 
Nanodrop ND-1000 spectrophotometer (Thermo Scientific). 
 
Gel Mobility Shift assay. The gel mobility shift assay was performed using a 
digoxigenin gel shift kit (second generation; Roche, Indianapolis, IN). Three 
fragments (a, b and c) from the rtxH/rtxB intergenic region and five fragments (d, e, f, 
g and h) from the plp/vah1 intergenic region were amplified by PCR and then 3′ end 
labeled with digoxigenin-11-ddUTP using terminal deoxynucleotidyl transferase. 
After the labeling efficiency was determined, each of the labeled probes (0.4 ng for 
fragment a, b and c, 0.2 ng for fragment d, e, f, g and h) was incubated with 350 ng 
purified HlyU protein in 20 µl binding buffer (100 mM HEPES, pH 7.6, 5 mM EDTA, 
50 mM (NH4)2SO4, 5 mM dithiothreitol, 1% (wt/vol) Tween 20, 150 mM KCl). For 
competition analysis, labeled probe (0.4 ng for fragment a, b and c, 0.2 ng for 
fragment d, e, f, g and h) and 350 ng HlyU protein were incubated with 100 ng/µl 
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unlabeled specific probe. The binding reactions were carried out at room temperature 
for 15 min, and then samples were separated by 6% polyacrylamide DNA retardation 
gel (Invitrogen, Carlsbad, CA).  The DNA-protein complex was transferred to 
positively charged nylon membrane by electroblotting, and then immunological 
detection and chemiluminescent signal detection were carried out according to the 
instructions of the manufacturer (Roche, Indianapolis, IN). 
 
DNase I protection assay.  The DNA probes for the DNase I protection assay were 
amplified from V. anguillarum genomic DNA using PCR using primers (Integrated 
DNA Technologies, Inc.) shown in Table 3. Thus, two rtxH/rtxB intergenic region 
probes (4 and 5) were labeled with 6-FAM at 5’ end on the upper strand and the lower 
strand, respectively.  The two plp/vah1 intergenic probes (2 and 3) were also labeled 
with 6-FAM at 5’ end on the upper strand and the lower strand, respectively.  The 
assay was carried out using a method modified from Zianni et al (25).  Briefly, 40 ng 
of a DNA probe and various amounts of rHlyU (up to 1.88 µg) were incubated at 37°C 
in a total volume of 20 µl, containing Binding Buffer (4 µl, 5x conc.) from the DIG 
Gel Shift Kit, (2nd Generation, Roche Applied Science), for 1 h.  The DNA – protein 
complex was then digested by adding 0.001 U RQ1 RNase-free DNase (Promega 
Corporation) in a total volume of 23 µl containing reaction buffer (2.3 µl, 10x conc.) 
at 37°C for 1 min.  The reaction was stopped by adding 2.6 µl stop solution (10× 
concentration) followed by heating (95°C, 10 min).  The DNA was purified using a 
QIAquick PCR Purification Kit (QIAGEN, Inc) using a QIAcube and its standard 
protocol, except that the elution volume was adjusted to 30 µl.  The DNA in the 
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elutant (5 µl) was added to 10 µl Hi-Di Formamide containing 0.1 µl GeneScan 600 
LIZ size standard (Applied Biosystems) and the mixture was submitted to capillary 
electrophoresis fragment analysis (Rhode Island Genomics and Sequencing Center). 
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Results 
Identification of the hlyU gene in V. anguillarum.  Previous studies 
indicated that the hlyU gene is a conserved transcriptional regulator in many Vibrio 
species (11, 12, 22, 23). We hypothesized that HlyU could be a putative regulator of 
the two hemolysin gene clusters in V. anguillarum.  In order to identify the unknown 
hlyU gene in V. anguillarum, several hlyU genes from Vibrio species, including V. 
cholerae, V. vulnificus, V. fischeri, and V. parahaemolyticus, were compared using 
freely available software and database from the Integrated Microbial Genomes (IMG) 
website (http://img.jgi.doe.gov).  The comparison revealed that the flanking genes of 
hlyU were identical among these Vibrio species and encoded a transcriptional activator 
protein NhaR and a ribosomal protein S20P (Fig. 1).  Conserved regions (sequence 
data obtained from http://www.ncbi.nlm.nih.gov) from both flanking regions were 
aligned (Fig. 1), and degenerate PCR primers (Table 2) were designed and used to 
perform degenerate PCR to amplify the putative hlyU gene and flanking DNA from V. 
anguillarum.  A single PCR reaction product was obtained by degenerate PCR (Fig. 
2) and was purified, cleaned, cloned, and sequenced.  As expected, DNA sequence 
data revealed that the PCR product included the intact 294-bp hlyU gene homologue 
(GenBank accession number HQ149334), which encodes a predicted protein with 97 
amino acids, a molecular mass of 11,095 Da, and strong homology to HlyU proteins 
found in a variety of Vibrio species including Vibrio furnissii (97% similarity and 92% 
identity), Vibrio coralliilyticus (95% similarity and 91% identity), V. cholerae (93% 
similarity and 86% identity), V. parahaemolyticus (92% similarity and 88% identity), 
and V. vulnificus (94% similarity and 87% identity).   
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Mutation in hlyU decreases hemolytic activity.  An insertional mutation by 
single crossover homologous recombination in the hlyU gene was obtained.  The 
hemolytic activity of the hlyU mutant was determined and found to decrease about 
5-fold compared with wild type strain M93Sm on sheep blood agar (Fig. 3).  
Complementation of the hlyU mutant restored the hemolytic activity, which was even 
higher than wild type (Fig. 3), indicating that HlyU is a positive regulator of hemolysis 
in V. anguillarum.   
Mutation in hlyU has no significant effect on cytotoxicity.  One hemolysin 
gene, rtxA, has been shown to be a major virulence factor for V. anguillarum (10).  
Previous studies revealed that RtxA has strong cytotoxic activity against Atlantic 
salmon kidney (ASK) cells, and causes cells to round-up, detach, and die (10).  
However, experiments showed that ASK cells still rounded up and died when 
incubated with S305, M93Sm, or S307 cells (Fig. 4A) at a moi = 100 for 4 h, 
indicating the mutation in hlyU did not completely knock out the cytotoxicity of V. 
anguillarum.  Indeed, the LDH release assay revealed that S305 retained ~75-80% (P 
> 0.1) of cytotoxicity at all moi values compared to the wild type strain M93Sm (Fig. 
4B) confirming that the mutation of hlyU had only a small, but statistically 
insignificant effect on cytotoxicity.  As a negative control, the rtxA vah1 double 
mutant strain S183 exhibited no cytotoxicity compared to wild type strain M93Sm 
(Fig. 4B), confirming that rtxA and vah1 are the major cytotoxins in V. anguillarum 
(10).  When strain S307 was assayed for cytotoxic activity by the LDH release assay, 
the activity was restored to same levels seen in M93Sm (Fig. 4B).    
HlyU positively regulates hemolysin genes at the transcriptional level.   
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Semi-quantitative RT-PCR and real-time qRT-PCR were performed to determine the 
expression levels of hemolysin genes, including vah1, plp, rtxA, rtxH, and rtxB, in the 
wild-type strain (M93Sm), hlyU mutant (S305), and the hlyU complement (S307) 
during both exponential and stationary growth phases. Previously, we demonstrated 
that the rtx gene cluster contains two divergently co-transcribed sets of genes: rtxHCA, 
with rtxH promoter proximal; and rtxBDE, with rtxB promoter proximal (10). As 
shown in Fig. 5, RNA expression of rtxH, rtxA, and rtxB decreased in the hlyU mutant 
compared to wild type expression levels during both exponential and stationary 
phases, indicating that the transcriptional level of rtx genes were down-regulated in the 
absence of HlyU.  Indeed, complementation of the hlyU mutation up-regulated the 
expression of rtx genes back to wild type levels (or higher) indicating that HlyU 
positively regulates the expression of rtx genes.  Real time qRT-PCR data also 
revealed that in the hlyU mutant during exponential and stationary phase, respectively, 
expression of rtxA decreased by 7.94- and 20-fold; expression of rtxB decreased by 
3.56- and 8.07-fold; and expression of rtxH decreased by 5.9- and 15.1-fold (Table 4).  
The data strongly suggest that HlyU is a positive regulator of rtx gene expression, 
playing an important role in the expression of rtx genes during both exponential and 
stationary phase.  In fact, the data show that the mutation in hlyU has a larger effect 
on stationary phase expression of rtx genes than on exponential phase expression.  
Additionally, expression of the same rtx genes increased to levels higher than wild 
type in the hlyU complement (Table 4), indicating the over-expression of hlyU 
positively regulates the expression of rtx genes.   
In contrast to rtx genes, expression of genes in the vah1 cluster, including vah1 
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and plp, exhibited little or no decrease in the hlyU mutant by the semi-quantitative 
RT-PCR experiments (Fig. 5).  Measurement of expression for vah1 and plp by 
real-time qRT-PCR were consistent with data from the semi-quantitative experiments 
showing no significant changes in expression in the hlyU mutant (Table 4), indicating 
that the absence of HlyU does not affect either vah1 or plp expression.  However, 
when the expression of vah1 and plp were examined by both semi-quantitative 
RT-PCR (Fig. 6) and qRT-PCR (Table 4) in the hlyU complement (S307), we 
observed that expression of both genes increased.  Specifically, expression of vah1 in 
S307 increased over wild type (M93Sm) levels by 11.6- and 26.3-fold during 
exponential and stationary phase, respectively; and expression of plp increased over 
levels in M93Sm by 8.32- and 86.2-fold during exponential and stationary phase, 
respectively.  These data indicate that over-expression of HlyU can positively 
regulate expression of vah1 and plp.  
Mapping transcriptional start sites of hemolysin genes.  Since it had been 
reported that HlyU is a DNA binding protein (17) that positively regulates hlyA 
(homologue of vah1) in V. cholerae (23) and rtxA1 (homologue of rtxA) in V. 
vulnificus (11), we wanted to determine possible HlyU binding sites in the vah1 gene 
cluster and rtxACHBDE cluster in V. anguillarum.  The transcriptional start sites of 
both hemolysin clusters were identified using 5’RACE.  In the vah1 gene cluster 
there is a 508-bp intergenic region between the divergent plp and vah1 genes. The 
5’-RACE results demonstrated that the region between the +1 sites of plp and vah1 
was 318 bases long (Fig. 6A).  The +1 transcriptional start site (A) of plp is 73 bases 
prior to its start codon, with a predicted -35 and -10 promoter sequence of: 
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TTGATT-N13-ATAAAT (Fig. 6A). The divergent hemolysin gene, vah1, had a 
transcriptional start site (G) 119 bases before the vah1 start codon, with a predicted 
-35 and -10 promoter sequence of TTGTGT-N16-TATTAA (Fig. 6A).    
For the rtx gene cluster, the intergenic space between the divergent rtxH and 
rtxB genes is 325-bp.  5’RACE results show that the region between the 
transcriptional start sites of rtxH and rtxB is 187 bp (Fig. 6B).  The +1 transcriptional 
start site (G) of rtxH is 103 bases prior to its start codon, with a predicted -35 and -10 
promoter sequence of: TTGCGT-N15-TATAAT (Fig. 7B).  The divergent rtxA 
transporter gene, rtxB, was found to have a transcriptional start site (C) 34 bases 
before the rtxB start codon, with a predicted -35 and -10 promoter sequence of 
TTGAGC-N18-TATAAT (Fig. 6B).  Analysis of the predicted promoter regions of 
these two hemolysin clusters revealed strong similarities to a σ70 consensus promoter:  
TTGACA-N17-TATAAT.  Additionally, the putative ribosomal binding site (RBS) 
for all genes was also located upstream of the ATG start codons (Fig. 6A and B).   
HlyU binds to the intergenic promoter regions of the hemolysin gene 
clusters.  Previously, Liu et al (11) demonstrated that HlyU binds to the promoter 
region of the rtxA1 operon of V. vulnificus.  In an effort to determine whether HlyU 
acted in a similar fashion to help regulate expression of the hemolysin gene clusters in 
V. anguillarum, we carried out gel mobility shift experiments using purified 
HlyU-His6 protein.  Briefly, the purified protein (350 ng) was reacted with each of 
the three DIG-labeled DNA sub-fragments amplified from the intergenic region 
between rtxH and rtxB (Fig. 7A) and with each of the five DIG-labeled DNA 
sub-fragments amplified from the intergenic region between plp and vah1 (Fig. 7C).  
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DNA mobility shift experiments were performed on the HlyU + DIG-labeled DNA 
mixtures.  The results revealed that HlyU bound to fragment b of the rtxH-rtxB 
intergenic region (Fig. 7B) and to fragment f of the plp-vah1 intergenic region (Fig. 
7D).  When unlabeled competitor DNA was added to each of these reactions, binding 
was decreased or abolished. 
In an effort to more closely characterize the binding sites of HlyU for each 
hemolysin gene cluster, each of the two DNA sub-fragments that bound HlyU was 
examined by a DNase I protection assay as described in the Materials and Methods.  
The results of these experiments revealed that HlyU protected an 18-bp region 
(5’TAATAAAAATCTTAAAAA3’) in fragment b  (Fig. 8A) with two 5-bp direct 
repeats of TAAAA.  This region starts 103 bp upstream of the +1 site of rtxH and 67 
bp upstream from rtxB.  Similarly, HlyU protected a 22-bp region 
(5’AATAAAAATATCAATAAAATTA3’) in fragment f (Fig. 8B) with the same two 
5-bp direct repeats of TAAAA.  The binding region in sub-fragment f starts 192 bp 
upstream of plp and 106 bp upstream of +1 site for vah1.    
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Discussion 
Hemolytic activity of V. anguillarum has been considered to be the virulence 
factor responsible for hemorrhagic septicemia during infection (1, 5).  We previously 
reported that there are two major hemolysin gene clusters in V. anguillarum M93Sm 
(10, 16).  The vah1 cluster consists of 4 genes, plp, vah1, llpA, and llpB gene.  Vah1 
is a putative pore-forming hemolysin, which shows strong homology to HlyA of V. 
cholerae.  HlyA integrates into the erythrocyte membrane to cause lysis (13).  The 
plp gene, divergent to the vah1 gene, encodes a hemolysin with phospholipase A2 
activity specific for phosphatidylcholine and is highly conserved among members of 
the Vibrionaceae as a lecithinase/thermolabile hemolysin.  Plp has the ability to lyse 
fish erythrocytes because of the abundance of phosphatidylcholine in their membranes 
(9).  Additionally, mutations in plp result in increased expression of vah1 (16).  The 
second hemolysin gene cluster in V. anguillarum is the rtxACHBDE cluster (10), in 
which rtxHAC is divergently transcribed from rtxBDE.  The V. anguillarum RtxA is 
a major virulence factor for V. anguillarum with both hemolytic and cytotoxic activity 
(10).  While mutations of both vah1 and rtxA are required for the complete loss of 
hemolytic activity on sheep blood agar (10), mutations in plp, vah1, and rtxA are 
required for a 90% loss of hemolytic activity against fish erythrocytes.  Thus all three 
genes encode proteins that are major hemolysins in the fish host (9).  However, prior 
to this study, little was known about the regulation of these hemolysins in V. 
anguillarum.  
 It has been reported that HlyU regulates the expression of hemolysins in 
Vibrio species. In V. cholerae, HlyU positively regulates the expression of hemolysin 
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HlyA (23) and the HlyA co-regulated gene hcp (24).  It was also suggested that 
mutation of hlyU attenuates the virulence of V. cholerae O17 in the infant mouse 
cholera infection model (22).  Recent evidence suggests that HlyU is a master 
regulator of virulence in V. vulnificus, as several virulence factors, including vah1 and 
rtxA1, a homologue of rtxA of V. anguillarum, appear to be regulated by HlyU (8, 
11).  Therefore, we hypothesized that the hlyU gene in V. anguillarum might encode 
a regulator for both hemolysin clusters in V. anguillarum.  In this study, we used 
degenerate PCR to discover the unknown hlyU gene from the V. anguillarum 
genome. The experiment successfully identified an hlyU gene (Fig. 2) from V. 
anguillarum with strong homology to other hlyU genes in Vibrio species. 
HlyU is a member of SmtB/ArsR protein family.  Some members of this 
transcriptional regulator family, such as NolR of Rhizobium meliloti, SmtB of 
Synechococcus sp. strain PCC 7942, and ArsR of Staphylococcus aureus, act to 
repress target gene expression by binding metal ions to a metal binding site located on 
the repressor protein to enhance binding to the DNA binding site (19).  However, 
recent studies suggested that HlyU in V. cholerae acts as a positive regulator because 
of the absence of the metal binding site on HlyU (17).  Further, the crystal structure 
of HlyU from V. vulnificus strain CMCP6, recently solved by Nishi et al (15), 
confirmed that HlyU has no metal binding site.  Analysis of the HlyU amino acid 
sequence using the ClustalW program reveals that the V. anguillarum HlyU, as well as 
other Vibrio species (V. cholerae, V. vulnificus, V. fischeri, and V. parahemolyticus), 
does not contain a metal binding site and probably has similar binding characteristics 
to the homologues found in V. cholerae and V. vulnificus. 
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Evidence suggests that mutation of hlyU has a strong effect on virulence.  For 
example, a mutation in hlyU attenuates V. cholerae O17 virulence in the infant mouse 
cholera infection model (22).  In V. vulnificus, the LD50 increased about 104-fold in a 
hlyU mutant using the iron-overloaded mouse infection model (11) or the iron-normal 
mouse infection model (8).  Additionally, cytotoxic activity was lost in an hlyU 
mutant of V. vulnificus (11).  However, we found that in V. anguillarum cytotoxicity 
of the hlyU mutant remained relatively high according to both the LDH release assay 
and observations of morphological changes in ASK cells exposed to the hlyU mutant 
(Fig. 4).  These observations indicate that rtxA was still expressed in the hlyU mutant, 
even though rtxA expression was significantly decreased in the mutant (Fig. 5 and 
Table 4).  While our data indicate that HlyU is a positive regulator of rtxA, rtxH, and 
rtxB, these genes are still expressed in the absence of HlyU in V. anguillarum.  It is 
interesting to note that transcription of rtxA, rtxH, and rtxB in the wild type strain and 
hlyU mutant all decrease during stationary phase (Table 4).  This may suggest that 
either greater amounts of HlyU are required during stationary phase or that hlyU 
expression may be repressed during stationary phase. 
Additionally, cytotoxicity data were consistent with the hemolytic activity 
assay, in which the hlyU mutant did not completely eliminate the hemolysis on the 
sheep blood agar (Fig. 3), indicating that the hemolysins were expressed in the mutant.  
Interestingly, real-time RT-PCR data showed that the hlyU mutant did not effect the 
expression of vah1 and plp compared to the wild type strain (Table 4).  However, the 
observation that over-expression of HlyU in the hlyU complement dramatically 
increased expression of both vah1 and plp, suggests that vah1 and plp are regulated by 
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HlyU in a different manner than the rtx gene cluster.  This is supported by our 
previous observation that plp null mutations increase hemolysin activity and vah1 
transcription (16).  Thus the results presented here suggest that in addition to HlyU 
one or more other factors may regulate the hemolysins/cytotoxins of V. anguillarum.  
While HlyU is a positive regulator of V. cholerae hlyA (22, 23), there is no 
experimental evidence to demonstrate that HlyU binds to the hlyA promoter region.  
Therefore it is still unclear if HlyU is a direct transcriptional activator binding to the 
hlyA promoter region, or if it interferes with an unknown repressor of hlyA to cause 
de-repression of hlyA by HlyU (17).  The later assumption was recently supported by 
the study in V. vulnifucus where HlyU was found to bind to the upstream region of 
rtxH, which competes with the binding site of rtxA1 repressor H-NS (12).  Similar to 
V. anguillarum, expression of rtxH and rtxA1 in V. vulnificus are regulated by the 
same rtxH proximal promoter. Therefore, it was suggested that the absence of HlyU 
would increase the H-NS binding, which repressed the expression of rtxA1 in V. 
vulnificus (12).  It is reasonable to think that a similar situation might exist in the 
both hemolysin clusters of V. anguillarum.   
In this study, transcriptional start sites of both hemolysin clusters were 
identified, and promoter regions for the potential HlyU binding were targeted (Fig. 6).  
We found that the central regions of the intergenic sequence for each hemolysin gene 
cluster contains a conserved binding site for HlyU, as determined by both DNA 
mobility shift experiments (Fig. 7) and DNase I protection assays (Fig. 8).  The two 
binding sites are quite similar (Fig. 8); the intergenic rtxH-rtxB protected binding 
region is 18 bp long, while the intergenic plp-vah1 region is 22 bp long and both have 
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identical 5-bp direct repeats of TAAAA, strongly suggesting that HlyU binds as a 
dimer as suggested by Saha and Chakrabarti (17).  In fact, the direct repeat may be a 
bit longer than 5 bp.  If one uses an imperfect match, the direct repeat is 7-bp: 
(A/T)TAAAA(A/T).  Additionally, examination of the sequences immediately 
adjacent to the protected regions reveals that both the rtxH-rtxB and the plp-vah1 
intergenic regions contain 25-to 26-bp regions that are nearly identical with 10-bp 
inverted repeats at each end (Fig. 6).  The rtxH-rtxB intergenic region contains 
identical 10-bp inverted repeats at each end of its 25-bp region with a nucleotide 
sequence of: ATAATAAAAA.  Similarly, the plp-vah1 intergenic region has nearly 
identical 10-bp inverted repeats at each end of the 26-bp region.  The nucleotide 
sequence of the plp proximal repeat is: 5’-TTAATAAAAA-3’.  The nucleotide 
sequence of the vah1 proximal repeat is: 3’-ATATTAAAAT-5’.    Further, 
comparison between the HlyU binding sites identified here and the site identified by 
Liu et al (12) reveals that in both cases HlyU binds to AT-rich regions upstream of the 
transcriptional start sites of the regulated hemolysin genes.  However, Liu et al (10, 
12) found that HlyU bound far upstream (-376 to -417 bp) of the transcriptional start 
site of the rtxA1 operon.  In contrast, we have located HlyU binding somewhat closer 
to the start transcription sites of rtxH-rtxB and plp-vah1.  The binding site of HlyU is 
104 bp and 68 bp upstream of the rtxH and rtxB +1 sites, respectively, and 150 bp and 
145 bp upstream of plp and vah1 +1 sites, respectively.  While we have not yet 
demonstrated H-NS repressor binding to these regulatory regions in V. anguillarum, 
the shorter distance between HlyU binding sites and the transcriptional start sites in V. 
anguillarum compared to V. vulnificus may indicate that V. anguillarum has fewer 
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H-NS binding sites than the five sites found for the V. vulnificus rtxA1 regulatory 
region (12). 
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Table 1. Bacterial strains and plasmids used in this study. 
Strains Genotype and features References 
V. anguillarum   
M93Sm Spontaneous Smr mutant of M93 (serotype 
J-O-1) 
(3, 4) 
S305 Smr Cmr; M93Sm hlyU mutant This study 
S307 Smr Cmr Tetr; M93Sm hlyU complement This study 
S183 Smr Cmr Kanr; M93Sm rtxA vah1 double 
mutant 
(10) 
E. coli 
 
 
Sm10 thi thr leu tonA lacY supE recA 
RP4-2-Tc::Mu::Km (λ pir) 
(14) 
M15  NalS StrS RifS thi– lac– ara+ gal+mtl– F– 
recA+uvr+ lon+ (pREP4, KmR) 
Qiagen, USA 
Plasmid   
pNQ705-1 Cmr; suicide vector with R6K origin (14) 
pSUP202 E. coli – V. anguillarum shuttle vector  (14) 
PCR2.1 Cloning vector Invitrogen, USA 
pQE30UA Expression vector with N-terminal His6-tag QIAGEN, USA 
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Table 2.  Primers used in this study. 
Primers Sequence (5’ to 3’) Description 
Pm301 AGYTAYGARATGYTNGATACGTNAAYTA Degenerate hlyU F 
Pm302 CGTCGYCAGCAYAAYGCTAGCCGTCGYTC Degenerate hlyU R 
Pm297 ACTGAGAGCTCGGTGTTGTTAAAGGCTATGGC hlyU insertional mutation F 
Pm298 ATCGATCTAGAGTATCCACTAACCCATCTCTT hlyU insertional mutation R 
R vah1 RT (BF) GGCTCAACCTCTCCTTGTAACCAA 5’ RACE vah1 
plpF RT CAGACGACCACCAGTAACCACTAA 5’ RACE plp 
Pm112 TGGTTGTAAGCCGCAGCAC 5’ RACE rtxH 
Pm163 GGGGTATCTGAGTCACATGGATGAATT 5’ RACE rtxB 
Primer AP GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV 5’ RACE anchor primer 
Pm303 ATGGAAAAAAATTCCGCTAAAGCA Entire HlyU protein F 
Pm304 CTAGCGGCAGTATAAACCGTGTAA Entire HlyU protein R 
Pm305 CCCGGATCCGCAACTTATC hlyU complementation F 
89 
GGTCAGATTGATG 
Pm306 CCCGGATCCGATGCGCACTTACATGAAGAAAAC hlyU complementation R 
 
a
 Restriction sites for SacI (GAGCTC), XbaI (TCTAGA), EcoRI (GGATCC) are 
underlined.  V=A, C, or G; N=A, C, T, or G; R= A or G; Y=C or T 
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Table 3.  List of primers used to amplify DNA probes in DNase I protection 
assay. 
Intergenic 
Region 
Probe 
Name 
Probe 
Length  
Primer 
Name 
Primer 
Sequence 
Primer 5’ 
Label 
Primer 
Strand 
rtxH/rtxB 
Probe 
#4 336 bp 
Pm414 
CAGTGGCT
CATAAAAG
CAGTTGC 
6-FAM rtxH sense 
strand 
Pm318 
CAGCGGTA
AGTAGACT
GATA 
none 
rtxB sense 
strand 
Probe 
#5 394 bp 
Pm315 
CTCAGACA
TAAATAAA
TCACC 
none 
rtxH sense 
strand 
Pm415 
CAGCGGTA
AGTAGACT
GATAAGCA
ATG 
6-FAM rtxB sense 
strand 
plp/vah1 
Probe 
#2 496 bp 
Pm412 
CCGTATTT
TCTGCAAT
CGCCATGG  
6-FAM plp sense 
strand 
Pm322 
AAAATAAA
AGGACATT
GGTTTTTT
GG 
none 
vah1 sense 
strand 
Probe 
#3 468 bp 
Pm327 
GTATTTTC
TGCAATC 
GCCATG 
none 
plp sense 
strand 
Pm413 CACCTTTG
TGGCGAAT
6-FAM 
vah1 sense 
91 
TATTAATA
GATCTT 
strand 
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Table 4. Real time qRT-PCR analysisa 
  
V. 
anguillarum 
strainb 
Log phase Stationary phase 
rtxA 
expression 
RNA copy 
number M93Sm 2.74×10
4±1300 8.88×103±252 
  S305 3.45×103±800 4.47×102±15 
  S307 1.18×105±424 1.48×10
4±123
7 
 
Relative change 
(n-fold) in 
expression 
M93Sm 1 1 
  S305 - 7.94±0.4 -20.00±0.6 
  S307 4.30±0.01 1.68±0.14 
rtxB 
expression 
RNA copy 
number M93Sm 3.40×10
4±2298 2.92×104±736 
  S305 9.54×103±596 3.62×103±141 
  S307 9.83×104±6045 3.60×10
4±777
1 
 
Relative change 
(n-fold) in 
expression 
M93Sm 1 1 
  S305 -3.56±0.2 -8.07±0.3 
  S307 2.89±0.18 1.23±0.3 
rtxH 
expression 
RNA copy 
number M93Sm 4.74×10
4±0 1.93×10
4±933
3 
  S305 7.43×103±643 1.18×103±410 
  S307 1.46×10
5±1060
6 2.96×10
5±707 
 
Relative change 
(n-fold) in 
expression 
M93Sm 1 1 
  S305 -5.90±0.5 -15.1±6 
  S307 3.08±0.2 14.6±0.03 
vah1 
expression 
RNA copy 
number M93Sm 3.17×10
2±56 5.57×102±302 
  S305 3.36×102±17 6.92×102±58 
  S307 3.66×103±556 1.47×10
4±157
2 
 
Relative change 
(n-fold) in 
expression 
M93Sm 1 1 
  S305 1.06 ±0.05 1.24±0.1 
  S307 11.6 ±1.7 26.3 ±2.7 
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plp 
expression 
RNA copy 
number M93Sm 2.70×10
2±34 6.83×102±46 
  S305 4.22×102±62 3.27×102±53 
  S307 2.25×103±445 5.92×10
4±346
7 
 
Relative change 
(n-fold) in 
expression 
M93Sm 1 1 
  S305 1.56 ±0.05 -2.08 ±0.01 
  S307 8.32 ±1.1 86.2 ±7.8 
 
a
 The data presented is a representative experiment of two independent experiments.  
Each sample is the average of three replicates.  
b
 V. anguillarum strains: M93Sm (wild type), S305 (hlyU mutant), and S307 (hlyU 
complement).  
94 
Figure 1. The protein alignments of the hlyU flanking genes, encoding ribosomal 
protein S20P (A) and the transcriptional regulator NahR (B), in five Vibrio-related 
bacterial species. The rectangle bars above the alignment indicate the relative amount 
of conservation of amino acid residues. The black boxed regions were used to design 
the degenerate primers according to their original DNA sequences. The black arrows 
shows the orientation of primers.   
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Figure 2.  The degenerate PCR product was amplified from V. anguillarum M93Sm 
genomic DNA using primer pair Pm301/Pm302.  The PCR product was separated 
and visualized in a 1% agarose gel using a Promega® 1 kb DNA ladder as the size 
standard, and was 1.6 kbp long.  The PCR product was purified, cleaned, and cloned 
into PCR2.1 vector, and then transformed into E. coli DH5α strain. The plasmid, 
purified from the appropriate colony, was sequenced.  
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Figure 3.  Hemolytic activity of V. anguillarum strains M93Sm (wild type), S305 
(hlyU mutant) colonies, and S307 (hlyU complement) transferred onto 5% TSA-sheep 
blood agar, and incubated at 27ºC for 24 h.  Relative hemolytic activity was 
determined by measuring the β-hemolysis zone surrounding each colony.  
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Figure 4. The hlyU mutation and its complement did not significantly effect the 
cytotoxicity of V. anguillarum against ASK cells. (A) ASK cells were incubated with 
various strains of V. anguillarum at moi =100 for 4 h at 20ºC.  Data showed that 
strain S305 (hlyU mutant) still caused ASK cells to round-up, as did wild type strain 
M93Sm and strain S307 (hlyU complement).  ASK cells treated with NSS buffer 
(mock) exhibited no rounding or detachment during the course of the experiment. The 
photograph magnification was 100×. (B) LDH release from ASK cells treated with 
wild type M93Sm (), hlyU strain S305 (), hlyU complement S307 (), and 
rtxA/vah1 double mutant S183 (○) at various moi (20, 50, 100, and 200) for 4 h.  
LDH release was measured in Relative Fluorescence Units (RFU), and then calculated 
to yield % cytotoxicity according to the instructions of the manufacturer.  The 
incubation time at 0 was the base level of LDH in ASK cells treated with NSS buffer.  
Data are the representative of three separate experiments done with three replicates.  
Error bars show standard deviation of average. *, The statistical difference of strain 
S305 from the wild type treated data (P>0.1). 
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Figure 5.  HlyU regulates both hemolysin clusters positively at the transcriptional 
level. Semi-quantitative RT-PCR was used to determine the expression levels of rtxA, 
rtxB, rtxH, vah1, and plp with 100 µg of RNA extracted from V. anguillarum cells 
grown to exponential phase (A) and stationary phase (B).  Data show that the 
expression of rtxA, rtxB, and rtxH decreased in the hlyU mutant (S305).  However, 
expression of vah1 and plp did not decrease in S305, but did increase in the hlyU 
complement (S307).  The M93Sm genomic DNA was used as positive control (+).  
RT-PCR reactions with no added reverse transcriptase used as negative controls 
showed no amplified bands (data not shown). The DNA molecular size standards (Std) 
are a 100 bp Promega® DNA ladder. 
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 Figure 6.  Intergenic regions of the rtxACHBDE gene cluster (A) and vah1/plp gene 
cluster (B).  The transcriptional start sites of hemolysin genes are indicated by solid 
triangle marked with a +1.  The -10 and -35 promoter sequences of hemolysin genes 
are indicted by underlined nucleotides labeled as -10 and -35 and are predicted to be 
σ
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 promoters.  Black arrows indicate that start codons of genes. Lines indicating 
ribosomal binding sites of hemolysin genes are labeled RBS.  The boxed sequences 
represent inverted repeats located with the HlyU-DNase I protected sequences, which 
are indicated as protected region. 
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Figure 7.  DNA gel mobility shift demonstrating binding of purified HlyU to 
intergenic regions of the rtxACHBDE operon (A and B) and the vah1/plp gene cluster 
(C and D).  DIG-labeled DNA fragments of the intergenic region between rtxH and 
rtxB (A) and between plp and vah1 (C) were obtained by PCR amplification.  
Individual DIG-labeled fragments (0.4 ng) were reacted with no additions (lane 1), 
350 ng HlyU (lane 2), and 350 ng HlyU + 100 ng unlabeled DNA fragment (lane 3); 
Panel B – fragments a, b, and c from the intergenic regions of the rtxACHBDE operon; 
and Panel D – fragments d, e, f, g, and h from the intergenic regions of the vah1/plp 
gene cluster. 
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Figure 8.  Capillary electrophoresis of 6-FAM labeled DNA fragments b (A) and f 
(B) from DNase protection assays in the presence (grey traces) and absence (black 
traces) of HlyU demonstrating that HlyU binds to specific sequences in fragments b 
and f of the rtxACHBDE and plp/vah1 intergenic regions, respectively, and protects 
against DNase I digestion.  DNA fragments b and f were prepared and labeled with 
6-FAM, reacted with HlyU (0 or 1.88 µg) followed by DNase I, and then analyzed by 
DNA fragment analysis as described in the Materials and Methods.  The double 
black lines show the binding regions.  The binding region sequences are shown 
below the double black line.  Underlined bases indicate those that are higher in the 
presence of HlyU (grey trace) than in its absence (black trace). 
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Abstract 
Hemolysins produced by V. anguillarum have been implicated in the 
development of hemorrhagic septicemia during vibriosis, a fatal fish disease.  
Previously, two hemolysin gene clusters were identified in V. anguillarum, the 
vah1-plp gene cluster and the rtxACHBDE gene cluster, which are responsible for the 
hemolysis and cytotoxicity of V. anguillarum.  In this study, we identified the hns 
gene, which encodes the H-NS protein, and acts as a negative regulator of the both 
gene clusters.  The V. anguillarum H-NS protein shares strong homology with other 
bacterial H-NS proteins.  An hns mutant exhibited increased hemolytic activity and 
cytotoxicity compared to the wild type strain.  Complementation of the hns mutation 
restored hemolytic activity and cytotoxicity levels to near wild type levels.  Further, 
expression of rtxA, rtxH, rtxB, vah1 and plp increased in the hns mutant, and 
decreased in the complemented hns mutant strain when compared to the wild type 
strain.  Additionally, experiments using DNase I, showed that purified recombinant 
H-NS protected multiple sites in the promoter region of both gene clusters.  The hns 
mutant also exhibited significantly attenuated virulence against rainbow trout.  
Complementation of the hns mutation restored virulence to wild type levels, 
suggesting that H-NS regulates many genes that affect fitness and virulence.  
Previously, we showed that HlyU is a positive regulator of expression for both gene 
clusters. In this study, we demonstrate that up-regulation by hlyU is hns-dependent, 
suggesting that H-NS acts to repress or silence both gene clusters, and HlyU acts to 
relieve that repression or silencing.  
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Introduction 
Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic 
septicemic disease.  V. anguillarum infects more than 50 fresh and salt-water fish 
species including various species of economic importance to the larviculture and 
aquaculture industry, such as salmon, rainbow trout, turbot, sea bass, sea bream, cod, 
eel, and ayu (1).  Infections by this bacterium have a mortality rate of 30% to 100% 
resulting in severe economic losses to aquaculture worldwide (2). 
The ability of V. anguillarum to infect and cause disease in fish is dependent 
upon several virulence factors and their proper regulation (3).  One of these virulence 
factors is hemolytic activity.  In V. anguillarum M93Sm there are two known gene 
clusters that encode at least three hemolysins (4, 5).  Rock and Nelson (4) reported 
that the vah1-plp hemolysin gene cluster (Fig. 1A) contains at least two genes, vah1 
and plp, that affect hemolytic activity.  Vah1 (encoded by vah1) is a putative 
pore-forming hemolysin causing vacuolization of target cells with strong amino acid 
sequence identity to Vibrio cholerae EI Tor hemolysin (hlyA) and V. 
fluvialis hemolysin (5).  Mutations in the divergently transcribed plp result in both 
increased expression of vah1 and increased hemolysis of sheep’s blood, suggesting 
that Plp (encoded by plp) is a putative repressor of vah1 transcription (4).  
Restoration of plp by complementation restores the wild-type level of vah1 
transcription and hemolysis (4).  Plp is a phosphotidylcholine (PC)-specific PLA2, 
which causes lysis of PC–rich fish erythrocytes (L. Li et al., unpublished data).  
These observations suggest that Plp plays a dual role both as a repressor and as a 
phospholipase.  A second hemolysin gene cluster, rtxACHBDE (Fig. 1B), was 
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identified in V. anguillarum (5).  This gene cluster contains rtxA, which encodes a 
multifunctional autoprocessing repeat-in-toxin (MARTX) toxin, and specialized T1SS 
genes (rtxDBE) responsible for the secretion of RtxA.  RtxA exhibits cytotoxic 
activity causing Atlantic salmon kidney (ASK) cells to round and die (5).  Loss of 
rtxA function results in avirulence (5), while mutation of vah1 causes slight 
attenuation of V. anguillarum virulence (4).  Mutations in both vah1 and rtxA lost 
98% cytotoxicity in ASK cells, suggesting Vah1 and RtxA are the major two 
cytotoxin when ASK cells are treated with V. anguillarum (6).  These observations 
strongly suggest that the RtxA hemolysin is a major virulence factor of V. 
anguillarum, while vah1 plays a more minor role in virulence. 
The histone-like nucleoid structuring protein (H-NS) is a conserved global 
regulator that belongs to a family of small nucleoid-associated proteins, including the 
factor for inversion stimulation (FIS), the heat-unstable protein (HU), and the 
integration host factor (IHF) (7).  It is reported that function of H-NS is based on 
self-oligomerization and binding to DNA motifs to create DNA–protein–DNA bridges 
that can impede the movement of RNA polymerase (8).  H-NS has been shown to 
repress expression of several virulence genes, including cholera toxin ctx (9, 10) and 
exopolysaccharide biosynthesis (vps) genes in V. cholerae (10, 11), the RTX toxin 
gene (rtxA1) in V. vulnificus (12), and T3SS1 genes in V. parahaemolyticus (13).  In 
many bacterial species, repression by H-NS can be relieved by other regulators, and 
each bacterial system has developed specific approaches to attenuate the H-NS 
repressive action (8).  In V. vulnificus, HlyU acts as a competitor that antagonizes the 
binding of H-NS, resulting in derepression of rtxA1 (12).  Transcriptional silencing 
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of V. cholerae tcpA and ctx promoters by H-NS is antagonized by the AraC-like 
transcriptional regulator ToxT and IHF (10, 14, 15).  While there is no report 
regarding H-NS in V. anguillarum, we hypothesize that H-NS is a regulator of the two 
hemolysin gene clusters in V. anguillarum. 
In this study, we identified the sequence of an hns homologue in V. 
anguillarum using the V. anguillarum M93Sm draft genome, and subsequently 
constructed several hns mutant strains, including an hns mutant, an hns/hlyU double 
mutant,an hns/hlyU double mutant with hns complemented and an hns/hlyU double 
mutant with hlyU complemented.  The hemolytic activity and cytotoxicity of these 
strains were determined.  The expression levels of various hemolysin genes, 
including vah1, plp, rtxA, rtxH and rtxB in these strains were also quantified.  
Additionally, the H-NS binding sites in the intergenic regions in both hemolysin gene 
clusters were localized.  Finally, the virulence of the hns mutant and hns 
complemented strains was tested in rainbow trout (Oncorhynchus mykiss) and 
compared to the virulence of the wild type strain. 
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Materials and Methods 
Identification of genes in V. anguillarum.  V. anguillarum M93Sm draft genome 
(unpublished data) was annotated by the RAST (Rapid Annotation using Subsystem 
Technology) service (http://rast.nmpdr.org/rast.cgi) using the default settings (16).  
 
Fish cell line, bacterial strains, plasmids and growth conditions.  Atlantic salmon 
kidney (ASK) cells (American Type Culture Collection (ATCC) Manassas, VA) were 
cultured at 20ºC in Leibovitz-15 medium containing 100 µg/ml streptomycin, and 
17% fetal bovine serum (FBS) (Life Technologies, Grand Island, NY).  All bacterial 
strains and plasmids used in this report are listed in Table 1.  V. anguillarum strains 
were routinely grown in Luria-Bertani broth plus 2% NaCl (LB20) (17), supplemented 
with the appropriate antibiotic, in a shaking water bath at 27°C.  E. coli strains were 
routinely grown in Luria-Bertani broth plus 1% NaCl (LB10).  Antibiotics were used 
at the following concentrations: streptomycin, 200 µg/ml (Sm200); ampicillin, 100 
µg/ml (Ap100); chloramphenicol, 20 µg/ml (Cm20) for E. coli and 5 µg/ml (Cm5) for V. 
anguillarum; kanamycin, 50 µg/ml (Km50) for E. coli and 80 µg/ml (Km80) for V. 
anguillarum; tetracycline, 15 µg/ml (Tc15) for E. coli, 1 µg/ml (Tc1) for V. 
anguillarum grown in liquid medium, and 2 µg/ml (Tc2) for V. anguillarum grown in 
solid medium. 
 
Insertional mutagenesis.  Insertional mutations were made by using a modification 
of the procedure described by Milton et al. (18). Briefly, primers SD_hns(F) and 
SD_hns(R) (Table 2) were designed based on the target gene sequence of M93Sm.  
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Then a 200-300 bp DNA fragment of hns was PCR amplified and ligated into the 
suicide vector pNQ705 (GenBank accession no. KC795685) after digestion with SacI 
and XbaI.  The ligation mixture was introduced into E. coli Sm10 by electroporation 
using BioRad Gene Pulser II (BioRad, Hercules, CA).  Transformants were selected 
on LB10 Cm20 agar plates.  The construction of pNQ705-hns was confirmed by both 
PCR amplification and restriction analysis.  The mobilizable suicide vector was 
transferred from E. coli Sm10 into V. anguillarum M93Sm by conjugation (18). 
Transconjugants were selected by utilizing the chloramphenicol resistance gene 
located on the suicide plasmid.  The incorporation of pNQ705-hns was confirmed by 
PCR amplification. 
 
Construction of hns/hlyU double mutant.  The hns/hlyU double mutant was 
constructed by allelic exchange of hns, followed by insertional mutation of hlyU.  
The allelic exchange mutation was made by using a modification of the procedure 
described by Milton et al. (18).  Briefly, the plasmid pDM4 (GenBank accession no. 
KC795686) was used to construct the hns::Km allelic exchange mutant as described 
previously (18).  The 5′ region of hns was amplified using the primer pair pr40 and 
pr41 (Table 2), digested with XhoI and XbaI, and then cloned into the region between 
the XhoI and XbaI sites on pDM4.  The 3′ region of hns was amplified using the 
primer pair pr42 and pr37 (Table 2), digested with XbaI and SacI, and then cloned into 
the region between the XbaI and SacI sites on the derivative pDM4 containing the 5’ 
region of hns.  Finally, the kanamycin resistance gene was amplified from the 
TOPO2.1 vector (Life Technologies) with the primer pair pr38 and pm173 (Table 2), 
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digested with XbaI, and inserted into the XbaI site between the 5′ and 3’ hns regions 
on the derivative pDM4.  The resulting pDM4-hns::Km was transformed into E. 
coli Sm10 to produce the transformant strain D112, which was mated with V. 
anguillarum M93Sm.  Single-crossover transconjugants were selected with LB20 
Kan80 Sm200 Cm5 plates and, subsequently, double-crossover transconjugants were 
selected with LB20 Kan80 Sm200 5% sucrose plates.  The resulting V. 
anguillarum mutants were checked for the desired allelic exchange using PCR 
amplification and then subjected to insertional mutation of hlyU as described above. 
 
Complementation of the mutants.  The various mutants were complemented by 
cloning the appropriate target gene fragment into the shuttle vector pSUP202 
(GenBank accession no. AY428809) as described previously by Rock and Nelson (4). 
Briefly, primers hns_comp(F) and hns_comp(R) (Table 2) were designed with a PstI 
site added at the 5’ end of each primer.  The primer pair was then used to amplify the 
entire target gene plus ~500 bp of the 5’ and ~200 bp 3’ flanking regions from 
genomic DNA of V. anguillarum M93Sm.  The DNA fragment was then ligated into 
pSUP202 after digestion with EcoRI and AgeI, and the ligation mixture was 
introduced into E. coli Sm10 by electroporation using a BioRad Gene Pulser II.  
Transformants were selected on LB10 Tc15Ap100 agar plates.  The complementing 
plasmid was transferred from E. coli Sm10 into the V. anguillarum mutant by 
conjugation (18).  Transconjugants were selected by utilizing the tetracycline 
resistance gene located on the plasmid.  The transconjugants were then confirmed by 
PCR amplification and restriction digestion. 
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Hemolytic activity assay.  The blood agar hemolysis assay was carried out using the 
method described by Rock et al. (4).  Briefly, V. anguillarum colonies were 
transferred onto blood agar plates and hemolytic activity was determined by 
measuring the diameter of β-hemolysis on plates containing Trypticase soy agar (TSA) 
plus either 5% sheep (Northeast Laboratories Service, Waterville, ME) or 5% trout 
blood after 24 h at 27°C.  Trout blood was taken from live, healthy, farm-raised 
rainbow trout (Oncorhynchus mykiss) using a 3 ml sterile syringe supplemented with 
10 µl 0.5M Disodium EDTA (Sigma-Aldrich).  The blood was then stored on ice and 
used in casting plates within 6 hours. 
 
Cytotoxicity assay.  This assay was carried out using a modification of the method 
described by Li et al. (6).  Cytotoxic activity of V. anguillarum strains was 
determined by measurement of released lactate dehydrogenase (LDH).  ASK cells 
(20,000 cells/well for assays using V. anguillarum supernatants and 10,000 cells/well 
for assays using washed V. anguillarum cells) were seeded into a 96-well tissue 
culture plate and incubated in Leibovitz’s L-15 medium supplemented with 17% FBS 
at 20°C for 24 h to allow cells to attach.  V. anguillarum cultures grown for 18 h 
were centrifuged (9,000 × g, 5 min, 4°C).  The resulting culture supernatant was 
harvested and filter-sterilized using 22 m filters (Millipore Corp., Billerica, MA).  
The bacterial pellet was washed twice in nine salts solution (NSS) (19) and 
resuspended in fresh NSS (at ~2 × 109 cells ml-1).  V. anguillarum culture supernatant 
(50 µl) was added to wells containing ASK cells plus 50 µl pH =7.4 phosphate 
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buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM 
KH2PO4) and incubated at 20°C for 6 h.  Washed bacterial cells were added to ASK 
cells at multiplicities of infection (MOI) = 200 and incubated at 20°C for 4 h.  To 
determine the release of LDH, a CytoTox-ONE Homogeneous Membrane Integrity 
Assay Kit (Promega, Madison, WI) was used following the manufacturer’s 
instructions.  The assay measures the generation of the fluorescent resorufin product, 
which is proportional to the amount of LDH at 560 nmExcitation/590 nmEmission.  
Fluorescence was read by a Stratagene MX3005P QPCR System at 550 nmExcitation/570 
nmEmission. 
 
RNA isolation.  Exponential phase cells (~0.5 × 108 CFU ml-1) and stationary phase 
cells (2 × 109 CFU ml-1) of various V. anguillarum strains were treated with 
RNAprotect Bacteria Reagent (QIAGEN, Valencia, CA), following the 
manufacturer’s instructions.  Total RNA was isolated using the RNeasy kit and 
QIAcube (QIAGEN) following the manufacturer’s instructions.  All purified RNA 
samples were quantified spectrophotometrically by measuring absorption at 260 nm 
and 280 nm using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific, Pittsburgh, PA) and stored at -75ºC for future use. 
 
Real-time quantitative RT-PCR (qRT-PCR).  qRT-PCR was used to quantify 
various mRNAs using an Mx3005 Multiplex Quantitative PCR System and the 
Brilliant II SYBR Green Single-Step QRT-PCR Master Mix (Agilent Technologies, 
Wilmington, DE ), with 10 ng of total RNA in 25 µl reaction mixtures.  The thermal 
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profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 30 s and 
55°C for 30 s.  Fluorescence was measured at the end of the 55°C-step during every 
cycle.  Samples were run in triplicate along with no-RT and no-template controls.  
All experiments were repeated at least twice. 
 
Over-expression and purification of the V. anguillarum H-NS protein.  The DNA 
fragment encoding H-NS was PCR amplified by using Pm416 and Pm417 (Table 2) 
and cloned into a six-His tag expression plasmid, pQE30-UA (QIAGEN), generating 
the plasmid pQE-30 UA/H-NS (Table 1), which encodes H-NS with an N-terminal 
fusion tag.  The correct recombinant clone (confirmed by sequencing) was used for 
expression of His-tagged H-NS protein in E. coli M15.  Expression and purification 
of rH-NS was carried out using a modification of the procedures described in Li et al. 
(6).  Briefly, 10 ml of an overnight bacterial culture growing at 37°C in Luria broth 
supplemented with 50 µg/ml kanamycin and 100 µg/ml ampicillin, was added to 250 
ml of the same fresh medium.  When the OD600 reached 0.6, 1 mM IPTG was added 
to induce the expression of the H-NS protein.  After bacteria were grown for an 
additional 5 h at 37°C, the cells were collected and lysed by sonication under 
non-denaturing conditions.  The soluble supernatant containing rH-NS was then 
purified from this fraction by affinity chromatography using Ni-nitrilotriacetic acid 
resin columns (QIAGEN), according to the manufacturer's instructions.  The 
concentration of the purified rH-NS protein was determined by measuring the 
absorbance at 280 nm using a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific).  The purity of the rH-NS was assessed by SDS-polyacrylamide gel 
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electrophoresis with only a single band visible following staining with Coomassie 
blue. 
 
DNase I protection assay.  DNA probes for the intergenic region of each of the 
hemolysin gene clusters were amplified from V. anguillarum genomic DNA using 
PCR (Table 2).  Probes were labeled with 6-FAM at the 5’ end of a certain strand of 
each probe (Fig. S1).  The assay was carried out using a method modified from Li et 
al. (6).  Briefly, 7.5 × 1011 copies of DNA probe and various amounts of rH-NS (up 
to 3 µM) were incubated for 1 h at 27°C in a total volume of 20 µl, containing 4 µl of 
5× binding buffer, 1 µg poly-L-lysine, and 1 µg poly [d(I-c1)] (DIG Gel Shift Kit, 2nd 
Generation, Roche Applied Science, Indianapolis, IN ). The DNA-protein complex 
was then digested by adding 0.005 U RQ1 RNase-free DNase (New England Biolabs, 
Ipswich, MA) in a total volume of 25 µl containing 2.5 µl of 10× concentrated 
reaction buffer at 37°C for 15 min. The reaction was stopped by heating (95°C, 10 
min).  The DNA was purified using a QIAquick PCR Purification Kit (QIAGEN) 
using a QIAcube and its standard protocol, except that the elution volume was 
adjusted to 30 µl. The DNA in the eluate (3 µl) was added to 9 µl Hi-Di Formamide 
containing 1 µl GeneScan 600 LIZ size standard (Applied Biosystems) and the 
mixture was submitted to capillary electrophoresis fragment analysis (Rhode Island 
Genomics and Sequencing Center). 
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GC content plotting.  GC content of the two gene clusters (shown in Fig. 1) were 
plotted using the GC-Profile program (http://tubic.tju.edu.cn/GC-Profile) (20) using 
the following settings (Halting parameter = 1; Minimum length to segment = 100 bp). 
 
Fish infection studies.  Various V. anguillarum strains were tested for virulence with 
rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection.  Briefly, V. 
anguillarum cells grown in LB20 supplemented with appropriate antibiotics for 22 h 
at 27°C were harvested by centrifugation (9,000 × g, 5 min, 4°C), washed twice in 
NSS, and resuspended in NSS (~2 × 109 cells ml-1).  Initial cell density was estimated 
by measurement of optical density at 600 nm.  The actual cell density of NSS 
suspensions was determined by serial dilution and spot plating.  All fish were 
examined prior to the start of each experiment to determine that they were free of 
disease or injury.  It should be noted that all the negative control fish survived.  Fish 
were anesthetized with tricaine methanesulfonate (Western Chemical, Ferndale, WA), 
with 100 mg/L for induction and 52.5 mg/L for maintenance.  V. anguillarum strains 
were IP-injected into fish in 100 l NSS vehicle.  Fish that were between 15 and 25 
cm long were injected with bacteria diluted with NSS at a dose of ~4×105 CFU/fish, or 
NSS only as negative control.  Ten fish were used for each experimental group.  
Fish inoculated with different bacterial strains were maintained in separate 10-gallon 
tanks with constant water flow (200 ml/min) at 19 ± 1 ºC.  The tanks were separated 
to prevent possible cross-contamination.  Death due to vibriosis was determined by 
the observation of gross clinical signs and confirmed by the recovery and isolation of 
V. anguillarum cells resistant to the appropriate antibiotics from the head kidney of 
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dead fish.  Observations were made for 14 days.  All fish used in this research 
project were obtained from the URI East Farm Aquaculture Center.  All fish 
infection protocols were approved by the URI IACUC. 
 
Statistical analysis.  Two-tailed Student's T-tests assuming unequal variances were 
used for statistical analyses for all experiments except for the fish infection experiment 
(P values of <0.05 were considered statistically significant.  For fish infection 
experiments, a Kaplan-Meier survival analysis with log rank significance test was 
performed on fish survival percentage (P values of <0.05 were considered statistically 
significant). 
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Results 
Identification of hns in V. anguillarum.  The V. anguillarum hns gene (GenBank 
accession number KC795684) was found in the RAST annotation of V. anguillarum 
M93Sm draft genome (unpublished data).  It encodes for a predicted 137 amino acid 
protein with a molecular mass of 15,299 Da and has strong homology to H-NS 
proteins found in a variety of Vibrio species including Vibrio harveyi (92% similarity 
and 84% identity), Vibrio coralliilyticus (84% similarity and 76% identity), V. 
cholerae (90% similarity and 82% identity), V. parahaemolyticus (90% similarity and 
85% identity), and V. vulnificus (93% similarity and 87% identity).  
 
Mutation of hns increases hemolytic activity.  It was previously shown that V. 
anguillarum wild type cells exhibit β-hemolysis on 5% TSA-sheep blood agar (5).  
When the hemolytic activity of the hns mutant (M114, hns-) was tested on 5% 
TSA-sheep blood agar, it was found that mutation of hns resulted in increased 
hemolysis when compared to the wild type (M93Sm) (Fig. 2).  Further, when the hns 
mutation was complemented (M116, hns+), hemolysis was reduced to levels below 
wild type (Fig. 2), suggesting that H-NS is a negative regulator of at least one of the 
two hemolysins, RtxA and Vah1.  The lower hemolytic activity was probably due to 
the overexpression of H-NS since pSUP202 is a multicopy plasmid. 
 
Mutation of hns increased cytotoxicity against Atlantic salmon kidney (ASK) 
cells.  It was previously demonstrated that both vah1 or rtxA contribute to the 
cytotoxicity of V. anguillarum cells against ASK cells (5).  In order to determine 
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whether hns acts to regulate cytotoxic activity, we tested the cytotoxic activity of both 
culture supernatants and washed cells from the hns mutant (hns-) and the 
complemented hns mutant (hns+) and compared their activities against culture 
supernatant and washed cells from the wild type (M93Sm).  The results show that 
mutation of hns significantly increased the cytotoxicity of both V. anguillarum culture 
supernatant by >40%, and cells (MOI 200) by ~80% against ASK cells compared to 
wild type V. anguillarum M93Sm.  Complementation of the hns mutation decreased 
cytotoxicity significantly of both culture supernatant and cells against ASK cells 
compared to the cytotoxic activities of the hns mutant (Fig. 3A and B).  These data 
support the suggestion that hns negatively regulates at least one of the two 
hemolytic/cytotoxic activities encoded by rtxA and vah1. 
 
H-NS negatively regulates hemolysin genes at the transcriptional level.  Since the 
two hemolysin/cytotoxin gene clusters are each organized into two divergent 
transcriptional units (Fig. 1) with intergenic regions shown to bind HlyU (6), we 
wanted to investigate the effects of H-NS upon the expression of the various genes 
within the gene clusters.  Real-time qRT-PCR was performed to quantify expression 
of members of the hemolysin gene clusters, including vah1, plp, rtxA, rtxH, and rtxB, 
in the wild-type strain (M93Sm), hns mutant (hns-), and the hns complement (hns+) 
during both exponential and stationary growth phases.  Real time qRT-PCR data 
revealed that in the hns mutant during exponential and stationary phase, respectively, 
when compared to the wild type, expression of rtxA increased by 2.91- and 2.14-fold; 
expression of rtxB increased by 1.28- and 1.43-fold; and expression of rtxH increased 
126 
by 4.56- and 2.39-fold; and expression of vah1 increased by 16.21- and 20.01-fold; 
and expression of plp increased by 31.27 and 36.88-fold (Fig. 4 and Table S1).  
Further, complementation of the hns mutation down-regulated the expression of these 
genes back to or below wild type levels.  The data strongly suggest that H-NS is a 
negative regulator of gene expression from both the rtxACHBDE and vah1-plp gene 
clusters. 
  
Mutation of hns does not affect the expression of hlyU.  Since HlyU had 
previously been shown to bind to the intergenic regions of both hemolysin gene 
clusters to increase their transcription (Li et al. 2011), we wanted to determine 
whether mutation of hns would affect hlyU transcription.  Real-time qRT-PCR was 
performed to measure the expression of hlyU in the wild-type strain (M93Sm), the hns 
mutant (hns-), and the hns complement (hns+) during exponential and stationary 
growth phases (Fig. S2A).  No statistically significant difference in expression of 
hlyU was found between M93Sm and both the hns mutant (hns-) and the hns 
complement (hns+) in either log phase or stationary (Fig. S2A).  These results rule 
out the possibility that H-NS regulates hemolysin gene expression by regulating the 
expression of hlyU. 
 
Up-regulation of hemolysin genes by hlyU is hns-dependent.  As noted above, Li 
et al. (6) showed that an hlyU mutant (S305, hlyU-) had decreased hemolytic activity 
on sheep blood agar compared to wild type, and that complementation of hlyU (S307) 
resulted in increased activity compared to the wild type.  In an effort to determine the 
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roles of hns and hlyU in the regulation of hemolysin gene transcription, we examined 
the hemolytic activity and measured the transcription of hemolysin genes (vah1, plp, 
rtxA, and rtxB) in each hemolysin transcriptional unit.  The first set of these 
determinations was carried out in cells lacking a functional hlyU: the hlyU mutant 
(hlyU-), the hns/hlyU double mutant (ES114, hns-/hlyU-), and the hns/hlyU double 
mutant with hns complemented (ES116, hns+/hlyU-); determinations of hemolytic 
activity and hemolysin gene expression were also done for wild type M93Sm (Fig. 5).  
Hemolytic activity in the hlyU mutant decreased compared to that of wild type 
M93Sm, as previously reported by Li et al. (6).  In contrast, hemolytic activity in the 
hlyU/hns double mutant increased over that in M93Sm and when hns was 
complemented in the double mutant, hemolysis decreased to levels seen in the hlyU 
mutant (compare Fig. 5A with Fig. 2).  Changes in transcription of rtxA, rtxB, vah1, 
and plp corresponded with the changes in hemolysis (Fig. 5B and Table S1).  
Specifically, transcription of each gene (rtxA, rtxB, vah1, and plp) increased in the 
absence of a functional hns and decreased in the presence of a functional hns. 
The second set of determinations was carried out in cells lacking a functional 
hns: the hns mutant (hns-), the hns/hlyU double mutant (hns-/hlyU-), and the hns/hlyU 
double mutant with hlyU complemented (ES115, hns-/hlyU+); determinations of 
hemolytic activity and hemolysin gene expression were also done for wild type 
M93Sm (Fig. 6).  In absence of a functional hns, hemolytic activity increased 
regardless of the presence or absence of hlyU (Fig. 2 and Fig. 6A).  Determination of 
hemolysin transcription by RT-qPCR corresponded with the hemolysis assay (Fig. 6B).  
In absence of hns, rtxA and rtxB expression increased over levels in wild type cells.  
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For rtxA, all increases were >2-fold and significant (P<0.05).  For rtxB, increases 
were small (generally <2-fold) and generally not significant.  The presence or 
absence of hlyU had little or no effect (<2-fold) on rtxA and rtxB gene expression (Fig. 
6B and Table S1).  Similarly, in the absence of a functional hns, expression of both 
vah1 and plp increased >9-fold in both exponential and stationary phase cells 
regardless of the presence or absence of a functional hlyU (Fig. 6B and Table S1).  
As with the rtxACHBDE gene cluster, our data show that in absence of hns, the 
complement of hlyU (hns-/hlyU+) only exhibited minimal changes in expression of 
both vah1 and plp (around 2-fold) over the hns- strain and almost no change in vah1 
and plp expression between the two strains (Fig. 6B and Table S1).  These data 
indicate that up-regulation of hemolysin genes by hlyU is hns-dependent. 
  
H-NS binds to the intergenic region of both hemolysin gene clusters.  Previously, 
Li et al. (6) demonstrated that HlyU binds to the intergenic regions between the 
divergently transcribed genes of each of the two hemolysin gene clusters to upregulate 
gene expression.  In an effort to determine whether H-NS acted in a similar fashion 
to help regulate expression of the hemolysin gene clusters in V. anguillarum, we 
carried out DNase I protection assays as described in the Materials and Methods.  
The results of these experiments revealed that rH-NS protected multiple regions in 
both rtxB/H and vah1/plp intergenic regions (Fig. 7). These regions are AT-rich 
(72-74% AT) and correspond to other H-NS binding sites described in other bacteria 
(21-27) (Fig. 8). The H-NS binding sites cover the promoter regions of all four genes 
(rtxB, rtxH, plp, vah1) with little or no overlap with the HlyU binding site in each of 
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the intergenic regions (Fig. 8) (6).  In the vah1/plp intergenic region, rH-NS bound to 
five sites, covering the -10 and -35 regions of both plp and vah1 promoters, but did not 
cover the HlyU binding site.  In the rtxB/H intergenic region, rH-NS bound to six 
sites, covering the -35 region of both rtxB and rtxH promoters.  In addition, rH-NS 
also bound to a seventh site just within the rtxB coding sequence.  The rH-NS also 
was found to protect the three rtxB-proximal bases of the HlyU binding site (Fig. 8). 
 
The vah1-plp and the rtxACHBDE gene clusters are unlikely to have been 
horizontally acquired. Recently, it was reported that a major role of H-NS proteins is 
to silence horizontally acquired genetic elements distinguished by AT-rich sequences 
(25-27).  This raised the question of whether either or both of the hemolysin gene 
clusters (rtxACHBDE and vah1-plp) might be xenogenic in origin.  We examined the 
GC content of the two gene clusters and compared them to the average GC content of 
the whole genome of V. anguillarum.  The result of this examination revealed that 
the GC content of the rtxACHBDE gene cluster is 47.3% and the GC content of the 
vah1-plp gene cluster is 42.5%.  Both values are very similar to the average GC 
content of the whole genome (44.51%) of V. anguillarum (28).  The intergenic 
regions do have low GC/elevated AT percentages, with the plp-vah1 intergenic region 
at 26% GC and the rtxB/H region at 28% GC (Fig. 1).  Additionally, examination of 
the published V. anguillarum 775 genome (GenBank assembly ID 
GCA_000217675.1 ) revealed that the placement of the hemolysin genes in relation to 
the surrounding genes, within 7.5 kbp to 10 kbp of DNA flanking each gene cluster, is 
the same as that found in strain M93Sm.  Further, we saw no evidence of any tRNA 
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genes, tranposases, interrupted genes, or pseudogenes in these surrounding regions.  
Finally, when we examined the codon usage patterns for the hemolysin genes and 
compared them to the chromosome in which each is found (rtx genes in choromosome 
I and plp and vah1 in chromosome II), no significant differences were found.  These 
observations suggest that while the two hemolysin gene clusters are negatively 
regulated by H-NS, they were not horizontally acquired.  
 
The hns mutant has attenuated virulence against rainbow trout.  Since the 
expression of both hemolysin gene clusters is affected by H-NS, we tested the 
virulence of M93Sm, hns-, and hns+.  Groups of ten rainbow trout were infected by 
IP-injection as described in the Materials and Methods with the wild type M93Sm. 
hns-, or hns+ stains of V. anguillarum in NSS at a dose of ~4 × 105 CFU/fish, or with 
NSS only as a negative control.  All M93Sm infected trout died by day 4, while 60% 
of hns- infected trout died by day 14.  These results (Fig. 9) show that there was a 
significant difference (P = 0.005) in the virulence of the M93Sm wild type and the hns 
mutant.  Complementation of hns restored virulence back to wild type levels with 
90% mortality by day 4.  Thus there was a significant difference (P = 0.029) in the 
virulence of the hns+ and hns- strains, and no significant difference (P = 0.413) 
between the wild type and hns+ strains.   
At first glance, the decline in virulence for the hns mutant would appear to be 
counterintuitive, since both hemolysin gene clusters are up regulated in the hns mutant.  
However, hns is considered important for bacterial fitness by properly regulating 
virulence and other genes during growth (26, 27).  To determine whether the loss of 
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hns affected the growth of V. anguillarum, we tested the growth of M93Sm, hns-, and 
hns+ in LB20 (Fig. S3).  While the three strains grew to nearly identical cell 
densities (OD600 = 1.04 (M93Sm), 0.97 (hns-) and 0.97 (hns+) at stationary phase, 
hns- had a longer generation time compared to the wild type (58 min vs. 48 min, P 
<0.05).  However, complementing the hns mutation did not result in a shorter 
generation time than the hns- (60 min vs. 58 min), suggesting there is no correlation 
between virulence in fish and fitness in LB20 for these three strains. 
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Discussion 
Vibriosis caused by V. anguillarum has been recognized as a major problem 
for salmonid culture due to the significant economic loses it causes (29).  While these 
bacteria use a variety of virulence factors including: iron transport/siderophore 
systems (30), the EmpA metalloprotease (31, 32), motility (33, 34), 
lipopolysaccharides (LPS) (33, 34), and exopolysaccharides (EPS) (35), it is the 
hemolysins/cytotoxins that directly kill host cells (4, 5) and are thought to be the major 
contributors to the hemorrhagic septicemia that is characteristic of vibriosis (2).  
Previously, we identified and described three hemolysin/cytotoxin genes in V. 
anguillarum M93Sm, vah1 (4, 36), rtxA (5) and plp (4) (Li, Mou, and Nelson 
unpublished data).  The three hemolysin genes (and associated transport genes) are 
organized into two gene clusters (Fig. 1).  Additionally, both hemolytic activity and 
expression of the three hemolysin genes, vah1, plp and rtxA, are all higher in log phase 
than in stationary phase (6).  Recently, we reported that HlyU positively regulates the 
expression of both hemolysin gene clusters by specifically binding to the vah1/plp and 
the rtxB/H intergenic regions (6).   
In this study, we examined the role of H-NS in the regulation of hemolysin 
activity and gene expression in V. anguillarum M93Sm.  Initially, the hns homologue 
in V. anguillarum was identified using the V. anguillarum M93Sm draft genome and 
an hns mutant and an hns complement strain were constructed.  Mutation of hns 
resulted in increased hemolytic activity on 5% TSA-sheep blood agar, while 
complementation of the hns mutation reduced hemolysis to levels below wild type 
(Fig. 2).  Mutation of hns also increased the cytotoxicity of both V. anguillarum 
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culture supernatant (diluted 1:1 with PBS) and V. anguillarum cells (at MOI = 200) 
against ASK cells, while complementation of the hns mutation reduced cytotoxic 
activity (Fig. 3).  Transcription of the three hemolysin genes (and related rtx genes) 
in the presence and absence of hns corresponded with hemolysin and cytotoxin 
activity, with increased transcription in the hns mutant and decreased transcription in 
the hns complement (Fig. 4 and Table S1).  These data show that H-NS is a negative 
regulator of hemolytic and cytotoxic activity by acting as a repressor of hemolysin 
gene expression.   
The results presented here correspond with the well-documented role of 
H-NS as a repressor and silencer of many genes in Gram-negative bacteria, especially 
in the repression of virulence genes (8).  Recently, Liu et al. (12) demonstrated that 
expression of rtxA1 in Vibrio vulnificus is repressed by H-NS and that HlyU acts as an 
anti-repressor by interfering with H-NS binding to the upstream regulatory region of 
rtxA1.  Specifically, data from competitive gel mobility shift assays between HlyU 
and H-NS showed HlyU could displace H-NS from the promoter, binding at a low 
concentration and that H-NS needs a much higher concentration to displace the bound 
HlyU (12).  Similarly, our data show that H-NS represses expression from both 
hemolysin gene clusters in V. anguillarum regardless of the presence of hlyU and that 
up-regulation of hemolysin gene expression by HlyU is dependent upon the presence 
of hns (Figs. 5 & 6, Table S1).  These observations strongly suggest that in V. 
anguillarum H-NS functions to repress transcription of both hemolysin gene clusters 
and that HlyU acts as an anti-repressor.  Additionally, both gene clusters are arranged 
as divergently transcribed genes with one HlyU binding site in the center of each 
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intergenic region (Fig. 8; see also Fig. 7 in Li et al (6)) flanked by 2-4 H-NS binding 
sites that extend towards the promoter sites (Fig. 8).  The sites protected by rH-NS 
(Fig. 8) are AT-rich.  The five H-NS binding sites in the vah1/plp intergenic region 
have A+T% that range from 64.5% to 84.3 %, while the seven H-NS protected sites in 
the rtxB/H intergenic region have A+T% that range from 47.4% to 81.25%.  In 
contrast, the flanking structural genes have much lower A+T%.  The A+T% for plp = 
57% and for vah1 = 55.7%; the A+T% for rtxACH = 51.6% and for rtxBDE = 54.5% 
(Fig. 1).  This reveals an interesting discontinuity between the structural genes and 
the intergenic regulatory regions.  A similar discontinuity is also seen between the rtx 
structural genes and the intergenic regions in V. vulnificus and V. cholerae.  
Additionally, that the structural genes have an A+T% nearly identical to the whole 
genome of V. anguillarum (55.49%) suggests that these virulence genes were not 
horizontally acquired.  This is further supported by the observations detailed above 
that there is no evidence for any tRNA genes, tranposases, interrupted genes or 
pseudogenes in the 7.5 to 10 kbp of DNA flanking the hemolysin gene clusters.  
Further, codon usage in the hemolysin genes is not significantly different from that of 
the chromosomes in which each gene cluster resides.   
It has been suggested that self-oligomerization and binding of H-NS to 
AT-rich DNA to form DNA–protein–DNA bridges impedes the movement of RNA 
polymerase, thus repressing gene expression (8).  H-NS repression may be reversed 
by different mechanisms (8).  In V. cholera, the binding site of the transcriptional 
activator ToxT overlaps with H-NS binding sites.  ToxT displaces H-NS and directly 
activates transcription (15).  In contrast, the activation of pagC and ugtL transcription 
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from H-NS-mediated repression in Salmonella enterica requires both SlyA and PhoP 
with SlyA displacing H-NS and PhoP acting as a transcriptional activator (37). There 
are several SlyA and H-NS binding sites in the pagC promoter region with little or no 
overlap between the sites (37).  In V. vulnificus, the binding site of the anti-repressor 
HlyU is far upstream of the start transcription site (-376 to -417) for the rtxA1 operon 
and overlaps with two H-NS binding sites (12).  Binding of HlyU to DNA relieves 
the H-NS repression at all H-NS binding sites of the rtxA1 promoter region (12).  Our 
results demonstrate that in V. anguillarum, HlyU relieves H-NS repression, but does 
not act to directly activate transcription.  We have not yet identified a transcriptional 
activator of hemolytic activity.  However, our data do indicate that transcription from 
both hemolysin gene clusters is higher during exponential growth than during 
stationary phase.  Additionally, the binding sites for HlyU and H-NS for the V. 
anguillarum intergenic rtxHB region are much closer to the +1 start transcription sites 
than in V. vulnificus CMCP6.  In V. vulnificus the five H-NS binding sites are at -289 
to -459 nt from the start transcription site of rtxH (vv20481) (12), while the H-NS 
binding sites in V. anguillarum are between -23 to -100 for rtxH proximal sites and 
+42 to -70 from the +1 site for rtxB proximal sites (Fig. 8).  These differences 
probably reflect the relative sizes of the intergenic regions for each organism.  In V. 
vulnificus CMCP6, the intergenic region between rtxH and rtxB is 1028 nt, while in V. 
anguillarum M93Sm the intergenic region is only 325 nt.  It would be interesting to 
examine the H-NS and HlyU binding sites in the rtx intergenic region of V. vulnificus 
YJ016, which is only 362 nt. 
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Although mutation of hns resulted in increased expression and activities of 
the three hemolysins (RtxA, Vah1 and Plp), the overall virulence of the hns mutant is 
slightly attenuated in rainbow trout.  Similar results were observed in uropathogenic 
Escherichia coli.  Mice injected intravenously with 108 CFU of the hns mutant had a 
higher survival rate compared to the wild type, although the mutant showed a higher 
level of alpha-hemolysin expression and activity (38).  Our data suggest there is no 
correlation between virulence in fish and fitness in LB20, but it should be noted that 
growth in LB20 is very different from growth in fish.  It is likely that the removal of 
H-NS-mediated repression/gene silencing results in an unfavorable alteration of 
virulence gene expression and a reduction in fitness in the host environment.  
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Table 1. Bacterial strains and plasmids used in this study. 
Strain or 
plasmid Genotype and feature(s) Reference 
V. 
anguillarum 
strains 
      
M93Sm 
Spontaneous Smr mutant 
of M93 (serotype J-O-1), 
virulent 
    (31) 
S305 hlyU mutant SmR CmR   (6) 
M114 hns mutant SmR CmR   This study 
M116 hns complement SmR CmR TetR  This study 
ES114 hns/hlyU double mutant SmR CmR  KmR This study 
ES115 hns/hlyU double mutant, hlyU complement Sm
R
 CmR TetR KmR This study 
ES116 hns/hlyU double mutant, hns complement Sm
R
 CmR TetR KmR This study 
E. coli strains       
Sm10 
thi thr leu tonA lacY supE 
recA RP4-2-Tc::Mu::Km 
(λ pir) 
   KmR (39) 
M15 
NalS StrS RifS thi– lac– 
ara
+
 gal+mtl– F– 
recA+uvr+ lon+ (pREP4, 
KmR) 
   KmR QIAGEN 
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D112 E. coli Sm10 with pDM4-hns5'-Kan-hns3'  Cm
R
  KmR This study 
Plasmid       
pNQ705-1 Cm
r; suicide vector with 
R6K origin     (40) 
pNQ705-hns For hns insertional 
mutantion     This study 
pSUP202 E. coli – V. anguillarum 
shuttle vector     (39) 
pSUP202-hly
U 
For complementation of 
hlyU     (6) 
pSUP202-hns For complementation of hns     This study 
pDM4 Cm
r
 Kanr SacBCr; suicide 
vector     (18) 
pDM4-hns5'-
Kan-hns3' 
For hns deletion 
mutantion     This study 
pQE-30 UA Expression vector with N-terminal His6-tag     QIAGEN 
pQE-30 
UA/H-NS For expression of rH-NS     This study 
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Table 2. Primers used in this study. 
Primers 
Sequence (5' to 3', 
underlined sequences are 
engineered restriction sites) 
Description Reference 
SD_hns(
F) 
GCTAGGAGCTCCAGCTT
GAAGAAGCACTAGA 
hns insertional mutation, 
forward, Sac I This study 
SD_hns(
R) 
GCTAGTCTAGACCAGAA
AGTGCAGAAATTAA 
hns insertional mutation, 
reverse, Xba I This study 
hns_com
p(F) 
GCTAGCTGCAGTCGGCG
ATAAAACCTTTCAC 
hns complement, forward, 
Pst I  This study 
hns_com
p(R) 
GCTAGCTGCAGGTTTAC
CTGAACGTGACGAC 
hns complement, reverse, 
Pst I  This study 
Pm416 TTAAATCTCGAATTCTTCTAGAGATTTACC hns ORF, forward This study 
Pm417 ATGTCTGAATTAACAAAAACTCTACTTAAT hns ORF, reverse This study 
pr40 CGGCTACTCGAGAGATTTACCTGCATCAAGTTG 
hns 5' region, forward, 
Xho I This study 
pr41 CGGCTATCTAGAGCACTTTCTGGTGAAACTAAG 
hns 5' region, reverse, 
Xba I This study 
pr42 CGGCTATCTAGAATTAATGCGCTTACATCAATA 
hns 3' region, forward, 
Xba I This study 
pr37 CGGCTAGAGCTCAGAAGCACTAGATAAATTAAC 
hns 3' region, reverse, Sac 
I This study 
pr38 CGGCTATCTAGAGAAAAGCTTGAACACGTAGAA 
kanamycin resistant gene, 
forward, Xba I This study 
Pm173 ACTGATCTAGATCAGAAGAACTCGTCAAGAAG 
kanamycin resistant gene, 
reverse, Xba I This study 
RT 
vah1-R1 
GACCGCCGAATCGATGA
TGAATC vah1 qRT-PCR, forward (4) 
pvah1JR GGTAGGACTGATGCCCACCTACAA vah1 qRT-PCR, reverse This study 
plpF RT CAGACGACCACCAGTAACCACTAA plp qRT-PCR, forward (4) 
plpR RT GCAATCATGATGACCCAGCAACAG plp qRT-PCR, reverse (4) 
Pm111 GGAAATTATTCCGCCGACGATGGA rtxA qRT-PCR, forward (5) 
Pm112 GCCGATACCGTATCGTTACCTGAA rtxA qRT-PCR, reverse (5) 
Pm285 GTGATGGTAGAAAACCTGCGG rtxH qRT-PCR, forward This study 
Pm286 ATGTCTGAGAAATTTGTCCAAACA rtxH qRT-PCR, reverse This study 
iPCR 
rtxB R 
CCGCTAACCGCATTGAT
ATTAAGCTTGGC rtxB qRT-PCR, forward This study 
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Pm104 TCACAATCGCCCCAACTTGCCTTG rtxB qRT-PCR, reverse This study 
Pm297 ACTGAGAGCTCGGTGTTGTTAAAGGCTATGGC hlyU qRT-PCR, forward (6) 
Pm298 ATCGATCTAGAGTATCCACTAACCCATCTCTT hlyU qRT-PCR, reverse (6) 
Pm412 CCGTATTTTCTGCAATCGCCATGG 
vah1 promoter region 
(probe 1), forward, 
5'-labled with 6-FAM 
(6) 
Pm324 CACATATTGACTGATTATAATTTTATTGATATT 
vah1 promoter region 
(probe 1), reverse (6) 
pr323a AGGGTTTTTATAAATCCTAATTTAGATA 
plp promoter region 
(probe 2), forward, 
5'-labled with 6-FAM 
This study 
Pm320 GAATACCCATTTTTTATTTTTTCAGACC 
plp promoter region 
(probe 2), reverse (6) 
Pm327 GTATTTTCTGCAATCGCCATG 
vah1/plp (probe 3) 
intergenic region, forward (6) 
Pm413 CACCTTTGTGGCGAATTATTAATAGATCTT 
vah1/plp (probe 3) 
intergenic region, reverse, 
5'-labled with 6-FAM 
(6) 
Pm414 CAGTGGCTCATAAAAGCAGTTGC 
rtxB/H intergenic region 
(probe 4), forward, 
5'-labled with 6-FAM 
(6) 
Pm318 CAGCGGTAAGTAGACTGATA 
rtxB/H intergenic region 
(probe 4), reverse (6) 
Pm315 CTCAGACATAAATAAATCACC 
rtxB/H intergenic region 
(probe 5), forward (6) 
Pm415 CAGCGGTAAGTAGACTGATAAGCAATG 
rtxB/H intergenic region 
(probe 5), reverse, 
5'-labled with 6-FAM 
(6) 
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Figure 1.  V. anguillarum hemolysin genes are arranged in two gene clusters: A) the 
vah1-plp gene cluster and B) the rtxACHBDE gene cluster. The GC content of each 
gene cluster is shown.  
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Figure 2.  Hemolytic activity of V. anguillarum wild type (M93Sm), hns mutant 
(hns-) and hns complement (hns+) on TSA-5% sheep blood agar after 24 h at 27°C. 
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Figure 3. Cytotoxicity experiment. A) Cytotoxicity of culture supernatant from V. 
anguillarum wild type (M93Sm), hns mutant (hns-) and hns complement (hns+) 
against Atlantic salmon kidney (ASK) cells after 6 h at 20°C.  B) Cytotoxicity of 
washed cells of V. anguillarum wild type (M93Sm), hns mutant (hns-) and hns 
complement (hns+) against Atlantic salmon kidney (ASK) cells after 4 h at 20°C at 
MOI 200.  Asterisks (*) represent P <0.05 between two bracketed strains. Error bars 
represent 1 standard deviation. 
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Figure 4.  qRT-PCR analysis. Expression of rtxA, rtxB, rtxH, plp, and vah1 
determined by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hns mutant 
(hns-), and hns complement (hns+) during logarithmic (Log) and stationary (Sta) 
phase.  The data presented are a representative experiment from two independent 
experiments.  Each sample is the average of three replicates.  Asterisks (*) represent 
P <0.05 between two bracketed strains. Error bars represent 1 standard deviation. 
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Figure 5. Repression of H-NS does not require hlyU. A) Hemolytic activity of V. 
anguillarum wild type (M93Sm), hlyU mutant (hlyU-), hns/hlyU double mutant 
(hns-/hlyU-) and hns/hlyU double mutant with hns complemented (hns+/hlyU-) on 
TSA-5% sheep blood agar after 24 h at 27°C.  B) Expression of rtxA, rtxB, plp, and 
vah1 determined by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hlyU 
mutant (hlyU-), hns/hlyU double mutant (hns-/hlyU-) and hns/hlyU double mutant 
with hns complemented (hns-/hns+) during logarithmic (Log) and stationary (Sta) 
phase.  The data presented are a representative experiment from two independent 
experiments.  Each sample is the average of three replicates. Asterisks (*) represent P 
<0.05 between two bracketed strains. Error bars represent 1 standard deviation. 
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Figure 6. Activation of HlyU requires hns. A) Hemolytic activity of V. anguillarum 
wild type (M93Sm), hns mutants (hns-), hns/hlyU double mutant (hns-/hlyU-) and 
hns/hlyU double mutant with hlyU complemented (hns-/hlyU+) on TSA-5% sheep 
blood agar after 24 h at 27°C.  B) Expression of rtxA, rtxB, plp, and vah1 determined 
by qRT-PCR analysis of V. anguillarum wild type (M93Sm), hns mutants (hns-), 
hns/hlyU double mutant (hns-/hlyU-) and hns/hlyU double mutant with hlyU 
complemented (hns-/hlyU+) during logarithmic (Log) and stationary (Sta) phase.  
The data presented are a representative experiment from two independent experiments.  
Each sample is the average of three replicates. Error bars represent 1 standard 
deviation. 
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Figure 7.  Dnase I protection assay. Capillary electrophoresis of 6-FAM labeled 
DNA (A) probe 1 and (B) probe 2 from the vah1/plp intergenic region, and (C) probe 
4 from the rtxB/H intergenic region from DNase protection assays in the presence 
(black lines) and absence (grey line) of rH-NS demonstrating that H-NS binds to 
specific sequences in the vah1/plp and rtxB/H intergenic regions, respectively, and 
protects against DNase I digestion.  DNA probes were prepared and labeled with 
6-FAM, incubated with rH-NS (0 or 3 µM) followed by DNase I, and then analyzed 
by DNA fragment analysis as described in the Materials and Methods.  The binding 
region sequences are indicated by the double black underline.  The underlined DNA 
fragments indicate those that are higher in the presence of rH-NS (black line) than in 
its absence (grey line).  The location of each probe is shown in Fig. S1. 
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Figure 8.  Intergenic regions of the (A) vah1-plp and (B) rtxACHBDE gene clusters.  
The transcriptional start sites are in bold, italicized sequences labeled with +1.  The 
-10 and -35 promoter sequences are bolded, italicized sequences labeled with -10 and 
-35.  Ribosomal binding sites are bolded, italicized sequences labeled with RBS.  
Sequences protected by HlyU are bolded, italicized, and labeled as HlyU protection.  
Sequences protected by H-NS are underlined. 
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Figure 9.  Fish infection experiment. Survival percentages of rainbow trout injected 
IP with NSS only (Mock, gray dashed line) or ~4×105 CFU/fish of wild-type M93Sm 
(gray solid line), hns mutant (hns-, black solid line), or hns complement (hns+, black 
dashed line).  Each experimental group had n = 10.  V. anguillarum cells were 
suspended in NSS.  Asterisks (*) represent P <0.05 between two bracketed strains. 
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Table S1. Real time qRT-PCR analysisa 
Parameter 
and gene 
expressed 
V. 
anguillarum 
strainb  
Average (±SDc) 
Log phase Stationary phase 
rtxA    
RNA Copy 
number M93sm 
2.66 × 104 (±3.76 × 
103)6 8.57 × 10
3
 (±3.60 × 102) 
 hns- 7.75 × 104 (±1.11 × 104) 1.83 × 104 (±2.13 × 103) 
 hns+ 9.72 × 102 (±10) 2.94 × 102 (±19) 
 hlyU- 2.38 × 102 (±1.38 × 102) 6.02 × 102 (±90) 
 hns-/hlyU- 6.47 × 104 (±9.92 × 103) 1.23 × 104 (±1.47 × 103) 
 hns-/hlyU+ 1.43 × 105 (±2.00 × 104) 2.13 × 104 (±4.91 × 102) 
 hns+/hlyU- 1.24 × 104 (±1.75 × 102) 3.74 × 103 (±4.65 × 102) 
    
Relative 
change (fold) 
to M93Smd 
M93Sm 1.00 (±0.14) 1.00 (±0.04) 
 hns- 2.91 (±0.42) 2.14 (±0.25) 
 hns+ -27.37 (±0.00) -29.15 (±0.00) 
 hlyU- -11.18 (±0.01) -14.23 (±0.01) 
    
Relative 
change (fold) 
to hlyU-d 
hlyU- 1.00 (±0.06) 1.00 (±0.15) 
 hns-/hlyU- 27.21 (±4.17) 20.50 (±2.43) 
 hns+/hlyU- 5.22 (±0.07) 6.22 (±0.77) 
    
Relative 
change (fold) 
to hns-d 
hns- 1.00 (±0.14) 1.00 (±0.12) 
 hns-/hlyU- -1.20 (±0.13) -1.48 (±0.08) 
 hns-/hlyU+ 1.84 (±0.26) 1.16 (±0.03) 
    
rtxH     
RNA Copy 
number M93Sm 6.80 × 10
4
 (±1.80 × 104) 2.45 × 104 (±3.19 × 103) 
 hns- 3.10 × 105 (±8.58 × 104) 5.85 × 104 (±3.56 × 103) 
 hns+ 9.43 × 103 (±1.31 × 103) 8.59 × 103 (±6.12 × 102) 
    
Relative 
change (fold) 
to M93Smd 
M93Sm 1.00 (±0.26) 1.00 (±0.13) 
 hns- 4.56 (±1.26) 2.39 (±0.15) 
 hns+ -7.21 (±0.02) -2.85 (±0.02) 
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rtxB     
RNA Copy 
number M93sm 4.17 × 10
4
 (±4.01 × 103) 1.71 × 104 (±1.23 × 103) 
 hns- 5.35 × 104 (±9.58 × 103) 2.44 × 104 (±3.10 × 103) 
 hns+ 3.89 × 103 (±5.19 × 102) 1.59 × 103 (±18) 
 hlyU- 9.54 × 103 (±5.96 × 102) 3.62 × 103 (±1.41 × 102) 
 hns-/hlyU- 7.31 × 104 (±7.23 × 103) 3.56 × 104 (±7.66 × 102) 
 hns-/hlyU+ 2.92 × 104 (±8.00 × 103) 1.85 × 104 (±2.48 × 103) 
 hns+/hlyU- 1.14 × 104 (±1.42 × 103) 1.47 × 104 (±5.74 × 102) 
    
Relative 
change (fold) 
to M93Smd 
M93Sm 1.00 (±0.10) 1.00 (±0.07) 
 hns- 1.28 (±0.23) 1.43 (±0.18) 
 hns+ -10.72 (±0.01) -10.77 (±0.00) 
 hlyU- -4.37 (±0.01) -4.73 (±0.01) 
    
Relative 
change (fold) 
to hlyU-d 
hlyU- 1.00 (±0.06) 1.00 (±0.04) 
 hns-/hlyU- 7.67 (±0.76) 9.84 (±0.21) 
 hns+/hlyU- 1.20 (±0.15) 4.06 (±0.16) 
    
Relative 
change (fold) 
to hns-d 
hns- 1.00 (±0.18) 1.00 (±0.13) 
 hns-/hlyU- 1.37 (±0.14) 1.46 (±0.03) 
 hns-/hlyU+ -1.83 (±0.15) -1.32 (±0.10) 
      
vah1    
RNA Copy 
number M93sm 1.40 × 10
3
 (±1.76 × 102) 6.19 × 102 (±94) 
 hns- 2.27 × 104 (±6.40 × 103) 1.24 × 104 (±2.69 × 103) 
 hns+ 1.06 × 103 (±3.62 × 102) 1.88 × 102 (±17) 
 hlyU- 3.24 × 103 (±1.94 × 102) 4.74 × 102 (±88) 
 hns-/hlyU- 1.68 × 104 (±3.21 × 103) 1.95 × 104 (±2.90 × 103) 
 hns-/hlyU+ 1.30 × 104 (±1.48 × 102) 3.04 × 104 (±1.93 × 103) 
 hns+/hlyU- 5.34 × 103 (±5.30 × 102) 6.45 × 103 (±4.17 × 102) 
    
Relative 
change (fold) 
to M93Smd 
M93Sm 1.00 (±0.13) 1.00 (±0.15) 
 hns- 16.21 (±4.57) 20.01 (±4.35) 
 hns+ -1.32 (±0.26) -3.30 (±0.03) 
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 hlyU- 2.31 (±0.14) -1.30 (±0.14) 
    
Relative 
change (fold) 
to hlyU-d 
hlyU- 1.00 (±0.06) 1.00 (±0.19) 
 hns-/hlyU- 5.20 (±0.99) 41.02 (±6.11) 
 hns+/hlyU- 1.65 (±0.16) 13.60 (±0.88) 
    
Relative 
change (fold) 
to hns-d 
hns- 1.00 (±0.28) 1.00 (±0.22) 
 hns-/hlyU- -1.35 (±0.14) 1.57 (±0.23) 
 hns-/hlyU+ -1.75 (±0.01) 2.46 (±0.16) 
    
plp     
RNA Copy 
number M93sm 8.50 × 10
2
 (±2.07 × 102) 3.02 × 102 (±8) 
 hns- 2.66 × 104 (±4.08 × 103) 1.11 × 104 (±2.43 × 102) 
 hns+ 4.21 × 102 (±1.08 × 102) 3.18 × 102 (±73) 
 hlyU- 1.14 × 103 (±3.38 × 102) 3.46 × 102 (±50) 
 hns-/hlyU- 8.46 × 103 (±1.64 × 103) 1.18 × 104 (±2.15 × 103) 
 hns-/hlyU+ 8.58 × 103 (±8.21 × 102) 2.39 × 104 (±8.47 × 102) 
 hns+/hlyU- 2.02 × 103 (±5.75 × 102) 3.58 × 103 (±1.54 × 102) 
    
Relative 
change (fold) 
to M93Smd 
M93Sm 1.00 (±0.24) 1.00 (±0.03) 
 hns- 31.27 (±4.80) 36.88 (±0.81) 
 hns+ -2.02 (±0.13) 1.05 (±0.24) 
 hlyU- 1.34 (±0.40) 1.15 (±0.17) 
    
Relative 
change (fold) 
to hlyU-d 
hlyU- 1.00 (±0.30) 1.00 (±0.15) 
 hns-/hlyU- 7.46 (±1.44) 34.02 (±6.21) 
 hns+/hlyU- 1.78 (±0.51) 10.35 (±0.44) 
    
Relative 
change (fold) 
to hns-d 
hns- 1.00 (±0.15) 1.00 (±0.02) 
 hns-/hlyU- -3.14 (±0.06) 1.06 (±0.19) 
  hns-/hlyU+ -3.10 (±0.03) 2.15 (±0.08) 
a
 The data presented is a representative experiment of two independent experiments.  
Each sample is the average of three replicates.  
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b
 V. anguillarum strains: M93Sm (wild type), hns- (hns mutant, M114), hns+ (hns 
complemente, M116), hlyU- (hlyU mutant, S305), hns-/hlyU- (hns/hlyU double 
mutant, ES114), hns-/hlyU+ (hns/hlyU double mutant with hlyU complemented, 
ES115), hns+/hlyU- (hns/hlyU double mutant with hns complemented, ES116) 
c
 Standard Deviation 
d
 Gene expression is up-regulated (positive number) or down-regulated (negative 
number) compared to expression in M93Sm. 
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Figure S1. Supplement data for Dnase I protection assay. 6-FAM labeled DNA probes 
(probes 1-5) used for DNaseI protection studies of the intergenic regions between A) 
plp and vah1 and B) rtxH and rtxB were obtained by PCR amplification using the 
primers in Table 2.  
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B. 
A. 
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Figure S2. Supplement data for qRT-PCR analysis. Real-time qRT-PCR was 
performed to determine A) the expression level of hlyU in the wild-type strain 
(M93Sm), hns mutant (hns-), and the hns complement (hns+) during exponential and 
stationary growth phases. Each sample is the average of three replicates. The data 
presented are the averages of two independent experiments.  B) Expression level of 
hns in the wild-type strain (M93Sm) during exponential and stationary growth phases. 
Each sample is the average of three replicates.  Statistically significant differences 
between samples are marked with a bracket and an * symbol. Error bars represent 1 
standard deviation. 
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Figure S3. Growth profiles of V. anguillarum strains. A) Growth curve of V. 
anguillarum wild type (M93Sm), hns mutant (hns-) and hns complemented (hns+) 
strains in LB20. B) Generation time of V. anguillarum wild type (M93Sm), hns 
mutant (hns-) and hns complemented (hns+) strains grown in LB20. Statistically 
significant differences between samples are marked with a bracket and an * symbol. 
Error bars represent 1 standard deviation. 
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Abstract 
We have been investigating the regulation and roles of the 
hemolysin/cytotoxin genes in pathogenesis by V. anguillarum, the causative agent of 
vibriosis in fish.  We have shown that there are three major hemolysin genes (vah1, 
plp and rtxA) and have created an avirulent strain by knocking rtxA. In this study, we 
aimed to create avirulent and immunogenic V. anguillarum strains that can be used as 
a live vaccine for fish, without knocking out any of the hemolysin genes. For this 
purpose, six genes (mdh, icd, sucA, sucC, sdhC, and fumA) encoding enzymes in 
tricarboxylic acid (TCA) cycle and one gene (cra) encoding a fructose metabolism 
repressor were identified and mutated in wild type V. anguillarum M93Sm (serotype 
O2a). Among all mutants, icd mutant showed high attenuation of virulence and lowest 
cell density limit in two forms of rich media. All mutants exhibited the same or higher 
levels of hemolysin gene expression compared to wild type during exponential phase. 
Further, fish that were pre-treated by immersion with icd mutant protected rainbow 
trout from the subsequent challenge of V. anguillarum M93Sm; and fish that were 
pre-treated injection of icd mutant elicited cross-serotype immunity against the 
subsequent challenge of V. anguillarum NB10 (serotype O1). The results suggest the 
TCA cycle mutation approach is likely to be an easy method to construct modified live 
vaccine for a wide variety of pathogenic bacteria. 
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Introduction 
Vibrio anguillarum is the causative agent of vibriosis, a fatal hemorrhagic 
septicemic disease. V. anguillarum infects more than 50 fresh and salt-water fish 
species including various species of economic importance to the larviculture and 
aquaculture industries, such as salmon, rainbow trout, turbot, sea bass, sea bream, cod, 
eel, and ayu (1). The mortality rate from infections ranges from 30% to 100% (2). V. 
anguillarum also causes vibriosis in crustaceans and bivalves (2). Infections by this 
bacterium have resulted in severe economic losses to aquaculture worldwide (2). In 
Norway, killed vaccines against V. anguillarum are proven successful in salmon 
aquaculture. During the 1980s, salmon farming in Norway experienced huge losses 
due to vibriosis and cold water vibriosis, and a total crash in the industry was only 
prevented by the use of vast amounts of antibiotics (3). Currently, all farmed salmon 
and trout in Norway are vaccinated against vibriosis (V. anguillarum), cold-water 
vibriosis or Hitra disease (Aliivibrio salmonicida), and furunculosis (Aeromonas 
salmonicida), and few reports of vibriosis were observed (4). The success of these 
killed vaccines immediately resulted in a decline in the use of antibiotics (3).  
Shoemaker (5) reported an example of a successfully commercialized 
modified live vaccine (AQUAVAC-ESC) currently used in US catfish industry which 
highlights the live vaccine strategy. Modified live vaccines have several advantages 
over killed vaccines: First, modified live vaccines can be administered by immersion 
(5), which avoids the injection procedure frequently used in killed vaccines and make 
it possible to apply the vaccines to the larval or fry stages or some vulnerable species 
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(3). Second, modified live vaccines are able to elicite humoral, mucosal and 
cell-mediated immunity (6), while killed or subunit vaccines are not effective at 
eliciting cellular responses (7). Third, modified live vaccines do not require an 
adjuvant, such as mineral oil, which is reported to cause side effects including 
decreased growth rates, chronic peritonitis, adhesions, granulomas and pigmentation 
in the peritoneal cavity (8). Fourth, due to omission of injection and adjuvant, 
modified live bacterial vaccines have a lower cost (7, 9). Currently, there are eight 
licensed bacterial vaccines for fish in the United States. Five of them are killed 
vaccines and three of them are live cultures (Arthrobacter, Edwardsiella ictaluri and 
Flavobacterium columnare) (10). While there is a great need for modified live 
vaccines, modification of a specific pathogenic bacterium to result in a live vaccine 
strain may require a comprehensive understanding of its pathogenesis. 
In vibriosis, V. anguillarum invades its host fish through the intestine and 
skin (11, 12). Infected fish usually die within 1-4 days (13-16) with systemic infection 
of V. anguillarum. Chemotactic motility and the metalloprotease EmpA were shown to 
be important during the invasion stage, while the siderophore anguibactin, flagellin 
subunits, lipopolysacharides (LPS), and the MARTX toxin RtxA were shown to be 
important at least for the persistence in the host during the post-invasion stage (see 
reviews by Frans et al, 2011, and by Naka and Crosa, 2011) (1, 17). Recently, a V. 
anguillarum mutant with a global regulator H-NS knocked-out showed attenuation in 
virulence when injected intraperitoneally, suggesting bacterial fitness is also a 
important factor during the post-invasion stage (15). 
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Additionally, it has been demonstrated in Salmonella enterica, an 
intracellular bacterial pathogen, that some tricarboxylic acid (TCA) cycle mutant 
strains were avirulent and immunogenic for subsequent wild-type S. enterica infection 
(18-20). A functional fructose repressor (Cra) is also required for S. enterica (21). 
Similar results have also been observed for the uropathogenic Escherichia 
coli (UPEC), another intracellular bacterial pathogen (22).  The TCA cycle- and 
gluconeogenesis-defective strains demonstrate significant fitness reductions during 
urinary tract infections (22). These observations suggest that the central metabolism of 
pathogens is important for pathogenesis. 
The observations concerning the effects of the TCA cycle upon virulence 
allowed us to hypothesize that mutations in central metabolism-related genes, such as 
those that encode the TCA cycle enzymes could interrupt the infection process in fish. 
To test the hypothesis, we identified and created six TCA cycle mutant strains plus 
one fructose metabolism mutant strain and tested their virulence against rainbow trout 
(Oncorhynchus mykiss). Further, we examined their ability to grow in three different 
media, monitored their expression of each of the three hemolysins, performed 
infection experiments on rainbow trout to determine the virulence of each mutant, and 
performed challenge experiments to demonstrate the ability of the one highly 
attenuated (icd) mutant to elicit a protective response against virulent strains of V. 
anguillarum. 
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Materials and Methods 
Identification of genes in V. anguillarum. V. anguillarum M93Sm draft genome 
(unpublished data) and V. anguillarum 775 genome (17) were annotated by the RAST 
(Rapid Annotation using Subsystem Technology) 
service (http://rast.nmpdr.org/rast.cgi) using the default settings (23). 
Bacterial strains, plasmids and growth conditions. V. anguillarum strains (Table 1) 
were routinely grown in Lysogeny broth containing 2% NaCl (LB20) (24), 
supplemented with the appropriate antibiotic, in a shaking water bath at 27°C.  E. 
coli strains (Table 1) were routinely grown in Lysogeny broth containing 1% NaCl 
(LB10).  Antibiotics were used at the following concentrations: streptomycin, 200 µg 
ml-1 (Sm200); chloramphenicol, 20 µg ml-1 (Cm20) for E. coli and 5 µg ml-1 (Cm5) for 
V. anguillarum; kanamycin, 50 µg ml-1 (Km50) for E. coli and 80 µg ml-1 (Km80) for V. 
anguillarum. 3M-Glucose [Minimal Marine Medium (25) plus 0.2 % Glucose] and 
NSSM (Nine Salts Solution plus fish gastrointestinal mucus) (26) were used in 
specific experiments. 
Insertional mutagenesis.  Insertional mutations were made by using a modification 
of the procedure described by Milton et al. (27). Briefly, primers (Table 2) were 
designed based on the target gene sequence of M93Sm.  Then a 200~300 bp DNA 
fragment of the target gene was PCR amplified and ligated into the suicide vector 
pNQ705-1 (Table 1) after digestion with SacI and XbaI.  The ligation mixture was 
introduced into E. coli Sm10 by electroporation using BioRad Gene Pulser II (BioRad, 
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Hercules, CA).  Transformants were selected on LB10 Cm20 agar plates.  The 
construction of the recombinant pNQ705 was confirmed by both PCR amplification 
and restriction analysis.  The mobilizable suicide vector was transferred from E. coli 
Sm10 into V. anguillarum strains by conjugation. Transconjugants were selected by 
utilizing the chloramphenicol resistance gene located on the suicide plasmid.  The 
incorporation of the recombinant pNQ705 was confirmed by PCR amplification. 
Bacterial conjugation. Bacterial conjugation were carried out using the procedure 
modified from by Varina et al (28). Briefly, 100 µl V. anguillarum overnight was 
added into 2.5 ml NSS (Nine Salts Solution) (29); 100 µl E. coli culture overnight was 
added into 2.5 ml 10 mM MgSO4. The resulting V. anguillarum and E. coli suspension 
was mixed, vacuum filtered onto a autoclaved 0.22-µm-pore-diameter nylon 
membrane (Millipore, USA), placed on an LB15 agar plate (LB-plus-1.5% NaCl), and 
allowed to incubate overnight at 27°C. Following incubation, the cells were removed 
from the filter by vigorous vortexing in 1 ml NSS. Cell suspensions (70 µl) were 
spread on LB20 plated with appropriate antibiotics and the plates were incubated at 
27°C until V. anguillarum colonies were observed (usually 24 to 48 h). 
Hemolytic assay. Single V. anguillarum colonies were transferred onto LB20-fish 
blood agar (LB20 agar plus 5% rainbow trout blood with heparin), and hemolytic 
activity was determined by measuring the hemolysis zone surrounding the colonies 
after incubation at 27°C. 
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RNA isolation.  Exponential phase cells (~0.5 × 108 CFU ml-1) of various V. 
anguillarum strains were treated with RNAprotect Bacteria Reagent (QIAGEN), 
following the manufacturer’s instructions.  Total RNA was isolated using the RNeasy 
kit and QIAcube (QIAGEN) following the manufacturer’s instructions.  All purified 
RNA samples were quantified spectrophotometrically by measuring absorption at 260 
nm and 280 nm using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific) and stored at -75ºC for future use. 
Real-time quantitative RT-PCR (qRT-PCR).  qRT-PCR was used to quantify 
various mRNAs using an LightCycler® 480 Real-Time PCR System (Hoffmann-La 
Roche Inc.) and the Brilliant II SYBR Green Single-Step QRT-PCR Master Mix 
(Agilent Technologies), with 10 ng of total RNA in 25 µl reaction mixtures.  The 
thermal profile was 50°C for 30 min, 95°C for 15 min, and then 40 cycles of 95°C for 
30 s and 55°C for 30 s.  Fluorescence was measured at the end of the 55°C stage of 
each cycle.  Samples were run in triplicate along with the no-reverse-transcriptase 
control and the no-template control.  All experiments were repeated at least twice. 
Fish infection experiment. Various V. anguillarum strains were tested for virulence 
with rainbow trout (Oncorhynchus mykiss) by intraperitoneal (IP) injection or 
immersion. Briefly, V. anguillarum cells grown in LB20 supplemented with 
appropriate antibiotics for 19 h at 27°C were harvested by centrifugation (9,000 × g, 5 
min, 4°C), washed twice in NSS, and resuspended in NSS. NSS suspensions with an 
estimated specific cell density were prepared according to the optical density at 600 
nm (OD600) of the culture and the conversion equation: cell density (108 CFU ml-1) = 
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44.905 × OD600, determined by experiment (Figure S1). The OD600 was determined by 
the following method: 100 µl of NSS suspension was transferred into a 96-well plate 
with a clear bottom. The OD600 was read by a VersaMax™ Absorbance Microplate 
Reader (Molecular Devices). The actual cell density of injection solution was 
confirmed by viable count. All fish were examined prior to the start of each 
experiment to determine that they were free of disease or injury. For IP injection, fish 
were anesthetized by tricaine methanesulfonate (Western Chemical, Ferndale, WA), 
with 100 mg L-1 for induction and 52.5 mg L-1 for maintenance. V. anguillarum strains 
were IP-injected into fish in 100 µl NSS vehicle. Fish that were between 15 and 25 cm 
long were injected with bacteria diluted with NSS to a specific dosage, or NSS only as 
negative control. For immersion, 1.5 % Instant Ocean sea salt (Pentair Aquatic 
Eco-Systems) water solution at 18 ± 1 ºC was used as immersion liquid. Each 
experiment group was provided with 10 L of immersion liquid in a bucket lined with a 
new, clean, 13-gallon (50L) household trash bag. After the sea salt was fully dissolved, 
10 ml the V. anguillarum suspended in NSS at a specific cell density, or 10 ml NSS 
only as the negative control, was added. After V. anguillarum was mixed, fish that 
were between 15 and 25 cm long were immersed for 1 h. For both methods, fish 
inoculated with different bacterial strains were maintained in separate 10-gallon tanks 
with constant water flow (200 ml/min) at 18 ± 1 ºC.  The tanks were separated to 
prevent possible cross-contamination.  Death due to vibriosis was determined by the 
observation of gross clinical signs and confirmed by the recovery and isolation of V. 
anguillarum cells resistant to the appropriate antibiotics from the head kidney of dead 
fish.  Observations were made for 14 days.  All fish used in this research project 
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were obtained from the URI East Farm Aquaculture Center.  All fish infection 
protocols were approved by the URI IACUC. 
Statistical analysis. Student's T-tests assuming unequal variances were used for 
statistical analyses for all experiments except for the fish infection experiment. 
P values of < 0.05 were considered statistically significant. A Kaplan-Meier survival 
analysis with log rank significance test was performed on the survival percentage in 
the fish infection experiment. P values of < 0.05 were considered statistically 
significant. 
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Results 
Gene identification and mutant construction in V. anguillarum.  The TCA cycle 
in Salmonella enterica consists of eight biochemical reactions catalyzed by nine 
enzymes/enzyme complexes, encoded by gltA, icd, sucAB, sucCD, sdhCDAB, fumAC, 
fumB, and mdh (18-20). Cra (encoded by cra) is a repressor of fruA, fru and fruK, 
which are required for fructose metabolism in Salmonella enterica (21). The nine TCA 
cycle enzyme genes, plus the cra gene, were examined in the RAST annotation results 
of V. anguillarum M93Sm draft genome (unpublished data) and V. anguillarum 775 
genome (17). BLASTx was performed on the identified sequences against the NCBI 
non-redundant protein sequences database to confirm the accuracy of annotation. 
Among the ten examined metabolism associated genes/operons, gltA, icd, sucAB, 
sucCD, sdhCDAB, fumA, mdh and cra were identified in V. anguillarum (Fig. 1 and 
Table 3). The sequences encoding icd, sucA, sucC, sdhC, fumA, mdh, and cra in V. 
anguillarum M93Sm were used to created insertional mutations in V. anguillarum 
M93Sm. Seven metabolism mutant strains were obtained and listed in Table 1. 
icd mutant is highly attenuated against rainbow trout. To test the hypothesis that 
mutation in central metabolism could interrupt the infection process in fish, we tested 
the virulence of the seven V. anguillarum metabolism mutants along with the M93Sm 
wild type on rainbow trout. Groups of five fish were infected by IP injection as 
described in the Materials and Methods with wild type V. anguillarum (M93Sm) cells 
or with cells from one of the seven mutant strains: icd (XM420), sucA (XM440), sucC 
(XM450), sdhC (XM460), fumA (XM470), mdh (XM410) or cra (XM430) in NSS at a 
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dosage of ~2 × 105 CFU/fish, or with NSS only as a negative control (mock). During 
the 14-day observation window, 40% of M93Sm infected fish survived.  In 
comparison, the sucA mutant, sdhC mutant and icd mutant infected fish all had higher 
survival percentages compared to M93Sm (50% for sucA mutant, 80% for sdhC 
mutant, and 100% for icd mutant); however, the difference between any of the three 
mutants and M93Sm is not statistically significant (P = 0.051 to 0.913) (Fig 2A). The 
fish infection experiment was repeated with a higher dose (~4 × 105 CFU/fish) of the 
V. anguillarum wild type and the three mutant strains (icd, sucA, and sdhC) that 
exhibited some attenuation of virulence in the first experiment. At this higher dose of 
V. anguillarum only 20% of fish infected with M93Sm (wild type) survived.  
Similarly, fish infected with either sucA or sdhC mutants survived at 0% or 20%, 
respectively.  In contrast, fish infected with the icd mutant had a significantly higher 
survival percentage (100%) compared to M93Sm (P = 0.013) (Fig 2B). The data 
indicate icd mutant is a highly attenuated or avirulent strain in these experimental 
conditions. 
We then compared the virulence of M93Sm with the icd mutant by another infection 
route - immersion. Groups of 10 fish were infected by immersion as described in the 
Materials and Methods with either M93Sm or the icd mutant in a 1.5% sea salt 
solution at a dose of ~4 × 106 CFU ml-1, or 1.5% sea salt solution without V. 
anguillarum as a negative control (mock).  Control experiments showed that neither 
the V. anguillarum cells nor the rainbow trout were adversely affected by the 1 h 
exposure to 1.5% sea salt solution (Fig. S2A and 2C). During the 14-day experiment, 
30% of M93Sm infected fish survived while 90% of icd mutant infected fish survived. 
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The difference is statistically significant (P = 0.007) (Fig 2C). Taken together, the two 
infection experiments demonstrate that the icd mutant exhibits highly attenuated 
virulence against rainbow trout. 
Growth rates and growth yields of V. anguillarum wild type and mutant strains. 
In order to determine the possible cause of attenuation in the icd mutant, we examined 
the growth curves of the wild type and the seven metabolism mutants of V. 
anguillarum in one minimal medium (3M-Glucose) and two forms of rich media 
(LB20 and NSSM). The cell density in 3M-Glucose and LB20 was measured by 
spectrophotometry at 600 nm, while the cell density in NSSM was measured by viable 
count. 
When cells were grown in Minimal Marine Medium plus 1% Glucose (3M-Glucose), 
the icd mutant and the sucA mutant failed to grow, since there is no alternative way to 
produce α-ketoglutarate or succinyl-CoA (Fig. 1). The sucC mutant, sdhC mutant, 
mdh mutant and cra mutant exhibited similar generation times to M93Sm (P = 0.139 
to 0.985), while the fumA mutant exhibited a 33% longer generation time than that of 
M93Sm (P = 0.022) (Table S1). 
In LB20 broth, M93Sm, icd mutant and cra mutant exhibited a classic bacterial 
growth curve with a lag phase, a log phase and a stationary phase, while the other 
strains sucA mutant, sucC mutant, sdhC mutant, fumA mutant and mdh mutant 
exhibited biphasic growth curves, with a lag phase then a log phase followed by 
slower growth (stationary/lag phase), then a second log phase, followed by a 
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stationary phase (Fig 3A). The log phase in the first growth stage was named log 
phase I and the log phase in the second growth stage was termed log phase II. The 
generation times during the log phase(s) of all mutants (52.4 to 115.3 min) were 
longer than for M93Sm (44.0 min) (Fig 3B). The generation time of the icd mutant 
(55.0 min) was only longer than M93Sm (44.0 min) and sucC mutant log phase I (52.4 
min), and shorter than all other mutants - sucA mutant (64.3 and 98.5 min), sdhC 
mutant (61.19 and 101.70 min), fumA mutant (73.6 and 89.4 min), mdh mutant (67.1 
and 115.3 min), and cra mutant (58.6 and 91.8 min). The maximum OD600 of the icd 
mutant was the lowest among all strains (0.75 vs. 0.96-1.10). The log phase generation 
time of the icd mutant was 25% longer than M93Sm (55.0 vs. 44.0 min) while the 
maximum OD600 was ~70% of that for M93Sm (0.75 vs. 1.10).  
To better mimic the colonization environment in fish intestine, we examined the 
growth of the wild type (M93Sm) and the icd mutant (XM420) strains in NSS plus 
fish gastrointestinal mucus (NSSM) broth by viable count. In these conditions, the 
shortest generation time of the icd mutant was only ~5% longer than M93Sm (66 vs. 
63 min) while the maximum cell density of the icd mutant was only 24% of that for 
M93Sm (3.27 × 108 vs. 1.37 × 109 CFU ml-1).  Taken together, these data indicate 
that the loss of icd severely limits the growth of V. anguillarum, even in nutrient-rich 
media.  
Expression of hemolysin genes in mutants and wild type strains. The attenuation in 
virulence of the icd mutant could be the result of down-regulation of one or more of 
the hemolysin (plp, vah1, and rtxA) genes used by V. anguillarum to promote 
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virulence (22). The genes encoding the three hemolysins are expressed most strongly 
during log phase (15, 16, 30). To examine this possibility, we determined the 
expression of vah1, rtxA and plp during log phase using qRT-PCR (Fig 4A). Data 
indicate in all mutants except the icd mutant, expression of vah1 and plp were 
up-regulated by 1.77-fold to 16.15-fold compared to M93Sm (P = 0.001 to 0.036). In 
the icd mutant, expression of plp was up-regulated by 1.76-fold, while the expression 
of vah1 was at approximately the same level as M93Sm (P = 0.083). Expression of 
rtxA by all mutants was also at the same level as M93Sm (P = 0.165 to 0.753). 
Therefore, all metabolism mutants exhibit the same or higher levels of hemolysin gene 
expression compared to the wild type and attenuation of the icd mutant is not due to 
reduced expression from the hemolysin genes. 
We have observed that Plp is the most efficient of the three hemolysins against fish 
erythrocytes (Li et al, unpublished data). Thus, zones of hemolysis on fish blood agar 
are primarily the result of Plp activity. The data indicate when compared to the wild 
type M93Sm, all TCA cycle mutants (but not the cra mutant) had significantly higher 
levels of hemolytic activity after 7 h of incubation on fish blood agar plates.  After 23 
h of incubation all TCA cycle mutants and the cra mutant had significantly larger 
zones of hemolysis on fish blood agar compared to M93Sm (P = 0.003 to 0.044) (Fig 
4B). The hemolysis activity results correspond with the expression data for plp and 
vah1 (Fig 4A). 
Expression level of hlyU is higher in sucA mutant and mdh mutant than that in 
wild type. Previously, we demonstrated that the three hemolysin genes, vah1, rtxA and 
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plp, are co-regulated by a repressor (H-NS) and an anti-repressor (HlyU) (15, 30). In 
order to examine their possible roles in regulating hemolysin gene expression in the 
metabolism mutants, we examined the expression of hlyU and hns during log phase 
using qRT-PCR in two TCA cycle mutants – the sucA mutant and mdh mutant (Fig 
4C). Data show that both hlyU and hns were expressed at significantly higher levels in 
both the sucA and mdh mutant compared to M93Sm (P = 0.015 to 0.018). The 
expression of hlyU was 76% (in the sucA mutant) and 63% (in the mdh mutant) higher 
than in M93Sm, while the expression of hns was 14% (in the sucA mutant) and 36% 
(in the mdh mutant) higher than in M93Sm. Compared to the increase in hlyU 
expression, the increase of hns was relatively small (14% vs. 76% in sucA mutant, 
36% vs. 63% in mdh mutant), suggesting the possibility that the relative increase in 
hlyU expression may be responsible for the increased expression of plp and vah1. 
Pre-treatment by immersion with icd mutant protected rainbow trout from the 
subsequent challenge of V. anguillarum M93Sm. In order to test whether rainbow 
trout previously exposed to the highly attenuated icd mutant by immersion were 
protected against vibriosis by the fully virulent wild type M93Sm, we performed an 
infection challenge on fish that had been pre-treated with the icd mutant. A group of 
five fish that survived from the initial infection experiment by immersion (labeled as 
“pre-treated by immersion” in Fig 5A) and group of five “untreated” fish were 
immersion-infected by M93Sm at a dosage of ~4 × 106 CFU ml-1 and observed for 14 
days. The pre-treated trout were challenged with the wild type cells 6 weeks after the 
initial infection with the icd mutant to allow adaptive immunity to develop. In the 
untreated group, no fish survived past day 2, while in the “pre-treated by immersion” 
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group, all five fish survived for the entire 14-day observation period (Fig 5A). The 
difference between the two experimental groups is statistically significant (P = 0.003). 
The results indicate that icd mutant elicits protective immunity when fish are 
inoculated by immersion. 
Pre-treatment by injection of icd mutant elicited cross-serotype immunity against 
the subsequent challenge of V. anguillarum NB10. In order to test whether 
pre-treatment of fish with the icd mutant was able to provide cross-serotype protection, 
we carried out a second infection challenge experiment using the virulent wild type 
strain of V. anguillarum NB10 (serotype O1) with a serotype different from that of the 
M93Sm-derived icd mutant (serotype O2a), on fish that had been pre-treated with the 
icd mutant. A group of three fish that survived the initial infection experiment by 
immersion (labeled as “pre-treated by immersion” in Fig 5B), and group of five fish 
that survived from the initial infection experiment by injection (labeled as “pre-treated 
by injection” in Fig 5B) were infected by immersion with NB10 at a dosage of ~4 × 
106 CFU ml-1 and observed for 14 days. As in the first challenge experiment, the 
pre-treated trout were challenged with the wild type cells 6 weeks after the initial 
infection with the icd mutant to allow adaptive immunity to develop. A group of four 
“untreated” fish were also included as a control. In the untreated group, no fish 
survived beyond day 4, while in the “pre-treated by immersion” group, one fish (33%) 
survived for the entire 14-day observation period. However, there is no statistically 
significant difference between the two experimental groups (P = 0.139). In the 
“pre-treated by injection” group, four fish (80%) survived for the entire 14-day 
observation period. When compared to the untreated control group, the number of 
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survivors is statistically significant (P = 0.007) (Fig 5B). The results indicate icd 
mutant elicited cross-serotype immunity against V. anguillarum NB10 at least when 
applied by injection. 
Discussion 
An ideal modified live vaccine would be a strain that retains its invasive 
ability but does not cause further damage to the fish host, so that not only humoral but 
also cell-mediated immunity would be elicited, by simply applying the vaccine by 
immersion. For this purpose, factors that are exclusively required in the post-invasion 
stage, rather than the virulence factors that required for the invasive stage of the 
pathogen, would be the preferred targets to modify or knock out. We hypothesized that 
disrupting the central fueling pathways, such as the TCA cycle enzymes, were likely 
to result in defects that would accomplish this goal, especially since other investigators 
had success with this approach in both UTI E. coli (22) and Salmonella enterica 
(18-20). It has been suggested that intracellular pathogens inside host cell phagosomes 
are in nutritionally restricted sites and are likely to be starved for essential nutrients, 
especially when central fueling pathways are disrupted (20). However, unlike S. 
enterica and UTI E. coli, V. anguillarum is an extracellular pathogen and does not 
invade host cells. Thus, it was not clear that disrupting the central fueling pathways 
would necessarily result in V. anguillarum mutants unable to persist and grow in the 
fish host.  To examine this question, we constructed 7 mutants – six TCA cycle 
mutants and one regulatory mutant (cra) and tested the mutants for virulence in 
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rainbow trout and, subsequently, tested the attenuated mutant for its ability to protect 
the trout against challenge by virulent wild type strains of V. anguillarum. 
For all metabolism mutants, there is no correlation between their virulence 
and growth rate in LB20, however, there is correlation between virulence and the 
maximum cell density since only the icd mutant had both the lowest virulence and the 
lowest maximum cell density (compare Fig 2A with Fig 3A), suggesting that a certain 
cell density is a prerequisite for a successful systemic infection. It is possible that once 
icd mutant cells get into the host fish, they are unable to grow to a high enough density 
to overwhelm the host innate immune defenses. Thus the host has time to mount an 
effective adaptive immune response.  This raises the question as to whether icd 
mutant growth is restricted in the GI tract of the fish and/or after it penetrates the 
epithelial cell layer and invades the fish host. Our data suggest that the growth 
restrictions may be in both environments.  Specifically, the icd mutant cells grew 
with nearly the same doubling time as the M93Sm wild type cells in NSSM, but their 
maximum cell density was only 24% that seen in M93Sm, suggesting that the cells 
may not reach a critical density necessary for successful invasion of the host.  
However, we also injected fish with potentially lethal doses of the icd mutant, but all 
injected fish survived (unlike fish IP injected with M93Sm).  This result suggests that 
even if icd mutant cells penetrate the epithelial layer and enter the fish host, they are 
unable to grow to a high enough density to overwhelm the host immune response. 
All mutants constructed in this study exhibited the same or higher levels of 
hemolysin gene expression and higher hemolytic activity than M93Sm (Fig 4A and 
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4B), ruling out the possibility that the attenuated virulence of the icd mutant is due to 
the lack of hemolytic activity. Additionally, we suggest that the presence of secreted 
hemolysins will act to further stimulate the inflammatory response (31) and are likely 
to serve as antigens to elicit immunity against themselves, which is an advantage of 
this TCA cycle mutation approach over constructing avirulent strains containing 
mutations in specific virulence genes, such as the avirulent rtxA mutant obtained 
previously (14). The increase in expression of vah1-plp gene cluster (for at least the 
sucA and mdh mutants) is correlated to the increase in expression of hlyU, the 
transcriptional activator/antirepressor of the vah1-plp gene cluster (compare Fig 4A 
with Fig 4C). It is unclear how mutations in TCA cycle enzymes trigger increase 
expression of hlyU. 
Immersion is the preferred method for vaccination in the aquaculture 
industry (3, 5, 32). In this study, rainbow trout pre-treated by immersion for 1 h with 
the icd mutant were fully protected from subsequent challenge with virulent wild type 
V. anguillarum M93Sm (Fig 5A). Moreover, since the TCA cycle exists in all aerobic 
organisms, as well as many facultative (like Vibrio) and anaerobic organisms, the 
TCA mutation approach is likely to be an easy method for the construction of 
modified live vaccines against a wide variety of pathogenic bacteria. Although there is 
a residual virulence of the icd mutant, a combination of icd and another TCA cycle 
gene mutation is expected to further attenuate the strain. In Samonella enterica, the 
combination of a sdhCDA deletion and frdABCD deletion resulted in further 
attenuation in virulence than either single gene deletion (19, 20). 
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Cross-serotype protection is also highly preferred in vaccine development. 
Data indicate the injection of icd mutant that derived from M93Sm (serotype O2a) had 
elicited cross-serotype immunity against the subsequent challenge of NB10 (serotype 
O1), demonstrating the potential of the TCA cycle mutation approach (Fig 5B). 
Although the administration of icd mutant by immersion didn’t show statistically 
significant protection against NB10 in this study, it should be noted that there were 
only three fish tested. More repeats need to be done to make a more solid conclusion.  
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Table 1. Bacterial strains and plasmids used in this study. 
Strain or 
plasmid Description Reference 
V. 
anguillarum 
strains 
    
M93Sm Spontaneous Smr mutant of M93 (serotype O2a) (33) 
NB10 Clinical isolate from the Sea of Bothnia (serotype O1) (34) 
XM420 Smr Cmr ; icd insertional mutant This study 
XM440 Smr Cmr ; sucA insertional mutant This study 
XM450 Smr Cmr ; sucC insertional mutant This study 
XM460 Smr Cmr ; sdhC insertional mutant This study 
XM470 Smr Cmr ; fumA insertional mutant This study 
XM410 Smr Cmr ; mdh insertional mutant This study 
XM430 Smr Cmr ; cra insertional mutant This study 
E. coli strains   
Sm10 thi thr leu tonA lacY supE 
recA RP4-2-Tc::Mu::Km (λ pir) (35) 
S100 Kmr; Sm10 containing plasmid pNQ705-1 This study 
Q420 Kmr Cmr; Sm10 containing plasmid pNQ706-icd This study 
Q440 Km
r
 Cmr; Sm10 containing plasmid 
pNQ708-sucA This study 
Q450 Km
r
 Cmr; Sm10 containing plasmid 
pNQ709-sucC This study 
Q460 Km
r
 Cmr; Sm10 containing plasmid 
pNQ710-sdhC This study 
Q470 Km
r
 Cmr; Sm10 containing plasmid 
pNQ711-fumA This study 
Q410 Km
r
 Cmr; Sm10 containing plasmid 
pNQ705-mdh This study 
201 
Q430 Kmr Cmr; Sm10 containing plasmid pNQ707-cra This study 
Plasmid   
pNQ705-1 Cmr; suicide vector with R6K origin (36) 
pNQ705-icd  Cmr; For icd insertional mutant This study 
pNQ705-sucA Cmr; For sucA insertional mutant This study 
pNQ705-sucC Cmr; For sucC insertional mutant This study 
pNQ705-sdhC Cmr; For sdhC insertional mutant This study 
pNQ705-fumA Cmr; For fumA insertional mutant This study 
pNQ705-mdh Cmr; For mdh insertional mutant This study 
pNQ705-cra Cmr; For cra insertional mutant This study 
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Table 2. Primers used in this study. 
Primer 
Sequence (5'to3', underlined 
sequences are designed 
restriction sites) 
Description Reference 
pr31 GGTGAGCTCTATTCTTTATTGCCGATTATC 
For icd insertional 
mutant, forward, SacI This study 
pr32 AAATCTAGAGTAAGTCGCTTTAATCGCTTC 
For icd insertional 
mutant, reverse, XbaI This study 
pr50 AAAGAGCTCGTGATCCAGATGTCGATGCTA 
For sucA insertional 
mutant, forward, SacI This study 
pr51 GGTTCTAGAGTTCAGTGTCGATAATGTGCA 
For sucA insertional 
mutant, reverse, XbaI This study 
pr52 AAAGAGCTCGGTCGGATTAGTACAGCGAAG 
For sucC insertional 
mutant, forward, SacI This study 
pr53 GGTTCTAGACTTTTTCAATTTCCACGCCGC 
For sucC insertional 
mutant, reverse, XbaI This study 
pr54 AAAGAGCTCATGTTCGTTGCGGTCGGAATT 
For sdhC insertional 
mutant, forward, SacI This study 
pr55 GGTTCTAGATCCAACTCTTCAAAGTGGCCC 
For sdhC insertional 
mutant, reverse, XbaI This study 
pr56 GGTGAGCTCTCCTTGCACCATATTGATATG 
For fumA insertional 
mutant, forward, SacI  This study 
pr57 GGGTCTAGAAGGCTTATCATCGAGAAGAGAG 
For fumA insertional 
mutant, reverse, XbaI This study 
pr29 GGTGAGCTCATGCCAGCGTTAACATTAAAC 
For mdh insertional 
mutant, forward, SacI This study 
pr30 AAATCTAGAGCTGTATGACATCGCACCGGT 
For mdh insertional 
mutant, reverse, XbaI This study 
pr33 AAAGAGCTCGCGGCGTGAGACTAAGGCATC 
For cra insertional 
mutant, forward, SacI This study 
pr34 AAATCTAGACAATGGCAAAGCGCAGAAGTA 
For cra insertional 
mutant, reverse, XbaI This study 
203 
F vah1 
RT 
(BF)  
GTTTGGTATGGAACACCGCT
CAAG 
For vah1 qRT-PCR, 
forward This study 
R vah1 
RT 
(BF) 
GGCTCAACCTCTCCTTGTAAC
CAA 
For vah1 qRT-PCR, 
reverse 
This study 
plpF RT CAGACGACCACCAGTAACCACTAA 
For plp qRT-PCR, 
forward (16) 
plpR 
RT 
GCAATCATGATGACCCAGCA
ACAG 
For plp qRT-PCR, 
reverse 
(16) 
Pm111 GGAAATTATTCCGCCGACGATGGA 
For rtxA qRT-PCR, 
forward (14) 
Pm112 GCCGATACCGTATCGTTACCTGAA 
For rtxA qRT-PCR, 
reverse 
(14) 
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Table 3. Gene identification in V. anguillarum 
Gene or 
operon Product 
Presence in V. 
anguillarum 
M93Sm draft 
genome  
Locus tag in V. 
anguillarum 775 
genome  
gltA Type II citrate synthase Yes VAA_03416 
icd Isocitrate dehydrogenase Yes VAA_02190 
sucAB 
2-oxoglutarate 
dehydrogenase 
(E1 component, E2 
component) 
Yes VAA_03410, VAA_03409 
sucCD 
Succinyl-CoA synthetase 
(beta subunit, alpha 
subunit) 
Yes VAA_03408, VAA_03407 
sdhCDAB 
Succinate dehydrogenase 
(cytochrome b556 subunit, 
membrane anchor subunit, 
flavoprotein subunit, 
iron-sulfur protein) 
Yes 
VAA_03415, 
VAA_03414, 
VAA_03413, 
VAA_03412, 
fumAC Aerobic fumarate hydratase (class I, class II) 
fumA: Yes; 
fumC: not found 
fumA: 
VAA_01430; 
fumC: not found 
fumB Anaerobic fumarate hydratase (class I) Not found Not found 
mdh Malate dehydrogenase Yes VAA_01685 
cra Fructose repressor protein Yes VAA_01008 
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Figure 1. Glycolysis pathway, gluconeogenic pathway, TCA cycle and metabolism of 
fructose as identified from the sequenced genomes of V. anguillarum 775 and 
M93Sm. The arrows indicate the physiological directions of the reactions. The gene 
symbols of the enzyme for each reaction are listed beside the reaction. Boxed genes 
indicate the mutants that were created (Table 1). 
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Figure 2. Survival percentage of rainbow trout IP injected with various V. 
anguillarum strains at a dosage of A) 2 × 105 CFU/fish and B) 4 × 105 CFU/fish. Five 
fish were infected with each strain. C) Immersion infection survival of fish infected 
with M93Sm, icd mutant, or mock infected. *Statistically significant difference 
compared to M93Sm. 
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Figure 3. Growth profiles of V. anguillarum strains. A) Growth curves of various V. 
anguillarum strains in LB20. B) Generation time of various V. anguillarum strains in 
LB20 grown in LB20. C) Growth curves of V. anguillarum wild type and icd mutant 
in NSSM. The data presented are from a representative experiment of two independent 
experiments. 
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Figure 4. qRT-PCR analysis. A) Real time qRT-PCR analysis of expression of rtxA, 
plp and vah1 in various V. anguillarum strains grown in LB20 in logarithmic (log) 
phase. B) Hemolytic activity of various V. anguillarum strains grown on fish blood 
agar. C) Real time qRT-PCR analysis of expression of hlyU and hns in various V. 
anguillarum strains grown in LB20 in log phase. *Statistically significantly higher 
than M93Sm. 
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Figure 5. Fish infection experiment. A) Survival percentage of untreated or treated 
rainbow trout immersed in V. anguillarum M93Sm (4 × 105 CFU ml-1). Five fish were 
used for each group. B) Survival percentage of untreated or treated rainbow trout 
immersed in V. anguillarum NB10Sm (4 × 105 CFU ml-1). 3~5 fish were used for each 
group. *Statistically significant difference compared to untreated fish. 
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Table S1. Generation time of various V. anguillarum strains in 3M-Glucose. 
Strain Generation Time (min) 
M93sm 78 (±5) 
 XM420 (icd) no growth 
 XM440 (sucA) no growth 
 XM450 (sucC) 76 (±12) 
 XM460 (sdhC) 78 (±10) 
 XM470 (fumA) 104 (±9) 
 XM410 (mdh) 77 (±10) 
 XM430 (cra) 84 (±2) 
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Figure S1. Cell density determined by viable count vs. OD600 of various V. 
anguillarum strains. The line indicates linear regression. 
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Figure S2. Supplement data for fish infection assay. A) Survival curve of V. 
anguillarum M93sm starved in water with various NaCl concentrations. B) Survival 
percentage of rainbow trout vs. V. anguillarum dosage (in CFU ml-1) in immersion 
infection experiment. The line indicates logarithmic regression. 
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